Sentence,class,file
"http://dx.doi.org/10.1038/   mp.2010.120  , 21079608  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.jad.2011.10.038  , 22134041  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1038/87865  , 11329053  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1097/YCT.0b013e3181a95da8  , 20190603  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/0028-3932(71)   90067-4  , 5146491  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"British Medical Bulletin 101, 127– 45. http://dx.doi.org/10.1093/bmb/lds004  , 22334281  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1177/0269881112450779  , 22767373  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.pscychresns.2011.10.004  , 22867951  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
http://dx.doi.org/10.1016/j.paid.,OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1016/j.pscychresns.2013.09.004  , 24090511  .",OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/10.1006/nimg.2001.0978  , 11771995  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
"http://dx.doi.org/   10.1192/bjp.bp.106.032201  , 17766761  .",Non-OADS,/arxiv_data1/oa_pdf/c3/45/main.PMC4081974.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/9a/main.PMC4081977.pdf
"The sinus endoscopy highlighted a foreign body at the bottom of the sinus, which led toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.05.003 2211-7539/ &2014 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.",Non-OADS,/arxiv_data1/oa_pdf/33/9a/main.PMC4081977.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/9a/main.PMC4081977.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/8b/main.PMC4081978.pdf
The mother was healthy and indicated that she did not noticed anything different in her daughter duringContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.06.001 2211-7539/ &2014 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/94/8b/main.PMC4081978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/8b/main.PMC4081978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.nicl.2014.05.0182213-1582/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
Structural parcellation Cortical reconstruction and volumetric segmentation were performed using the MPRAGE images with the Freesurfer image analysis suite (http://surfer.nmr.mgh.harvard.edu ).,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"Constrained spherical deconvolution ( Tournier et al., 2007, 2012 ) (http://nitrc.org/projects/mrtrix ) was employed to estimate the ﬁbre orientation distribution for tractography at a maximum harmonicorder of 8.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"Statistical analysis Statistical analysis of the brain network was performed using the NBS toolbox for Matlab ( https://sites.google.com/site/bctnet/comparison/nbs ; (Zalesky et al., 2010 )).",OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.ridd.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"13, 68. http://dx.doi.org/10.1186/1471-2377-13-68 .",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"512 (1), 53 –58.http://dx.doi.org/10.1016/j.neulet.2012.",OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1111/dmcn.1245 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.3174/ajnr.A0676 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.09.015 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.cortex.2008.05.002 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2012.06.081 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1111/j.1469-8749.2007.00144.x .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/ mrm.21890 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1093/cercor/bhh186 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/ 10.1016/j.bbr.2011.07.010 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.22786 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.05.018 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.01.020 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"http://dx.doi.org/10.1007/s00247-012-2427- .Pannek, K., Raffelt, D., Bell, C., Mathias, J.L., Rose, S.E., 2012b.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.07.022 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.1030 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1007/s00234-011-0996-2 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.10677 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1089/brain.2011.0034 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1111/j.1469- 8749.2012.04332.x .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.03.032 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1109/42.668698 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"420 (1), 34 –38.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"451 (1), 94 –97.http://dx.doi.org/10.1016/j.neulet.2008.12.033 .",OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1093/brain/ awh600 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2007.02.016 .,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
"22 (1), 53 –66.http://dx.doi.org/10.1002/ ima.22005 .",Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1007/s00234-010-0703-8 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1007/s00429-013-0656- .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1002/mrm.2196 .,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1148/radiol.,Non-OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2010.06.041 .92 K. Pannek et al.,OADS,/arxiv_data1/oa_pdf/ae/0c/main.PMC4081979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.0012213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
"SIENAX, which is part of FMRIB's Software Library (FSL, version 5.0.4; http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/ ) was used to calculate whole brain volume as well as total grey matter volume.",OADS,/arxiv_data1/oa_pdf/dd/a3/main.PMC4081980.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.0032213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
Motion and eddy current correction was performed by co-registering eachvolume to the ﬁrst b0 volume using an af ﬁne registration algorithm in FSL ( http://www.fmrib.ox.ac.uk/fsl ).,OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"Diffusion Tensor Images (DTIs) were estimated from the Diffusion-Weighted Images in Slicer v2.8 (http://www.slicer.org ), on the basis of a weighted-least-squares estimation.",OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"De ﬁnition of the six limbic regions-of-interest using FreeSurfer FreeSurfer (v4.2.0; http://surfer.nmr.mgh.harvard.edu/ ) was used to parcellate each participant's T1-weighted MRI into 34 neocortical regions ( Fischl et al., 2004 ).",OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"Tractography and extraction of the CB sub-connections Each participant's DTI underwent the following processing protocols in Slicer (v.2.8; http://www.slicer.org/ ): 1.Whole-brain tractography: Deterministic (streamline) tractography was performed from every putatively white matter voxel within each participant's Fractional Anisotropy (FA) image ( Whitford et al., 2011).",OADS,/arxiv_data1/oa_pdf/ab/c8/main.PMC4081981.pdf
"Unfortunately, his disease progressed rapidly despite treatment, resulting in death from disease-related complications seven months after diagnosis.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.04.004 2213-0489/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/17/c4/main.PMC4081982.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/c4/main.PMC4081982.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/0d/main.PMC4081983.pdf
"Chemotherapy for AML was withheld due to the severe pancytopenia, hypocellularity, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.04.002 2213-0489/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/62/0d/main.PMC4081983.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/0d/main.PMC4081983.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e4/c2/srep05580.PMC4082104.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5580 | DOI: 10.1038/srep05580 9",Non-OADS,/arxiv_data1/oa_pdf/e4/c2/srep05580.PMC4082104.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/78/ddu111.PMC4082364.pdf
"Thesoftware package LIMMA (R-library, bioconductor, http://www.R-project.org) was used for statistical analysis and thesearch for differentially expressed genes.",OADS,/arxiv_data1/oa_pdf/d0/78/ddu111.PMC4082364.pdf
Microarray data analysis Microarray data analysis was performed using the MetaCore software suite (http://thomsonreuters.com/metacore/) to iden-tify biological processes associated with gene expression pro-ﬁles.,OADS,/arxiv_data1/oa_pdf/d0/78/ddu111.PMC4082364.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/de/ddu115.PMC4082365.pdf
"Neither this variant, nor the 5 bp deletionwere present in the Exome Variant Server, NHLBI GO ExomeSequencing Project, Seattle, WA, USA (http://eversusgs.washington.edu/EVS/) (accessed Dec 2013) or in 1000 Genomes(http://browser.1000genomes.org/index.html).",OADS,/arxiv_data1/oa_pdf/65/de/ddu115.PMC4082365.pdf
Homozygosity analysis was performedusing dCHIP (http://biosun1.harvard.edu/complab/dchip; 21) and HomozygosityMapper (http://www.homozygositymapper.,OADS,/arxiv_data1/oa_pdf/65/de/ddu115.PMC4082365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/c6/ddu118.PMC4082368.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2014, 9: 24899 - http://dx.doi.org/10.3402/ljm.v9.24899 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/bb/8f/LJM-9-24899.PMC4082493.pdf
"Calciﬁed IUCD after removal.Awatuf Elshirif 2 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 24899 - http://dx.doi.org/10.3402/ljm.v9.24899",Non-OADS,/arxiv_data1/oa_pdf/bb/8f/LJM-9-24899.PMC4082493.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/f8/ncomms5102.PMC4082631.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Felis, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/53/f8/ncomms5102.PMC4082631.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5102 ARTICLE NATURE COMMUNICATIONS | 5:4102 | DOI: 10.1038/ncomms5102 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/53/f8/ncomms5102.PMC4082631.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/f4/ncomms5128.PMC4082632.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhu, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/f4/ncomms5128.PMC4082632.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5128 ARTICLE NATURE COMMUNICATIONS | 5:4128 | DOI: 10.1038/ncomms5128 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d5/f4/ncomms5128.PMC4082632.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5077 8 NATURE COMMUNICATIONS | 5:4077 | DOI: 10.1038/ncomms5077 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/07/a9/ncomms5077.PMC4082636.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tanentzap, A. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/07/a9/ncomms5077.PMC4082636.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5077 ARTICLE NATURE COMMUNICATIONS | 5:4077 | DOI: 10.1038/ncomms5077 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/07/a9/ncomms5077.PMC4082636.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/91/ncomms5051.PMC4082638.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Li, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/fd/91/ncomms5051.PMC4082638.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Timurdogan, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/48/08/ncomms5008.PMC4082639.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bb/ab/ncomms5109.PMC4082640.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Melinte, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/bb/ab/ncomms5109.PMC4082640.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5109 8 NATURE COMMUNICATIONS | 5:4109 | DOI: 10.1038/ncomms5109 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bb/ab/ncomms5109.PMC4082640.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: F.K.,Non-OADS,/arxiv_data1/oa_pdf/18/73/ncomms5101.PMC4082641.pdf
"All other authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Westermeier, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/18/73/ncomms5101.PMC4082641.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/45/ncomms5153.PMC4082642.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Suzuki, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/45/ncomms5153.PMC4082642.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5153 ARTICLE NATURE COMMUNICATIONS | 5:4153 | DOI: 10.1038/ncomms5153 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c2/45/ncomms5153.PMC4082642.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Okaba, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/07/a6/ncomms5096.PMC4082643.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5096 ARTICLE NATURE COMMUNICATIONS | 5:4096 | DOI: 10.1038/ncomms5096 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/07/a6/ncomms5096.PMC4082643.pdf
"21. van Dolder BD, van Geest-Daalderop JJH, van’t Land RP, Levi MM, Piersma-Wichers G. De kunst van het doseren: Richtlijn, leidraad en informatie voor het doseren van vitamine K-antagonisten.Available from http://www.fnt.nl/ .",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/12325_2014_Article_124.PMC4082646.pdf
Available from http://www.nice.org.uk/nicemedia/live/14091/ 66498/66498.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ac/a7/12325_2014_Article_124.PMC4082646.pdf
National Comprehensive Cancer Network Inc (2014) NCCN practice guidelines in oncology: cancer and chemotherapy-induced anemia - v.2.http://www.nccn.org/professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/fd/e0/520_2014_Article_2189.PMC4082648.pdf
available at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/molonc http://dx.doi.org/10.1016/j.molonc.2014.03.009 1574-7891/$ esee front matter ª2014 Federation of European Biochemical Societies.,Non-OADS,/arxiv_data1/oa_pdf/5f/fb/MOL2-8-0912.PMC4082767.pdf
"This would be in-line with data from the FANTOM5 ZENBU gLyphsGenome Browser ( http://fantom.gsc.rik en.jp/5/suppl/Kana- mori-Katayama_et_al_2011 ), indicating a number of tran- scription initiation sites at the 5 0end of the GLI1 gene both in the sense and antisense orientation, with somehaving the potential for transcriptional overlap(Supplementary Figure 2 ).",Non-OADS,/arxiv_data1/oa_pdf/5f/fb/MOL2-8-0912.PMC4082767.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2014.03.009 .Figure 7 eSchematic representation of the proposed mechanism for the interplay of the GLI1AS and GLI1 regulatory effects.,OADS,/arxiv_data1/oa_pdf/5f/fb/MOL2-8-0912.PMC4082767.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2013-203759).,Non-OADS,/arxiv_data1/oa_pdf/5a/aa/annrheumdis-2013-203759.PMC4083014.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Manzi S, Selzer F, Sutton-Tyrrell K, et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/aa/annrheumdis-2013-203759.PMC4083014.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:163-170 Interrelationships between the Retinal Neuroglia and  Vasculature in Diabetes Timothy S. Kern1,2 1Department of Medicine, Case Western Reserve University Medicine, Cleveland, OH; 2Department of Medicine, Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH, USA For years, diabetic retinopathy has been defined based on vascular lesions, and neural abnormalities were not regarded as impor - tant.",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"Surprisingly, dark adaptation did not increase retinal blood Review Complications http://dx.doi.org/10.4093/dmj.2014.38.3.163 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
164Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgflow in Sprague-Dawley rats.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
165Neurovascular interactions in diabetic retinopathy Diabetes Metab J 2014;38:163-170 http://e-dmj.orgarteries and veins in insulin-dependent diabetic patients [23]  and in healthy subjects made experimentally hyperglycemic  [24] have shown significant reduction compared to controls.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
166Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgare altered in diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
167Neurovascular interactions in diabetic retinopathy Diabetes Metab J 2014;38:163-170 http://e-dmj.orgtent with a role of photoreceptors in the development of dia - betic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"168Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgCONFLICTS OF INTEREST  This work was funded by PHS grants EY00300 and EY022938,  and by a Merit grant from the Veteran’s Administration.",Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
169Neurovascular interactions in diabetic retinopathy Diabetes Metab J 2014;38:163-170 http://e-dmj.orgcontrolled patients with type 1 diabetes without retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
170Kern TS Diabetes Metab J 2014;38:163-170 http://e-dmj.orgfects the course of early diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/46/88/dmj-38-163.PMC4083021.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:171-180 Ubiquitin Ligases in Cholesterol Metabolism Wei Jiang, Bao-Liang Song Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China To maintain cholesterol homeostasis, the processes of cholesterol metabolism are regulated at multiple levels including transcrip - tion, translation, and enzymatic activity.",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"), Review Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.3.171 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orga coupling of ubiquitin to endoplasmic reticulum (ER) degra - dation (Cue) domain (456-497 aa.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
173E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orgtry [4].,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"175E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.org In addition to HMGCR, Insig-1, Insig-2, as well as ApoB- 100, a series of other proteins are identified as substrates of  gp78.",Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.org100 aa.),Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
177E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.orgtion of LXR can decrease the abundance of LDLR without  changing its mRNA level and subsequently inhibited uptake of  LDL in different cells [52].,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orgsis: sterol-accelerated ubiquitination and degradation of HMG  CoA reductase.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
179E3s and cholesterol metabolism Diabetes Metab J 2014;38:171-180 http://e-dmj.org34.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
Diabetes Metab J 2014;38:171-180 http://e-dmj.orgnists.,Non-OADS,/arxiv_data1/oa_pdf/82/23/dmj-38-171.PMC4083022.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:181-186 The Role of Pyruvate Dehydrogenase Kinase in  Diabetes and Obesity In-Kyu Lee Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea The pyruvate dehydrogenase complex (PDC) is an emerging target for the treatment of metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"Four PDK isoenzymes (PDK1,  2, 3, and 4) and two PDP isoenzymes (PDP1 and PDP2) are Sulwon Lecture 2013 Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.3.181 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"182Lee IK Diabetes Metab J 2014;38:181-186 http://e-dmj.orginvolved in this phosphorylation [6,7].",Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
183The role of PDK in diabetes and obesity Diabetes Metab J 2014;38:181-186 http://e-dmj.orga disruption in the suppression of PDK4 by insulin.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
184Lee IK Diabetes Metab J 2014;38:181-186 http://e-dmj.orgpatients with atherosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
185The role of PDK in diabetes and obesity Diabetes Metab J 2014;38:181-186 http://e-dmj.orggene induction by dexamethasone through inactivation of  FOXO transcription factors.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
186Lee IK Diabetes Metab J 2014;38:181-186 http://e-dmj.orgCharcot-Marie-Tooth disease (CMTX6) is caused by muta - tions in the pyruvate dehydrogenase kinase isoenzyme 3  (PDK3) gene.,Non-OADS,/arxiv_data1/oa_pdf/ac/80/dmj-38-181.PMC4083023.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:187-193 Journal Metrics-Based Position of Diabetes &  Metabolism Journal  after the Change of Its Text  Language to English Sun Huh Department of Parasitology and Institute of Medical Education, Hallym University College of Medicine, Chuncheon, Korea After changing its language from Korean or English to English only in 2010, the journal metrics of Diabetes & Metabolism Jour - nal (DMJ) were analyzed to assess whether this change in the journal policy was successful.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"In  2011, the journal underwent another change in title to Diabe - tes & Metabolism Journal (DMJ) to broaden its scope to these Perspective Perspective   http://dx.doi.org/10.4093/dmj.2014.38.3.187 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
188Huh S Diabetes Metab J 2014;38:187-193 http://e-dmj.orgworldwide problems.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
189Position of Diabetes & Metabolism Journal  based on journal metrics Diabetes Metab J 2014;38:187-193 http://e-dmj.orgnals included in the Web of Science are presented in Figs.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
190Huh S Diabetes Metab J 2014;38:187-193 http://e-dmj.orgreports (36.5%) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
191Position of Diabetes & Metabolism Journal  based on journal metrics Diabetes Metab J 2014;38:187-193 http://e-dmj.orgJCR 2012.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"192Huh S Diabetes Metab J 2014;38:187-193 http://e-dmj.orgbeen cited by Korean researchers for a long time, its citation by  researchers throughout the world has only recently increased.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Available  from: http://pubmedcentral.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Available from:  http://pubmed.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Available from: http://koreamed.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
Avail - able from: http://komci.org/ (cited 2014 Apr 23).,OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
193Position of Diabetes & Metabolism Journal  based on journal metrics Diabetes Metab J 2014;38:187-193 http://e-dmj.org10.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/dmj-38-187.PMC4083024.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:194-196 It’s Still Not Too Late to Make a Change:   Current Status of Glycemic Control in Korea Sang Y ong Kim Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea Corresponding author: Sang Y ong Kim Department of Endocrinology and Metabolism, Chosun University Hospital,  Chosun University School of Medicine, 365 Pilmun-daero, Dong-gu,  Gwangju 501-717, Korea E-mail: diabetes@chosun.ac.krDiabetes is an important chronic disease causing economic  and social burden around the world.",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"There - fore, it is crucial to devise a plan-of-action to alleviate this situ - ation in one way or another.Editorial Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.3.194 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"195Glycemic control in Korea Diabetes Metab J 2014;38:194-196 http://e-dmj.org In this issue, Jeon et al.",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
196Kim SY Diabetes Metab J 2014;38:194-196 http://e-dmj.orgongoing and upcoming studies will discover valid ways to re - duce diabetic complications.,Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
Available from:  http://kostat.go.kr (updated 2013 Sep 25).,Non-OADS,/arxiv_data1/oa_pdf/41/dd/dmj-38-194.PMC4083025.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:197-203 Current Status of Glycemic Control of Patients with  Diabetes in Korea: The Fifth Korea National Health and  Nutrition Examination Survey Ja Y oung Jeon1, Dae Jung Kim1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Soo Lim3, Sung Hee Choi3, Chul Sik Kim4, Jee Hyun An5,  Nan Hee Kim5, Jong Chul Won6, Jae Hyeon Kim7, Bong-Yun Cha2, Kee-Ho Song8 on behalf of the Taskforce Team of Diabetes  Fact Sheet of the Korean Diabetes Association 1Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, 2Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of   Medicine, Anyang,  5Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul,  6Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul,  7Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 8Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea Background:  The Korea National Health and Nutrition Examination Survey (KNHANES) III (2005) reported that 22.9% of in - dividuals with diabetes have a glycated hemoglobin (HbA1c) <6.5% and that 43.5% have an HbA1c <7%.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
Diabetes is closely related to Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.3.197 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"Diabetes Metab J 2014;38:197-203 http://e-dmj.orgvarious cardiovascular diseases, including coronary arterial  disease, stroke, peripheral arterial disease, and cardiomyopa - thy; these comorbidities occur in 70% to 80% of patients with  type 2 diabetes mellitus, ultimately leading to death [3].",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"199Glycemic control in Korea Diabetes Metab J 2014;38:197-203 http://e-dmj.orgRESULTS  We first observed the baseline characteristics of the 1,341 dia - betic patients.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"Diabetes Metab J 2014;38:197-203 http://e-dmj.orgachieve glycemic control in approximately 50% of patients  reaching their goal of glycemic levels [5,7].",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"201Glycemic control in Korea Diabetes Metab J 2014;38:197-203 http://e-dmj.orgbetes refers to subjects with fasting plasma glucose (FPG) ≥126  mg/dL and/or HbA1c ≥6.5% in the absence of known diabe - tes, the prevalence of newly diagnosed diabetes is 4%.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
Diabetes Metab J 2014;38:197-203 http://e-dmj.org7.0% from 2003 to 2006 and a success rate of 52.5% from 2007  to 2010 [7].,Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"203Glycemic control in Korea Diabetes Metab J 2014;38:197-203 http://e-dmj.orgthe importance of diet and exercise, trains the patients to con - trol their own insulin usage volume and frequency, etc., are es - sential.",Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
Available from:  http://kostat.go.kr (updated 2013 Sep 25).,Non-OADS,/arxiv_data1/oa_pdf/b1/21/dmj-38-197.PMC4083026.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:204-210 Efficacy of the Smartphone-Based Glucose  Management Application Stratified by User Satisfaction Hun-Sung Kim1,2, Wona Choi2, Eun Kyoung Baek2, Yun A Kim2, So Jung Y ang2, In Y oung Choi3, Kun-Ho Y oon1,2,  Jae-Hyoung Cho1,2 1Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul,  2Institute of Catholic Ubiquitous Health Care, The Catholic University of Korea, Seoul,  3Department of Medical Informatics, The Catholic University of Korea College of Medicine, Seoul, Korea Background:  We aimed to assess the efficacy of the smartphone-based health application for glucose control and patient satisfac - tion with the mobile network system used for glucose self-monitoring.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"In addition, it Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.204 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
205Glucose control by smartphone application Diabetes Metab J 2014;38:204-210 http://e-dmj.orgcan also be used for receiving diabetes-related educational  content.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
Diabetes Metab J 2014;38:204-210 http://e-dmj.orgcommunication.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"207Glucose control by smartphone application Diabetes Metab J 2014;38:204-210 http://e-dmj.orgAnalysis of the questionnaire survey Of the 35 users, two patients expressed unchanged or increased  satisfaction and expectations when compared to the pre-use  survey.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
Diabetes Metab J 2014;38:204-210 http://e-dmj.orgimportant tool for blood glucose monitoring.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
209Glucose control by smartphone application Diabetes Metab J 2014;38:204-210 http://e-dmj.orgtion with the medical team.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
Diabetes Metab J 2014;38:204-210 http://e-dmj.orgimprove skilled attendance at delivery in Zanzibar: a cluster- randomised controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/dmj-38-204.PMC4083027.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:211-219 The Effect of DPP-4 Inhibitors on Metabolic Parameters  in Patients with Type 2 Diabetes Eun Y eong Choe1,*, Y ongin Cho1,*, Y ounjeong Choi1, Yujung Yun1, Hye Jin Wang2, Obin Kwon1,3, Byung-Wan Lee1,  Chul Woo Ahn1,4, Bong Soo Cha1,2,4, Hyun Chul Lee1,4, Eun Seok Kang1,2,4 1Division of Endocrinology and Metabolism, Department of Internal Medicine, 2Brain Korea 21 Plus Project for Medical Science, 3Department of  Pharmacology, 4Institute of Endocrine Research, Y onsei University College of Medicine, Seoul, Korea Background:  We evaluated the effects of two dipeptidyl peptidase-4 (DPP-4) inhibitors, sitagliptin and vildagliptin, on metabol - ic parameters in patients with type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"Among these drugs, dipepti - dyl peptidase-4 (DPP-4) inhibitors have been proven effective Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.211 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
Diabetes Metab J 2014;38:211-219 http://e-dmj.orgfor glucose control without inducing hypoglycemia and are  widely used as the primary therapeutic option.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
213Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgstrength of the relationships between the clinical and laborato - ry variables.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
Diabetes Metab J 2014;38:211-219 http://e-dmj.orggroup and 1.5±1.4 mg/L in the vildagliptin group at baseline.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
215Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgtient clinics.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
Diabetes Metab J 2014;38:211-219 http://e-dmj.orgused as an index of glycemic control during intensive diabetes  treatment as a more rapid glycation index than HbA1c for glu - cose control and excursion [27-29].,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
217Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgCONFLICTS OF INTEREST  No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"Diabetes Metab J 2014;38:211-219 http://e-dmj.orgsini A, Paolisso G. Decreased carotid atherosclerotic process by  control of daily acute glucose fluctuations in diabetic patients  treated by DPP-IV inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
219Effect of DPP-4 inhibitors Diabetes Metab J 2014;38:211-219 http://e-dmj.orgSupplementary  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/eb/dmj-38-211.PMC4083028.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:220-229 Factors Associated with Health-Related Quality of Life  among Saudi Patients with Type 2 Diabetes Mellitus:   A Cross-Sectional Survey Ayman A. Al Hayek, Asirvatham A. Robert, Abdulghani Al Saeed, Aus A. Alzaid, Fahad S. Al Sabaan Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia Background:  Diabetes mellitus (DM) is associated with high mortality, morbidity, poor general health, and loss of health-related  quality of life (HRQOL).",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"The chronic  consumption of high energy, high fat diets, and low levels of Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.220 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
221Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgphysical activity lead to changes in energy balance with con - servation of energy stored as fat.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.organd seven for depression (HADS-D).,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
223Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgOne hundred and seventy-eight were males (62.9%) and 105  were females (37.1%).,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.orgcomplication of DM ( P<0.05) compared to ≤5 years duration  of DM and DM patients without any complication respective - ly.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"225Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgfor longer duration (>15 years) had significantly higher risk of  subscale, physical functioning, role of physical health, role  emotional, general health, and health change.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.orgglycemic control is reported among more than half of Saudi  populations with T2DM [17].,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"227Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgmization of cardiovascular risk, avoidance of drugs that can  aggravate glucose or lipid metabolism, and screening for dia - betes complications are essential for the management of pa - tients with T2DM.",Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
Diabetes Metab J 2014;38:220-229 http://e-dmj.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
229Diabetes and health-related quality of life Diabetes Metab J 2014;38:220-229 http://e-dmj.orgQuality of life and associated characteristics in a large national  sample of adults with diabetes.,Non-OADS,/arxiv_data1/oa_pdf/9e/2e/dmj-38-220.PMC4083029.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:230-239 Current Status of Prescription in Type 2 Diabetic  Patients from General Hospitals in Busan Ji Hye Suk1, Chang Won Lee2, Sung Pyo Son3, Min Cheol Kim4, Jun Hyeob Ahn5, Kwang Jae Lee6, Ja Y oung Park2,  Sun Hye Shin3, Min Jeong Kwon7, Sang Soo Kim8, Bo Hyun Kim8, Soon Hee Lee7, Jeong Hyun Park7, In Joo Kim8, for the  Relationship between Cardiovascular Disease and Brachial-Ankle Pulse Wave Velocity (baPWV) in Patients with Type 2  Diabetes (REBOUND) Study Group 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Woori Medical Clinic, Busan 2Division of Endocrinology and Metabolism, Department of Internal Medicine, Busan St. Mary’s Hospital, Busan, 3Division of Endocrinology and Metabolism, Department of Internal Medicine, Bong Seng Memorial Hospital, Busan, 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Ilsin Christian Hospital, Busan, 5Division of Endocrinology and Metabolism, Department of Internal Medicine, Moonhwa Hospital, Busan, 6Division of Endocrinology and Metabolism, Department of Internal Medicine, Daedong Hospital, Busan, 7Division of Endocrinology and Metabolism, Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine,    Busan, 8Division of Endocrinology and Metabolism, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of   Medicine, Busan, Korea Background:  Data regarding the prescription status of individuals with diabetes are limited.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Despite  taking into account the regional difference or the change of Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.3.230 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"231Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgstandard diagnostic criteria of diabetes, the prevalence in - creased by ~5-fold during the previous 30 years.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Diabetes Metab J 2014;38:230-239 http://e-dmj.org‘missing value’ [7].,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
233Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgRESULTS Clinical and laboratory characteristics of the study  population  Table 1 shows the basal characteristic of the study population.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"Diabetes Metab J 2014;38:230-239 http://e-dmj.orgfrequently (43%), followed by Met+dipeptidyl peptidase 4 in - hibitors (DPP4I), Met+TZD, SU+AGI, and SU+TZD combi - nation, which comprised 24%, 14%, 6%, and 5%, respectively  (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"235Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.org Regarding antidyslipidemic therapy, most patients (88%)  were treated with single class, 12% with two classes, and 0.1%  with three classes.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"Diabetes Metab J 2014;38:230-239 http://e-dmj.orglowed by cilostazol, clopidogrel, sarpogrelate, beraprost, and  ticlopidine, which were used by 20%, 12%, 15%, 1.2%, and  0.1%, respectively (Table 8).",Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
237Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgnation.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Diabetes Metab J 2014;38:230-239 http://e-dmj.orgalso believe that an organized and standardized national re - search is required.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
Available from: http://www-project.org  (cited 2007 Dec 5).,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
239Prescription status in type 2 diabetic patients Diabetes Metab J 2014;38:230-239 http://e-dmj.orgtes Registry Group; Royal College of Physicians Edinburgh.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/dmj-38-230.PMC4083030.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:240-241 Association of Vaspin with Metabolic Syndrome:   The Pivotal Role of Insulin Resistance   (Diabetes Metab J 2014;38:143-9) Sung Hee Choi Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College  of Medicine, Seongnam, Korea Corresponding author: Sung Hee Choi Division of Endocrinology and Metabolism, Department of Internal  Medicine, Seoul National University Bundang Hospital, Seoul National  University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 463-707, KoreaDear Editor,  Vaspin is an interesting adipokine, which was isolated from  visceral white adipose tissue of obese, diabetic rat model [1,2].",Non-OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"Of note, despite these differences between two Letter http://dx.doi.org/10.4093/dmj.2014.38.3.240 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"241Vaspin and metabolic syndrome Diabetes Metab J 2014;38:240-241 http://e-dmj.orgethnical groups, hyper-TG and obesity index was a common  metabolic factors, which showed significant correlation with  vaspin levels in both groups.",OADS,/arxiv_data1/oa_pdf/08/53/dmj-38-240.PMC4083031.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:242-243 Association of Vaspin with Metabolic Syndrome:   The Pivotal Role of Insulin Resistance   (Diabetes Metab J 2014;38:143-9) Alireza Esteghamati, Sina Noshad, Mostafa Mousavizadeh, Ali Zandieh, Manouchehr Nakhjavani Endocrinology and Metabolism Research Center, Vali-Asr Hospital, Tehran University of Medical Sciences School of Medicine, Tehran, Iran Corresponding author: Alireza Esteghamati Endocrinology and Metabolism Research Center, Vali-Asr Hospital, Tehran  University of Medical Sciences School of Medicine, P .O.",Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
Response http://dx.doi.org/10.4093/dmj.2014.38.3.242 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
243Vaspin and metabolic syndrome Diabetes Metab J 2014;38:242-243 http://e-dmj.orgCONFLICTS OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/dmj-38-242.PMC4083032.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/02/dmj-38-244.PMC4083033.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:244Erratum http://dx.doi.org/10.4093/dmj.2014.38.3.244 pISSN 2233-6079 · eISSN 2233-6087 Erratum: Corrected Sentence  The Appropriateness of the Length of Insulin  Needles Based on Determination of Skin and  Subcutaneous Fat Thickness in the Abdomen and  Upper Arm in Patients with Type 2 Diabetes Kang Hee Sim1, Moon Sook Hwang2, Sun Y oung Kim1, Hye Mi Lee1, Ji Y eun Chang3, Moon Kyu Lee4 1Department of Nursing, Samsung Medical Center, Seoul, 2Department of Nursing Science, Woo Suk University, Wanju, 3Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, 4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,     Seoul, Korea Diabetes Metab J 2014;38:120-133. http://dx.doi.org/10.4093/dmj.2014.38.2.120 An error was found in the following published article: Sim KH, Hwang MS, Kim SY , Lee HM, Chang JY , Lee MK,  ‘The Appropriateness of the Length of Insulin Needles Based on Determination of Skin and Subcutaneous Fat Thick - ness in the Abdomen and Upper Arm in Patients with Type 2 Diabetes.",Non-OADS,/arxiv_data1/oa_pdf/32/02/dmj-38-244.PMC4083033.pdf
"113 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHEditorial Dendritic cells (DCs) are professional antigen presenting cells, which play a pivotal  role in antigen-specific (Ag-specific) T cell immunity.",Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
"As of 2014, 289 clinical studies of DC-based cancer vaccines are registered and un - der investigation (2014, http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:113-116 http://dx.doi.org/10.7774/cevr.2014.3.2.113 pISSN 2287-3651 • eISSN 2287-366X  Md.",Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed et al • Dendritic cell-based tumor vaccine 114 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.113of 7.1% [4].,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed et al • Dendritic cell-based tumor vaccine 115 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.113systemic antitumor immune responses in tumor bearing mice.,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed http://orcid.org/0000-0002-9601-8031  Yong-Soo Bae http://orcid.org/0000-0002-2233-9449 References 1.,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
Selim Ahmed et al • Dendritic cell-based tumor vaccine 116 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.113cells in patients with metastatic renal cell carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/40/31/cevr-3-113.PMC4083062.pdf
"117 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHSpecial article Introduction Avian influenza is an acute infectious disease that occurs and spreads very fast in poul - try, waterfowls, wild birds, animals, and able to zoonotically be transmitted to humans.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Avian influenza is listed as one of the most dangerous diseases by World Organisation  for Animal Health (OIE; http://www.oie.int/eng/normes/mmanual/A_summry.htm)  that a special attention is needed for control.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:117-127 http://dx.doi.org/10.7774/cevr.2014.3.2.117 pISSN 2287-3651 • eISSN 2287-366X  Thanh Hoa Le, Nga Thi Bich Nguyen Department of Immunology, Institute of  Biotechnology, Vietnam Academy of Science and  Technology, Hanoi, Vietnam Received: April 18, 2014 Revised: May 2, 2014 Accepted: May 11, 2014 Corresponding author: Thanh Hoa Le, DVM, PhD  Department of Immunology, Institute of Biotech - nology, Vietnam Academy of Science and Technol - ogy, 18 Hoang Quoc Viet Rd., Cau Giay, Hanoi,  Vietnam Tel: +84-4-37567297, Fax: +84-4-38363144 E-mail: imibtvn@gmail.com No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 118 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117genomes contain a single-stranded negative RNA ([-]ssRNA)  of 8 segments (polymerase basic 2 [PB2], polymerase basic 1  [PB1], polymerase acid [PA], HA, nucleoprotein [NP], NA,  matrix [M], non-structural polypeptides [NS]) [1,2], encoding  for 15 proteins in overall, including PB2, PB1, PA, HA, NP , NA,  M1, M2, NS1, NS2, and supplementary proteins recently iden - tified with little or unknown functions [3], i.e., PB1-F2 [4], PB1- N40 [5], PA-X [6], PA-N155 and PA-N182 [7].",OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
" Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 119 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117tral source, have since then spread over the world causing  numerous epidemics [3,14,31].",OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 120 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117fication, even within clade 2.3.2.1, there have been novel en - demic, dynamically differentiated variants of a, b, c subgroups,  during 2010-2014 in Vietnam.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
" Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 121 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117vaccines (clade 2.3.4 origin) imported from China were in use  and a national project of testing NIBRG-14 masterseed (rgA/ Vietnam/1194/2004, clade 1, obtained from National Insti - tute for Biological Standards and Control [NIBSC, UK]), was  launched for vaccine production [61,62].",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Due to decline in protection and wide  spread of clade 2.3.2.1c, Re-6 vaccine is planned to import for  use in 2014 [49]; according to the Vietnam authority, Depart - ment of Animal Health, 2014 (http://www.cucthuy.gov.vn/).",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
"Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 122 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117ported in China, South Korea, Japan, Mongolia, Nepal, Laos,  Russia, Bangladesh and Indonesia [3,58,69,70]; and similar to  those of clade 2.3.2 origin, but different from clade 2.3.4 and  clade 1 (and 1.1) (Table 1) [3,42,43].",OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
 Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 123 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117in some provinces of the North of Vietnam.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 124 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117ed poulty in the field.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
 Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 125 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.117ORCID Thanh Hoa Le http://orcid.org/0000-0003-3841-368X References  1.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Avail - able from: http://www.cdc.gov/ﬂu/about/viruses/types.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 126 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.11727.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Available from: http://www.who.int/in - fluenza/vaccines/virus/201402_h5h7h9h10_vaccineviru - supdate.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
Available from:  http://www.rr-asia.oie.int/fileadmin/Regional_Re presen- tation/Programme/H_HPAI/JTF/2012_5th_ExpMeeting/  2-1_Dr_Inui.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
 Thanh Hoa Le et al • Dynamic of H5N1 clades and vaccines in Vietnam 127 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.11752.,OADS,/arxiv_data1/oa_pdf/ea/b7/cevr-3-117.PMC4083063.pdf
128 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction The direct efficacy and effectiveness of the inactivated influenza vaccination among  healthy is relatively well-known.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:128-132 http://dx.doi.org/10.7774/cevr.2014.3.2.128 pISSN 2287-3651 • eISSN 2287-366X  Tae Hyong Kim Division of Infectious Diseases, Department of  Internal Medicine, Soonchunhyang University  College of Medicine, Seoul, Korea Received: December 5, 2013 Revised: January 28, 2014 Accepted: February 5, 2014 Corresponding author: Tae Hyong Kim, MD, PhD Department of Internal Medicine Soonchunhyang  University Hospital, Soonchunhyang University  College of Medicine, 59 Daesagwan-ro, Yongsan- gu, Seoul 140-743, Korea Tel: +82-2-709-9194, Fax: +82-2-709-9083 E-mail: geuncom@schmc.ac.kr  No potential conflict of interest relevant to this  article was reported.The seasonal influenza vaccine programs in many regions aimed to protect most vulnerable  population, but current trivalent influenza vaccine does not provide sufficient effectiveness  among people under high risk for severe outcome of the influenza.",Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
" Tae Hyong Kim • Influenza and vaccine herd effect 129 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.128Failure to Protect Elderly and Chronically Ill  Persons Since the introduction of influenza vaccination after the World  War II, immunization against seasonal influenza was focused  on reducing mortality and morbidity of elderly, chronically ill  persons, pregnant women and young children [5].",Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
Tae Hyong Kim • Influenza and vaccine herd effect 130 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.128nated contacts of vaccine and control cohorts (Table 1).,OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
 Tae Hyong Kim • Influenza and vaccine herd effect 131 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.1282008 [34].,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
ORCID  Tae Hyong Kim http://orcid.org/0000-0003-2920-9038 References   1.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
Available from: http://www.who.int/media - centre/factsheets/fs211/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
Tae Hyong Kim • Influenza and vaccine herd effect 132 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.128Socioeconomic impact of influenza on healthy children  and their families.,Non-OADS,/arxiv_data1/oa_pdf/75/31/cevr-3-128.PMC4083064.pdf
"133 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Influenza A viruses (IAVs) are highly contagious viral pathogens that have been isolat - ed from a wide variety of animals such as birds, humans, pigs, horses, dogs, cats, and  marine mammals [1].",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:133-139 http://dx.doi.org/10.7774/cevr.2014.3.2.133 pISSN 2287-3651 • eISSN 2287-366X  Dong-Hun Lee, Jae-Keun Park,  Chang-Seon Song Avian Disease Laboratory, College of Veterinary  Medicine, Konkuk University, Seoul, Korea Received: February 6, 2014 Revised: March 4, 2014 Accepted: March 4, 2014 Corresponding author: Chang-Seon Song, PhD Avian Disease Laboratory, College of Veterinary  Medicine, Konkuk University, 120 Neungdong-ro,  Gwangjin-gu, Seoul 143-701, Korea Tel: +82-2-450-3712, Fax: +82-2-455-3712  E-mail: songcs@konkuk.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 134 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133Influenza Virus in Animals The IAV genome consists of 8 segments of single-stranded  RNA, each of which encodes a different polypeptide includ - ing 2 surface glycoproteins (hemagglutinin [HA] and neur - aminidase [NA]), nucleoprotein (NP), 3 polymerase proteins  (polymerase basic 2, polymerase basic 1 and polymerase  acidic), 2 matrix proteins (M1 and M2), and 2 nonstructural  proteins (NS1 and NS2) [9].",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
 Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 135 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133Table 1.,Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 136 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133chickens, as a vaccine that can be produced without a purifi - cation process costs less than the highly purified VLP vaccines  reported in other studies.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
" Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 137 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133for the production of influenza VLPs for veterinary use, as in - sect cells can readily co-express multiple proteins and assem - ble them into structurally complex VLPs.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
ORCID  Dong-Hun Lee http://orcid.org/0000-0002-0820-7378 Jae-Keun Park http://orcid.org/0000-0002-3367-1770 Chang-Seon Song http://orcid.org/0000-0002-4158-6402 References 1.,Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 138 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.13311.,Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
" Dong-Hun Lee et al • Influenza virus-like particle vaccines for veterinary use 139 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.133ple baculovirus recombinant coexpressing H5, N3, M1  proteins against a homologous H5N3 low-pathogenicity  avian influenza virus challenge in Muscovy ducks.",Non-OADS,/arxiv_data1/oa_pdf/03/09/cevr-3-133.PMC4083065.pdf
"140 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Influenza A (flu A) viruses belong to the Orthomyxoviridae  family of RNA viruses and  are the causative agent of influenza, a contagious respiratory viral disease of birds and  humans [1].",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:140-148 http://dx.doi.org/10.7774/cevr.2014.3.2.140 pISSN 2287-3651 • eISSN 2287-366X  Philippe Noriel Q. Pascua,   Young Ki Choi Department of Microbiology, College of Medicine  and Medical Research Institute, Chungbuk  National University, Cheongju, Korea Received: February 8, 2014 Revised: March 28, 2014 Accepted: April 2, 2014 Corresponding author: Young Ki Choi, DVM, PhD  Department of Microbiology, College of Medicine  and Medical Research Institute, Chungbuk   National University, 776 Naesudong-ro,  Heungdeok-gu, Cheongju 361-711, Korea Tel: +82-43-261-3384, Fax: +82-43-272-1603 E-mail: choiki55@chungbuk.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
" Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 141 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140Generally, flu A viruses are found in migratory waterfowls,  the principal natural reservoirs [5].",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Sporadic cases of AIV A/H9N2 zoonoses followed  ever since with at least 16 human total infections as shown in  the influenza virus sequence database (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 142 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140Table 1.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
 Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 143 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140ing one fatality.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
"Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 144 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140developing high fever, cough and shortness of breath, but ful - ly recovered upon early medication.",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
" Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 145 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140(e.g., H6, H9, and H10).",Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
ORCID Philippe Noriel Q. Pascua http://orcid.org/0000-0001-6777-2994 Young Ki Choi http://orcid.org/0000-0002-1894-9896 References 1.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 146 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140generation in pigs of influenza A viruses with pandemic  potential.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www.cidrap.umn.edu/news- perspective/2014/01/fatal-h5n1-case-canada-north-amer - icas-first.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
 Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 147 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140of serum samples from humans exposed to avian H7 in - fluenza viruses in Italy between 1999 and 2003.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www1.paho.org/English/AD/ DPC/CD/eid-eer-07-may-2004.htm.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from: http://www.jx - wst.gov.cn/gzdt/201402/t20140213_308109.htm.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Philippe Noriel Q. Pascua et al • Direct avian-to-human avian influenza virus transmissions and vaccine development 148 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.140and pathology of human-isolated H7N9 influenza virus in  ferrets and pigs.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
Available from:  http://apps.who.int/gb/pip/pdf_files/pandemic-influen - za-preparedness-en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/cd/cevr-3-140.PMC4083066.pdf
"149 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Vaccination is one of the great medical success stories, utilizing immune system.",Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:149-154 http://dx.doi.org/10.7774/cevr.2014.3.2.149 pISSN 2287-3651 • eISSN 2287-366X  Chae Gyu Park Laboratory of Immunology, Severance Biomedical  Science Institute, Brain 21 PLUS project for  Medical Science, Yonsei University College of  Medicine, Seoul, Korea Received: February 8, 2014 Revised: March 26, 2014 Accepted: March 30, 2014 Corresponding author: Chae Gyu Park, PhD Laboratory of Immunology, Severance Biomedi - cal Science Institute, Brain 21 PLUS project for  Medical Science, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul  120-752, Korea Tel: +82-2-2228-0795, Fax: +82-2-2227-8129  E-mail: ChaeGyu@yuhs.ac  No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
Chae Gyu Park • Dendritic cell targeted vaccine 150 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149Dendritic Cells DCs are specialized populations of leukocytes essential for  controlling the immune system to tolerate or react properly  against a vast number of different challenges it encounters.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
 Chae Gyu Park • Dendritic cell targeted vaccine 151 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149in vivo  actively establish T cell tolerance by presenting anti - gens from self and environment during the steady state.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
Chae Gyu Park • Dendritic cell targeted vaccine 152 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149Fig.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
" Chae Gyu Park • Dendritic cell targeted vaccine 153 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149heavily on antibody response, the vaccine protein targeted to  DCIR2, compared to CD205, on DCs in vivo  induced higher  antibody titers and thus achieved better protection [20].",Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
ORCID  Chae Gyu Park http://orcid.org/0000-0003-1906-1308 References 1.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
Chae Gyu Park • Dendritic cell targeted vaccine 154 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.149senzweig MC.,Non-OADS,/arxiv_data1/oa_pdf/94/bb/cevr-3-149.PMC4083067.pdf
155 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Tuberculosis (TB) remains a worldwide public health problem.,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:155-167 http://dx.doi.org/10.7774/cevr.2014.3.2.155 pISSN 2287-3651 • eISSN 2287-366X  Jae-Min Yuk, Eun-Kyeong Jo Department of Microbiology and Infection  Signaling Network Research Center, Chungnam  National University School of Medicine, Daejeon,  Korea  Received: March 3, 2014 Revised: April 1, 2014 Accepted: April 7, 2014 Corresponding author: Eun-Kyeong Jo, MD, PhD  Department of Microbiology and Infection   Signaling Network Research Center, Chungnam  National University College of Medicine, 266  Munhwa-ro, Jung-gu, Daejeon 301-747, Korea Tel: +82-42-580-8243, Fax: +82-42-585-3686 E-mail: hayoungj@cnu.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 156 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155tracellular trafficking is a fundamental obstacle in the design  and development of a novel vaccine [9].,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
" Jae-Min Yuk et al • Host immune responses and TB vaccine development 157 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155actions during TB infection [35,36].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 158 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155pathway in improving the effects of a mucosal vaccine against  TB [59].,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
" Jae-Min Yuk et al • Host immune responses and TB vaccine development 159 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155Antigen 85 complex  The antigen 85 (Ag85) complex comprises the mature secre - tory proteins of Mtb and BCG, and is encoded by three sepa - rate genes on the mycobacterial genome; it consists of three  related antigens, Ag85A (32 kDa), Ag85B (30 kDa), and Ag85C  (32.5 kDa) [83,84].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"Jae-Min Yuk et al • Host immune responses and TB vaccine development 160 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155fusion-protein incorporating ESAT-6, Ag85B, combined with  Rv2660c, conferred protective immunity, promoted CD4+ T  cell responses, and controlled reactivation when administered  post-exposure in mouse models of latent TB [115].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
" Jae-Min Yuk et al • Host immune responses and TB vaccine development 161 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155oxal detoxification pathway, induced DC maturation and en - hanced cytokine generation and polarization of Th1 respons - es [125].",OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"Jae-Min Yuk et al • Host immune responses and TB vaccine development 162 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155improve vaccine efficacy based on the safety, tolerance, and  immunogenicity.",Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
ORCID  Jae-Min Yuk http://orcid.org/0000-0002-0630-9194  Eun-Kyeong Jo http://orcid.org/0000-0002-9623-9037  References      1.,Non-OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
 Jae-Min Yuk et al • Host immune responses and TB vaccine development 163 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155  27.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 164 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155diated and humoral immune responses.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
 Jae-Min Yuk et al • Host immune responses and TB vaccine development 165 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155  78.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
Jae-Min Yuk et al • Host immune responses and TB vaccine development 166 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.15552.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
 Jae-Min Yuk et al • Host immune responses and TB vaccine development 167 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.155sible molecular marker of active pulmonary tuberculo - sis.,OADS,/arxiv_data1/oa_pdf/75/64/cevr-3-155.PMC4083068.pdf
"168 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Cervical cancer is the second most prevalent cancer among women, accounting for  500,000 cases per year [1].",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:168-175 http://dx.doi.org/10.7774/cevr.2014.3.2.168 pISSN 2287-3651 • eISSN 2287-366X  Kwang Sung Kim, Shin Ae Park,  Kyung-Nam Ko, Seokjae Yi,   Yang Je Cho Eyegene Inc., Seoul, Korea Received: April 15, 2014 Revised: May 16, 2014 Accepted: May 20, 2014 Corresponding author: Yang Je Cho, PhD Eyegene Inc., B-910, 401 Yangcheon-ro,   Gangseo-gu, Seoul 157-801, Korea Tel: +82-2-322-1687, Fax: +82-2-324-8059 E-mail: white@eyegene.co.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
" Kwang Sung Kim et al • Human papillomavirus vaccines  169 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168rivalent HPV (qHPV) vaccine, produced by Merck & Co. Inc.  (Gardasil®, Merck, Rahway, NJ, USA); and bivalent HPV vac - cine, produced by GlaxoSmithKline plc.",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Kwang Sung Kim et al • Human papillomavirus vaccines  170 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168and 3) clarification by tangential flow filtration.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
 Kwang Sung Kim et al • Human papillomavirus vaccines  171 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168APCs [40].,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
"Kwang Sung Kim et al • Human papillomavirus vaccines  172 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168frequently occurring AEFIs were fever (115 cases, 18%), local  reaction (105 cases, 16%), exanthema/erythema (47 cases,  7%), menstruation problems (44 cases, 7%), headache (44  cases, 7%), and malaise (38 cases, 6%).",Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
ORCID Kwang Sung Kim  http://orcid.org/0000-0001-9765-3443 Shin Ae Park  http://orcid.org/0000-0001-8195-142X Kyung-Nam Ko  http://orcid.org/0000-0002-0391-7936 Yang Je Cho  http://orcid.org/0000-0002-6914-9343 References 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
 Kwang Sung Kim et al • Human papillomavirus vaccines  173 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.168particles.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from:  http://patentscope.wipo.int/search/en/WO2012177970.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.fda.gov/ohrms/ dockets/ac/06/briefing/2006-4222B3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.merck.ca/as - sets/en/pdf/products/GARDASIL-PM_E.pdf.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.merck.com/investors/finan - cials/annual-reports/home.html.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://patentscope.wipo.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Kwang Sung Kim et al • Human papillomavirus vaccines  174 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.16833.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from:  http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/BloodVaccinesandOther - Biologics/VaccinesandRelatedBiologicalProductsAdviso - ryCommittee/UCM181371.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.fda.gov/downloads/ biologicsbloodvaccines/vaccines/approvedproducts/ ucm237976.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.gsk.com/content/  dam/gsk/globals/documents/pdf/GSK-form-20-F-2012.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.fda.gov/BiologicsBloodVac - cines/SafetyAvailability/VaccineSafety/ucm179549.htm.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
Available from: http://www.path.,Non-OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
 Kwang Sung Kim et al • Human papillomavirus vaccines  175 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.16856.,OADS,/arxiv_data1/oa_pdf/fb/b7/cevr-3-168.PMC4083069.pdf
"176 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Rabies is one of the most important zoonoses and caused by rabies virus (RABV), which  is mainly transmitted by rabid animal bites, and migrates to the central nerve system  and causes fatal encephalitis.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:176-184 http://dx.doi.org/10.7774/cevr.2014.3.2.176 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang1*,   Keisuke Nakagawa2*, Naoto Ito2,  Ha-Hyun Kim1, Bang-Hun Hyun1,  Jin-Ju Nah1, Makoto Sugiyama2,  Jae-Young Song1 1Viral Disease Division, Animal and Plant  Quarantine Agency, MAFRA, Anyang, Korea;   2The United Graduated School of Veterinary  Science, Gifu University, Gifu, Japan * These two authors contributed equally to this  work.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
" Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 177 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176to dramatic decrease of rabies in countries such as Thailand,  India and Korea where numerous of dogs are immunized  yearly with rabies vaccines.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 178 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.17624-well tissue culture plate (Fig.,Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
" Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 179 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176the microplates were reacted with specific monoclonal anti - body against rabies for 45 minutes at 37°C, and then stained  with FITC conjugated goat-anti mouse IgG+IgM.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 180 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176Fig.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
 Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 181 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176Fig.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 182 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176Fig.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
 Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 183 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.176ulence in animals [4].,Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
ORCID Dong-Kun Yang http://orcid.org/0000-0001-5765-3043   Keisuke Nakagawa http://orcid.org/0000-0002-6342-4738 Naoto Ito http://orcid.org/0000-0003-0296-966X Ha-Hyun Kim http://orcid.org/0000-000106473-0035 Bang-Hun Hyun http://orcid.org/0000-0002-3429-3425 Jin-Ju Nah http://orcid.org/0000-0002-5021-0941 Makoto Sugiyama http://orcid.org/0000-0002-4300-893X Jae-Young Song http://orcid.org/0000-0002-9554-9252 References 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
Dong-Kun Yang et al • Recombinant rabies virus induces complete protection 184 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.1769.,OADS,/arxiv_data1/oa_pdf/dc/47/cevr-3-176.PMC4083070.pdf
185 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Urinary tract infections (UTIs) are the second most common infectious disease [1].,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:185-193 http://dx.doi.org/10.7774/cevr.2014.3.2.185 pISSN 2287-3651 • eISSN 2287-366X  Abbas Ali Imani Fooladi1,   Ghasem Bagherpour1,   Nima Khoramabadi2,   Jalil Fallah Mehrabadi3,   Mehdi Mahdavi4, Raheleh Halabian1,   Mohsen Amin5, Jalal Izadi Mobarakeh6,  Behzad Einollahi7 1Applied Microbiology Research Center,  Baqiyatallah University of Medical Sciences,  Tehran; 2Bacteriology Faculty of Medical Sciences,  Tarbiat Modares University, Tehran; 3Department  of Genetic Engineering, Faculty of Biosciences  and Biotechnology, Malekashtar University of  Technology, Tehran; 4Department of Virology,  Pasteur Institute of Iran, Tehran; 5Department  of Drug and Food Control, Tehran University  of Medical Sciences, Tehran; 6Department of  Physiology and Pharmacology, Pasteur Institute of  Iran, Tehran; 7Nephrology and Urology Research  Center, Baqiyatallah University of Medical  Sciences, Tehran, Iran  Received: December 12, 2013 Revised: February 4, 2014 Accepted: February 15, 2014 Corresponding author: Abbas Ali Imani Fooladi, PhD Applied Microbiology Research Center, Baqiyatallah  University of Medical Sciences, Molla-Sadra Street,  Tehran, P .O.",Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 186 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185duce apoptosis) [4].,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
 Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 187 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185Iran) and maintained in the animal facility under standard  conditions.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
All animal experimentations were performed ac - cording to the guidelines of the National Institutes of Health  (http://oacu.od.nih.gov/training/index.htm).,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
"Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 188 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185Histopathology Bladders of mice from the same groups were removed at the  same time, fixed with 1% formalin, and evaluated histopatho - logically.",Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
" Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 189 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.1854,500 4,000 3,500 3,000 2,500 2,000 15,00 1,000 500 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBS Mice groupsIFN-γ (pg/mL)*** **** A CMice groups90 80 70 60 50 40 30 20 10 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBSIL -12 (pg/mL)***** B D100 90 80 70 60 50 40 30 20 10 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBS Mice groupsIL -4 (pg/mL)100 90 80 70 60 50 40 30 20 10 0 pV-FimH(mam)+BoostpV-FimH(wt)+BoostProtein pV(control)PBS Mice groupsIL -17 (pg/mL)*** *** Fig.",Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 190 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185Fig.,OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
 Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 191 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185optimization.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 192 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185richia coli triggers oxygen-dependent apoptosis in human  neutrophils through the cooperative effect of type 1 fim - briae and lipopolysaccharide.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
 Abbas Ali Imani Fooladi et al • DNA vaccine against UTI 193 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.185expression of human genes in Escherichia coli: A multi- gene study.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/cevr-3-185.PMC4083071.pdf
194 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Influenza viruses have been the cause of morbidity and mortality in both animals and  humans [1-3].,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:194-201 http://dx.doi.org/10.7774/cevr.2014.3.2.194 pISSN 2287-3651 • eISSN 2287-366X  Byeong-Jae Lee1, Hyeok-il Kwon1,  Eun-Ha Kim1, Su-Jin Park1,   Sang-Ho Lee2,Young Ki Choi1,   Sang-Hyun Kim2 1College of Medicine and Medical Research  Institute, Chungbuk National University, Cheongju;  2Viral Infectious Disease Research Center,  Korea Research Institute of Bioscience and  Biotechnology (KRIBB), Daejeon, Korea Received: February 8, 2014 Revised: April 2, 2014 Accepted: April 10, 2014 Corresponding author: Sang-Hyun Kim, DVM, PhD Viral Infectious Disease Research Center, Korea  Research Institute of Bioscience and Biotechnolo - gy (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon  305-806, Korea  Tel: +82-42-879-8270, Fax: +82-42-879-8498 E-mail: skim@kribb.re.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 195 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194vants that allows cheaper and more effective vaccine produc - tion.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 196 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194and stored at -80°C until use.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 197 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.19480 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerH1N1+mOMV+Alum (0.05) H1N1+mOMV+Alum (0.1) H1N1+mOMV+Alum (0.5) E80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerH1N1 only (0.05) H1N1 only (0.1) H1N1 only (0.5)80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titermOMV only H1N1+mOMV (0.05) H1N1+mOMV (0.1) H1N1+mOMV (0.5) A B 80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerAlum only H1N1+Alum (0.05) H1N1+Alum (0.1) H1N1+Alum (0.5)80 60 40 20 0 A/California/04/09 (1st) A/California/04/09 (2nd)HI titerMF59 only H1N1+MF59 (0.05) H1N1+MF59 (0.1) H1N1+MF59 (0.5) C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 198 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1 only (0.1) H1N1 only (0.5) H1N1 only (0.05)A/California/04/09 (maCA04) only 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+mOMV (0.5) H1N1+mOMV (0.1) H1N1+mOMV (0.05) mOMV onlyA/California/04/09 (maCA04)+mOMV 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+Alum (0.1) H1N1+Alum (0.5) H1N1+Alum (0.05) Alum onlyA/California/04/09 (maCA04)+Alum 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+MF59 (0.5) H1N1+MF59 (0.1) H1N1+MF59 (0.05) MF59 onlyA/California/04/09 (maCA04)+MF59 110 100 90 80 70 60 50  0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days post-infectionBody weight change (%)H1N1+mOMV+Alum (0.5) H1N1+mOMV+Alum (0.1) H1N1+mOMV+Alum (0.05)A/California/04/09 (maCA04)+mOMV+Alum Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 199 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194the antigen only or the adjuvant only groups.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 200 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
ORCID Byeong-Jae Lee https://orcid.org/0000-0002-7492-7867 Hyeok-il Kwon http://orcid.org/0000-0003-2477-4492 Eun-Ha Kim http://orcid.org/0000-0003-1443-3416 Su-Jin Park http://orcid.org/0000-0002-8915-4799 Sang-Ho Lee http://orcid.org/0000-0002-0052-7932 Young Ki Choi http://orcid.org/0000-0002-1894-9869 Sang-Hyun Kim http://orcid.org/0000-0003-0432-0573 References 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
 Byeong-Jae Lee et al • Novel mOMV-adjuvant H1N1influenza vaccine 201 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.194940-5.,Non-OADS,/arxiv_data1/oa_pdf/fe/ae/cevr-3-194.PMC4083072.pdf
202 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Human and animal mortality from rabies remains a major burden in many countries  around the world.,Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:202-211 http://dx.doi.org/10.7774/cevr.2014.3.2.202 pISSN 2287-3651 • eISSN 2287-366X  Padinjaremattathil Thankappan  Ullas*, Anita Desai, Shampur  Narayan Madhusudana Department of Neurovirology, National Institute  of Mental Health and Neurosciences, Bangalore,  Karnataka, India Received: March 25, 2014 Revised: April 29, 2014 Accepted: May 1, 2014 Corresponding author:   Shampur Narayan Madhusudana, MD Department of Neurovirology, National Institute  of Mental Health and Neurosciences, Bangalore,  Karnataka 560029, India Tel: +91-80-26995129, Fax: +91-80-26564830 E-mail: mshampur@gmail.com *Present address: School of Chemical and Bio - technology, SASTRA University, Thanjavur, Tamil  Nadu, India No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
" Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 203 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202of susceptible canine population could prevent rabies trans - mission among canines [3], but this faces technical and logis - tic challenges [4].",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 204 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202tions were made using a commercial kit (EndoFree Plasmid  Purification Giga Kit, Qiagen, Hilden, Germany).",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
 Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 205 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202[8].,Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 206 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202(Rabipur), sterile normal saline, or the empty pIRES vector.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
" Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 207 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202restriction sites Xba I and SalI, yielding the construct pIRES- Rgp-Myd.",OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 208 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202ed for immunization experiments, we used a commercial  large-scale, endotoxin-free plasmid purification kit, as per  manufacturer instructions.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
" Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 209 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202Discussion Despite successful demonstrations of efficacy of plasmid DNA- based vaccination strategy for rabies in a number of animal  models, the technology is still constrained by poor immuno - genicity observed in larger animals and the delay in onset of  antibody responses.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
"Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 210 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202might represent efficacious vaccine candidates for generation  of long-lasting protective immunity against rabies and other  infectious diseases, especially for immunization of animals,  and needs to be evaluated further in field conditions.",Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
 Padinjaremattathil Thankappan Ullas et al • Myd88 enhances immune responses to a plasmid DNA rabies vaccine 211 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.202TRANCE as genetic adjuvants for a DNA vaccine to rabies  virus.,Non-OADS,/arxiv_data1/oa_pdf/41/32/cevr-3-202.PMC4083073.pdf
212 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Global warming can increase the activity of mosquito carrying out infectious virus to  animals and human.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:212-219 http://dx.doi.org/10.7774/cevr.2014.3.2.212 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang, Jin-Ju Nah,   Ha-Hyun Kim, Jae-Young Song  Viral Disease Division, Animal and Plant  Quarantine Agency, Ministry of Agriculture, Food  and Rural Affairs (MAFRA), Anyang, Korea Received: April 4, 2014 Revised: April 14, 2014 Accepted: April 20, 2014 Corresponding author: Dong-Kun Yang, PhD, DVM Viral Disease Division, Animal and Plant   Quarantine Agency, MAFRA, 175 Anyang-ro,  Anyang 430-757, Korea Tel: +82-31-467-1783, Fax: +82-31-467-1797 E-mail:yangdk@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 213 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212disease showing abortion and weak piglets and caused occa - sional fatal outcome in horses [3].,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 214 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212was adjusted to 8.0 with 1 N NaOH.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 215 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.21256°C for 30 minutes.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 216 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212Fig.,OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 217 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212Fig.,OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 218 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212 Humoral immune response is responsible for protecting  animals from the JEV challenge [25].,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
ORCID Dong-Kun Yang http://orcid.org/0000­0001­5765­3043 Jin-Ju Nah http://orcid.org/0000­0002­5021­0941 Ha-Hyun Kim http://orcid.org/0000­000106473­0035 Jae-Young Song http://orcid.org/0000­0002­9554­9252 References 1.,Non-OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
 Dong-Kun Yang et al • Immunogenicity of JEV vaccine for swine 219 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.212encephalitis virus vaccine.,OADS,/arxiv_data1/oa_pdf/24/75/cevr-3-212.PMC4083074.pdf
"220 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Although rabies is a reportable disease, the true incidence of the disease is greatly un - derestimated due to a lack of systematic surveillance and reporting by most develop - ing countries [1].",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:220-226 http://dx.doi.org/10.7774/cevr.2014.3.2.220 pISSN 2287-3651 • eISSN 2287-366X  Sami Darkaoui1, Franck Boué2,   Jean Michel Demerson2,   Ouafaa Fassi Fihri3,   Khadija Id Sidi Yahia1,   Florence Cliquet2 1Moroccan Office for Food Safety (ONSSA), Division  of Pharmacy and Veterinary Inputs, Rue Ikhlass,  Cité Yacoub El Mansour, Rabat, Morocco; 2French  Agency for Food, Environmental and Occupational  Health and Safety (ANSES), Nancy Laboratory for  Rabies and Wildlife, WHO Collaborating Centre for  Research and Management in Zoonoses Control,  OIE Reference Laboratory for Rabies, European  Union Reference Laboratory for Rabies, European  Union Reference Laboratory for Rabies Serology,  Technopôle agricole et vétérinaire, Malzéville Cedex,  France; 3Agronomic and Veterinary Institute Hassan  II, Unit of Microbiology, Immunology and Contagious  Diseases, Department of Pathology and Veterinary  Public Health, Rabat-Instituts, Rabat, Morocco Received: April 8, 2014 Revised: May 5, 2014 Accepted: May 11, 2014 Corresponding author: Sami Darkaoui, DVM Department of Veterinary Medicine, Moroccan Office  for Food Safety (ONSSA), Division de la Pharmacie et  des Intrants Vétérinaires, Rue Ikhlass, Cité Yacoub El  Mansour, BP 4509, Akkari, Rabat, Morocco Tel: +212-537690477, Fax: +212-537690133 E-mail: darkaouisami@gmail.com No potential conflict of interest relevant to this article  was reported.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
 Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 221 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220mains a serious health problem in Morocco and about 22 hu - man deaths are reported every year [5].,Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 222 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220recommended by World Health Organisation (WHO) to be  used in dogs by the oral route [11,12].",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
 Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 223 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220Table 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 224 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220cies, including 5 from the canine family (of which dog), wild  carnivores, rodents and non-human primates, demonstrated   that SAG2 is an avirulent rabies vaccine strain [28].",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
 Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 225 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220cost of vaccination could be reduced by the use of aerial dis - tribution in certain well defined and restricted areas.,Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"Sami Darkaoui et al • First trials of oral vaccination with rabies SAG2 dog baits in Morocco 226 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.220ing; 1997 Mar 4-6; Nairobi, Kenya; p.163-74.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cevr-3-220.PMC4083075.pdf
"227 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Protein cages, such as ferritins, small heat shock proteins, and viral capsids are prom - ising nanoplatform candidates for efficient delivery systems because they have uni - form size, structure, high biocompatibility and biodegradability [1-6].",Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:227-234 http://dx.doi.org/10.7774/cevr.2014.3.2.227 pISSN 2287-3651 • eISSN 2287-366X  Jae-Sun Ra*, Hyun-Hee Shin*,  Sebyung Kang, Yoonkyung Do School of Life Sciences, Ulsan National Institute  of Science and Technology, Ulsan, Korea Received: April 10, 2014 Revised: May 1, 2014 Accepted: May 12, 2014 Corresponding author: Yoonkyung Do, PhD School of Life Sciences, Ulsan National Insti - tute of Science and Technology, 50 UNIST-gil,  Eonyang-eup, Ulju-gun, Ulsan 689-798, Korea Tel: +82-52-217-5326, Fax: +82-217-5309 E-mail: doy@unist.ac.kr *These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 228 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227and fabrication of uniform layer-by-layer assemblies using  non-covalent interaction between surface displayed hexa - hisitidine and Ni-NTA of the AaLS [11].,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
" Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 229 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227with indicated proteins for 3 hours, washed and then co-cul - tured with the CFSE-labeled T cells at a ratio of 1:3 (DC, 1×105:  T cell, 3×105) in a 96-well U-bottom plate at 37°C.",OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 230 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227Results Surface and ribbon diagram representations of lumazine syn - thase (AaLS) were depicted (Fig.,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
 Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 231 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227 PBS OVA protein wt AaLS   PBS OVA protein wt AaLS   AaLS-OT -1AaLS-OT -1 A B Fig.,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
"Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 232 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227were used as a positive and a negative control groups, respec - tively.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
" Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 233 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227in E. coli , as well as with co-insertion of selective adjuvants  and antigens together.",OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
ORCID Jae-Sun Ra http://orcid.org/0000-0002-4525-7171 Hyun-Hee Shin http://orcid.org/0000-0003-4945-1059 Sebyung Kang http://orcid.org/0000-0001-7394-3550 Yoonkyung Do http://orcid.org/0000-0001-7947-4767 References 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
Jae-Sun Ra et al • Lumazine synthase as a novel DC-antigen delivery system 234 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.227technol 1997;15:26-32.,OADS,/arxiv_data1/oa_pdf/fd/45/cevr-3-227.PMC4083076.pdf
235 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculo - sis.,Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:235-243 http://dx.doi.org/10.7774/cevr.2014.3.2.235 pISSN 2287-3651 • eISSN 2287-366X  Jino Lee1, Jihye Kim1, Jeewon Lee1,  Sung Jae Shin2, Eui-Cheol Shin1 1Laboratory of Immunology and Infectious  Diseases, Graduate School of Medical Science  and Engineering, KAIST, Daejeon, 2Department  of Microbiology and Institute of Immunology  and Immunological Diseases, Yonsei University  College of Medicine, Seoul, Korea Received: April 14, 2014 Revised: May 12, 2014 Accepted: May 15, 2014 Corresponding author: Eui-Cheol Shin, MD, PhD Laboratory of Immunology and Infectious   Diseases, Graduate School of Medical Science  and Engineering, KAIST, 291 Daehak-ro,   Yuseong-gu, Daejeon 305-701, Korea Tel: +82-42-350-4236, Fax: +82-42-350-4240 E-mail: ecshin@kaist.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
"Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 236 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235ing countries where protection against TB is the most needed  [7,8].",Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
 Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 237 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235and further diluted to 1 mg/mL with phosphate-buffered sa - line (PBS).,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 238 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235 Optical density (450 nm) ControlRpfB DNARpfB proteinBCG4.0 3.0 2.0 1.0 0.0** **** Fig.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
 Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 239 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235Fig.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 240 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235Fig.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
 Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 241 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235 Polyfunctional T cells simultaneously exert multiple func - tions such as cytokine secretion and cytotoxic activity.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
ORCID Jino Lee http://orcid.org/0000-0003-2132-4963 Jihye Kim http://orcid.org/0000-0001-6297-4562 Jeewon Lee http://orcid.org/0000-0001-7457-2464 Sung Jae Shin http://orcid.org/0000-0003-0854-4582 Eui-Cheol Shin http://orcid.org/0000-0002-6308-9503 References 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 242 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235BR.,OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
" Jino Lee et al • Vaccination with RpfB DNA induces polyfunctional T cells 243 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.235losis vaccine, AERAS-402, induces robust and polyfunc - tional CD4+ and CD8+ T cells in adults.",Non-OADS,/arxiv_data1/oa_pdf/9f/0f/cevr-3-235.PMC4083077.pdf
244 http://www.ecevr.org/CLINICAL    EXPERIMENTAL VACCINE RESEARCHGuideline Guidelines for Vaccination of Dogs Guidelines for vaccination of general veterinary practice by World Small Animal   Veterinary Association (WSAVA) and American Animal Hospital Association (AAHA) Table 1 summarizes vaccination schedule base on  WSAVA vaccination guidelines in  2010 [1] and AAHA vaccination guideline in 2011 [2].,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2014;3:244-247 http://dx.doi.org/10.7774/cevr.2014.3.2.244 pISSN 2287-3651 • eISSN 2287-366X  Woo-Jin Song1, Hyun-Tae Kim1,  Han-Sang Yoo2, Hwa-Young Youn1 Departments of 1Veterinary Internal Medicine  and 2Infectious Disease, College of Veterinary  Medicine, Seoul National University, Seoul, Korea Received: March 27, 2014 Revised: April 7, 2014 Accepted: April 10, 2014 Corresponding author: Hwa-Young Youn, DVM, PhD Department of Veterinary Internal Medicine,  College of Veterinary Medicine, Seoul National  University, 1 Gwanak-ro, Gwanak-gu,   Seoul 151-742, Korea Tel: +82-2-880-1266, Fax: +82-2-880-1211 E-mail: hyyoun@snu.ac.kr No potential conflict of interest relevant to this  article was reported.This guideline contains the recommended vaccination schedules of dogs and cats from World  Small Animal Veterinary Association (WSAVA) and American Animal Hospital Association  (AAHA).",Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
 Woo-Jin Song et al • Vaccination guidelines of dogs and cats in Korea  245 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.244Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
Woo-Jin Song et al • Vaccination guidelines of dogs and cats in Korea  246 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.244Table 2.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
 Woo-Jin Song et al • Vaccination guidelines of dogs and cats in Korea  247 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2014.3.2.244Table 4.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
Continued ORCID Woo-Jin Song http://orcid.org/0000-0001-9563-6615 Hyun-Tae Kim http://orcid.org/0000-0001-5124-7976  Han-Sang Yoo http://orcid.org/0000-0003-0548-0835 Hwa-Young Youn http://orcid.org/0000-0002-0283-1348 References 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/cevr-3-244.PMC4083078.pdf
This pattern was also found /C2112014 Ishiuchi and Torres-Padilla This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f2/a7/1381.PMC4083083.pdf
"After six months, it is available under a Creative Com- mons License (Attribution-NonCommercial 4.0 International), as de- scribed at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/f2/a7/1381.PMC4083083.pdf
[Keywords : DNA methylation; evolution; KAP1; LINE1; piRNA; transposon] 1Corresponding author E-mail metp@igbmc.fr Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.246462.114.,OADS,/arxiv_data1/oa_pdf/f2/a7/1381.PMC4083083.pdf
[Keywords : R loops; gene expression; genome integrity] 1Corresponding author E-mail nicholas.proudfoot@path.ox.ac.uk Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.242990.114.,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/1384.PMC4083084.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.241661.114.,Non-OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
LV production protocols are detailed at http://tronolab.epfl.ch.,Non-OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
2011) were obtained from the ENCODEdatabase (https://genome.ucsc.edu/ENCODE).,OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
"Correlation analysis between ChIP-seq peaks, MeDIP-seq tags, and L1 elements was done using the ChIP-cor analysis module (http://ccg.vital-it.ch/chipseq/chip_cor.php).",OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
MeDIP-seq data sets (Hs1376 and Hs1303) were downloaded from http://www.genboree.org/epigenomeatlas.,OADS,/arxiv_data1/oa_pdf/32/1e/1397.PMC4083085.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c6/d2/1410.PMC4083086.pdf
Article and publication date are online at http://www.genesdev.or g/cgi/doi/10.1101/gad.240895.114.,Non-OADS,/arxiv_data1/oa_pdf/c6/d2/1410.PMC4083086.pdf
We considered regions annotated by RepeatMasker(http://www.repeatmasker.org) in the UCSC genome browser forthe mm10 genome (Meyer et al.,OADS,/arxiv_data1/oa_pdf/c6/d2/1410.PMC4083086.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/25/ad/1429.PMC4083087.pdf
org/licenses/by-nc/4.0/.13Corresponding authors E-mail qing_zhang@med.unc.edu E-mail william_kaelin@dfci.harvard.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.242131.114.,Non-OADS,/arxiv_data1/oa_pdf/25/ad/1429.PMC4083087.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.7Corresponding authors E-mail mkuroda@genetics.med.harvard.edu E-mail peter.kharchenko@post.harvard.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.241950.114.",Non-OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
Please see http://pklab.med.harvard.edu/mass.spec/viewms.html for the counts in other life stages.,Non-OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
"The total number of detected peptides is shown in each cell, with the number of unique peptidesshown in parentheses (for full data set, including peptide counts, see http://pklab.med.harvard.edu/mass.spec/viewms.html).",OADS,/arxiv_data1/oa_pdf/b9/84/1445.PMC4083088.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/85/e1/1461.PMC4083089.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.243832.114.,Non-OADS,/arxiv_data1/oa_pdf/85/e1/1461.PMC4083089.pdf
2013; Chung et al2014; http://daudin.icmb.utexas.edu) with RNA-STAR.,OADS,/arxiv_data1/oa_pdf/85/e1/1461.PMC4083089.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/49/33/1472.PMC4083090.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.4Corresponding author E-mail zou.lee@mgh.harvard.edu Article is online at http://www.genesdev.",Non-OADS,/arxiv_data1/oa_pdf/49/33/1472.PMC4083090.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/47/31/1485.PMC4083091.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.Present addresses:4Department of Molecular Biology, Max-Planck-Institute for Biophysical Chemistry, 37077 Go ¨ttingen, Germany;5The James H Clark Center, Stanford School of Medicine, Stanford, California 94305 USA; 6Department of Early Discovery Bioc hemistry, Genentech, South San Francisco, CA 94080 USA;7Department of Molecular Biology, Presidency University, Kolkata, India;8Department of Biophysics and Biophysical Chemistry, Johns Hopkins Universit y School of Medicine, Baltimore, MD 21205, USA 9Corresponding author E-mail jmberger@jhmi.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.241984.",Non-OADS,/arxiv_data1/oa_pdf/47/31/1485.PMC4083091.pdf
"Except where noted, this panel and all other structural panelswere rendered with PyMOL (http://www.pymol.org).Inhibition of E. coli gyrase by YacG GENES &DEVELOPMENT 1487",Non-OADS,/arxiv_data1/oa_pdf/47/31/1485.PMC4083091.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.4Corresponding authors E-mail allain@mol.biol.ethz.ch E-mail raul.mendez@irbbarcelona.org Article is online at http://www.genes dev.org/cgi/doi/ 10.1101/gad.241133.114.",Non-OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
"Data processing was performed withTopSpin2.1/TopSpin3.0 (Bruker), and analysis was performed with Sparky (http://www.cgl.ucsf.edu/home/sparky).",OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
1996) or PYMOL (http://www.pymol.org).,Non-OADS,/arxiv_data1/oa_pdf/69/65/1498.PMC4083092.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"Scale bars: (A, F, G), 200 mm, (B, H), 50 mm, (C, D, E), 10 mm.Intracellular localization of Treponema denticola chymotrypsin Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"MicrobesInfect 2006; 8: 1758 /C163.Intracellular localization of Treponema denticola chymotrypsin Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24349 - http://dx.doi.org/10.3402/jom.v6.24349",Non-OADS,/arxiv_data1/oa_pdf/b9/d7/JOM-6-24349.PMC4083148.pdf
"[cited: 10th Jan, 2014]; Available from: http://www.alz.",Non-OADS,/arxiv_data1/oa_pdf/38/2c/TONURSJ-8-17.PMC4083186.pdf
"[cited: 10th Jan, 2014]; Available from: http://www.pref.okinawa.jp/site/fukushi/korei/.../ninteityousa.pdf   Received: January 9, 2014 Revised: April 29, 2014 Accepted: May 2, 2014  © Mitoku and Shimanouchi; Licensee Bentham Open.",OADS,/arxiv_data1/oa_pdf/38/2c/TONURSJ-8-17.PMC4083186.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/2c/TONURSJ-8-17.PMC4083186.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/23/main.PMC4083229.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7c/23/main.PMC4083229.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: S.-H.C., S.K., C.O.K.",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/srep05603.PMC4083259.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5603 | DOI: 10.1038/srep05603 6",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/srep05603.PMC4083259.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/b8/srep05596.PMC4083260.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5590 | DOI: 10.1038/srep05590 5",Non-OADS,/arxiv_data1/oa_pdf/d9/c5/srep05590.PMC4083261.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/srep05588.PMC4083262.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5588 | DOI: 10.1038/srep05588 5",Non-OADS,/arxiv_data1/oa_pdf/c1/0e/srep05588.PMC4083262.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/25/srep05602.PMC4083263.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5602 | DOI: 10.1038/srep05602 12",Non-OADS,/arxiv_data1/oa_pdf/76/25/srep05602.PMC4083263.pdf
"Unpublished thesis, University of Iceland.http://hdl.handle.net/1946/ 11191 (2012).",Non-OADS,/arxiv_data1/oa_pdf/a7/4d/srep05589.PMC4083264.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a7/4d/srep05589.PMC4083264.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5589 | DOI: 10.1038/srep05589 10",Non-OADS,/arxiv_data1/oa_pdf/a7/4d/srep05589.PMC4083264.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b7/a7/srep05587.PMC4083265.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5587 | DOI: 10.1038/srep05587 12",Non-OADS,/arxiv_data1/oa_pdf/b7/a7/srep05587.PMC4083265.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/b4/srep05593.PMC4083277.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c7/9e/srep05548.PMC4083279.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/ae/srep05598.PMC4083283.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5599 | DOI: 10.1038/srep05599 10",Non-OADS,/arxiv_data1/oa_pdf/f8/a6/srep05599.PMC4083286.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5592 | DOI: 10.1038/srep05592 5",Non-OADS,/arxiv_data1/oa_pdf/ca/1d/srep05592.PMC4083293.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9d/61/srep05564.PMC4083294.pdf
Available from: http://www.unaids.org/en/media/unaids/con tentassets/documents/epidemiology/2012/gr 2012/20121120_UNAIDS_Global_Report_20 12_en.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Available from: http://www.nacoonline.org/NACO/About_NA CO/Policy__Guidelines/Policies__Guidelin es1/ 5.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Available from: http://www.who.int/hiv/ pub/paediatric/infants2010/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Estimating risk of disease pro- gression in HIV-infected children.Available from: http://www.hppmcs.org/.,Non-OADS,/arxiv_data1/oa_pdf/90/18/idr-2014-2-5167.PMC4083298.pdf
Available from: http://www.who.int/cancer/palliative/painladder/en/ 5. International Narcotics Control Board (INCB).,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
Available from: http://www.incb.org/docu-ments/Publications/AnnualReports/AR2010/SupplementAR10_availability_English.p df 6 .,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
Available from: http://www.incb.org/documents/Narcotic-Drugs/Technical- P ublications/2012/NDR_2012_Part4_Table s_EFS.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
Available from: http://www.parlamento.it/parlam/leggi/100 38l.htm 10.,Non-OADS,/arxiv_data1/oa_pdf/6f/d9/or-2014-2-5309.PMC4083307.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Local blood ﬂow versus capacity to raise blood ﬂow D Feuerstein et al 1127 &2014 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2014), 1117 – 1127",Non-OADS,/arxiv_data1/oa_pdf/92/94/jcbfm201453a.PMC4083373.pdf
The microarrayswere analyzed using R 3.0.1 (open source: http://www.r-project.org) andBioconductor 2.12 (open source: http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/4f/81/jcbfm201472a.PMC4083386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Maternal fructose and offspring brain mitochondria OH Mortensen et al 1211 &2014 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2014), 1205 – 1211",Non-OADS,/arxiv_data1/oa_pdf/4f/81/jcbfm201472a.PMC4083386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Meta-analysis: serotonin transporter in depression G Gryglewski et al 1103 &2014 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2014), 1096 – 1103",Non-OADS,/arxiv_data1/oa_pdf/92/1d/jcbfm201482a.PMC4083395.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Epple, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/0d/ncomms5132.PMC4083415.pdf
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif.Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/06/ncomms5245.PMC4083417.pdf
"Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions/ How to cite this article: Asakawa, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/79/06/ncomms5245.PMC4083417.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5245 ARTICLE NATURE COMMUNICATIONS | 5:4245 | DOI: 10.1038/ncomms5245 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/79/06/ncomms5245.PMC4083417.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/6a/ncomms5150.PMC4083419.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Steinkellner, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/6a/ncomms5150.PMC4083419.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5150 ARTICLE NATURE COMMUNICATIONS | 5:4150 | DOI: 10.1038/ncomms5150 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f4/6a/ncomms5150.PMC4083419.pdf
"Genome sequences and annotations were downloaded from http://www.amborella.org/ ( A. trichopoda assembly V1.0), http://congenie.org/ ( P. abies assembly V1.0) and the phytozome v9.1 database42 (containing the following annotation versions: A. thaliana TAIR release 10 ,G .m a x Glyma1.1 , M. truncatula Mt3.5v4 , P. trichocarpa JGI annotation v3.0, R. communis TIGR release 0.1 , V. vinifera March 2010 12X assembly and annotation from Genoscope , S. lycopersicum ITAG2.3, O. sativa MSU release 7.0 , S. bicolor Sbi1.4 models from MIPS/PASA, P. patens COSMOSS annotation v1.6 and S.moellendorfﬁi JGI annotation v1.0 ).",OADS,/arxiv_data1/oa_pdf/d7/a4/ncomms5268.PMC4083422.pdf
"Plant material and culture conditions .The Gransden, Honnef and Uppsala-K1 wild-type strains of P. patens (http://www.moss-stock-center.org/), wt4 wild-type strain of Ceratodon purpureus56and wild-type strain of Pseudocrossidium replicatum (gift of Dr Villalobos, CIBA-IPN, Tlaxcala, Mexico) were used in this study.",Non-OADS,/arxiv_data1/oa_pdf/d7/a4/ncomms5268.PMC4083422.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Maumus, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/d7/a4/ncomms5268.PMC4083422.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/29/ncomms5154.PMC4083423.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hatke, A. T. et al.",Non-OADS,/arxiv_data1/oa_pdf/3d/29/ncomms5154.PMC4083423.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5154 ARTICLE NATURE COMMUNICATIONS | 5:4154 | DOI: 10.1038/ncomms5154 | www.nature.com/naturecommunications 5 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/3d/29/ncomms5154.PMC4083423.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/d5/ncomms5170.PMC4083425.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhang, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/ncomms5170.PMC4083425.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5170 ARTICLE NATURE COMMUNICATIONS | 5:4170 | DOI: 10.1038/ncomms5170 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/ncomms5170.PMC4083425.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Klo¨ckner, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/99/ncomms5201.PMC4083426.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Yamaguchi, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/b3/ncomms5256.PMC4083427.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5595 | DOI: 10.1038/srep05595 4",Non-OADS,/arxiv_data1/oa_pdf/5a/1a/srep05595.PMC4083430.pdf
"Array hybridization of RNA isolated from mutant and control cerebella identiﬁed 110 genes differentially expressed at P0 that increased to 2,916 transcripts at P10 ( Po0.01, n¼3 per genotype, statistics was carried out using WEBARRAY online tool (http://www.webarraydb.org/webarray/index.html), which utilizes linear model statistical analysis (modiﬁed t-test)).",OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
Statistics was carried out using WEBARRAY online tool (http://www.webarraydb.org/webarray/index.html) that utilizes linear model statistical analysis (modi ﬁed t-test).NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5181 ARTICLE NATURE COMMUNICATIONS | 5:4181 | DOI: 10.1038/ncomms5181 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.,OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
"On the resulting raw background subtracted signals intra-array normalization (correcting for Cy5/Cy3 bias) was performed with global loess, inter-array normalization with the quantile method and statistical analysis via the WEBARRAY online tool (http://www.we-barraydb.org/webarray/index.html).",OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Alvarez-Saavedra, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5181 18 NATURE COMMUNICATIONS | 5:4181 | DOI: 10.1038/ncomms5181 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/15/f6/ncomms5181.PMC4083431.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: HJD is an employee of Boehringer Ingelheim Pharma GmbH & Co KG.,Non-OADS,/arxiv_data1/oa_pdf/a5/ee/ncomms4897.PMC4083433.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ortner, N. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/ee/ncomms4897.PMC4083433.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4897 10 NATURE COMMUNICATIONS | 5:3897 | DOI: 10.1038/ncomms4897 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a5/ee/ncomms4897.PMC4083433.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Cirloganu, C. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/7f/ncomms5148.PMC4083434.pdf
"Dosch, M. P. The anesthesia gas machine http://www.udmercy.edu/crna/agm (2006).",OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"Dosch, M. P. The anesthesia gas machine http://www.udmercy.edu/crna/agm/ 07.htm (2012).",Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Shekhah, O. et al.",Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5228 ARTICLE NATURE COMMUNICATIONS | 5:4228 | DOI: 10.1038/ncomms5228 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6a/8e/ncomms5228.PMC4083436.pdf
"Acknowledgements This work was supported by the European Union through the projects FP7-ICT-2011-9- 600838 (QWAD—Quantum Waveguides Application and Development—www.qwad-project.eu) and CHISTERA-QUASAR (http://www.chistera.eu/projects/quasar), and bythe ERC (European Research Council) Starting Grant 3D-QUEST (3D-Quantum Inte- grated Optical Simulation; grant agreement number 307783—www.3dquest.eu).",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: G.C., A.C., R.O.",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Corrielli, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5249 6 NATURE COMMUNICATIONS | 5:4249 | DOI: 10.1038/ncomms5249 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f1/08/ncomms5249.PMC4083439.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wientjes, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/82/5d/ncomms5236.PMC4083440.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/75/fd/ncomms5273.PMC4083441.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Li, Y.-F. et al.",Non-OADS,/arxiv_data1/oa_pdf/75/fd/ncomms5273.PMC4083441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5273 14 NATURE COMMUNICATIONS | 5:4273 | DOI: 10.1038/ncomms5273 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/75/fd/ncomms5273.PMC4083441.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/63/ncomms5081.PMC4083442.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Fumeaux, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/60/63/ncomms5081.PMC4083442.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5081 14 NATURE COMMUNICATIONS | 5:4081 | DOI: 10.1038/ncomms5081 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/60/63/ncomms5081.PMC4083442.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interest.,Non-OADS,/arxiv_data1/oa_pdf/eb/07/ncomms5133.PMC4083443.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Murakami, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/07/ncomms5133.PMC4083443.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5133 8 NATURE COMMUNICATIONS | 5:4133 | DOI: 10.1038/ncomms5133 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/eb/07/ncomms5133.PMC4083443.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/ca/ncomms5244.PMC4083444.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/42/ca/ncomms5244.PMC4083444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5244 10 NATURE COMMUNICATIONS | 5:4244 | DOI: 10.1038/ncomms5244 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/42/ca/ncomms5244.PMC4083444.pdf
Cells and ghosts were quantiﬁed using ImageJ software(http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Frandi, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5200 ARTICLE NATURE COMMUNICATIONS | 5:4200 | DOI: 10.1038/ncomms5200 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0a/be/ncomms5200.PMC4083446.pdf
Available from: http://www.fsi.org.in/cover_2011/uttarakhand.pdf [Last accessed 2013 Nov 10].,Non-OADS,/arxiv_data1/oa_pdf/97/d6/NAJMS-6-274.PMC4083529.pdf
"(Accessed April 24, 2014, at  http://www.health.govt.nz/publication/new-zealand-cardiovascular-risk-charts).",Non-OADS,/arxiv_data1/oa_pdf/c0/e2/NAJMS-6-284.PMC4083531.pdf
"Available from: (Accessed February 19, 2014, at http://www.bupa.com.au/health-and-wellness/tools-and-apps/tools-and-calculators/quick-health-age-check).",Non-OADS,/arxiv_data1/oa_pdf/c0/e2/NAJMS-6-284.PMC4083531.pdf
Available from: http://www.fdagov/downloads/Drugs/GuidanceComplianceRegulatory/ Information/Guidances/ucm070578.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/e1/IJPI-4-51.PMC4083534.pdf
"American Pharmaceutical review 2011, Available from: http://www.americanpharmaceuticalreview.com/Featured- Articles/37183-Understanding-Infrared-and-Raman-Spectra-of- Pharmaceutical-Polymorphs/.",Non-OADS,/arxiv_data1/oa_pdf/45/e1/IJPI-4-51.PMC4083534.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/58/e7/IJPI-4-77.PMC4083537.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/b5/34/IJPI-4-88.PMC4083538.pdf
Available from: http://www.ich.org/LOB/media/MEDIA4986.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/13/IJPI-4-93.PMC4083539.pdf
Available from: http://www.ich.org/LOB/media/MEDIA1957.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/13/IJPI-4-93.PMC4083539.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199-210    199Lessons in biostatistics ©Copyright by Croatian Society of Medical Biochemistry and Laboratory Medicine.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Observational and interventional study design types; an overview Matthew S. Thiese Rocky Mountain Center for Occupational and Environmental Health, University of Utah, Salt Lake City, Utah, USA *Corresponding author: Matt.thiese@hsc.utah.edu Introduction Study design plays an important role in the quali - ty, execution, and interpretation of biomedical and  public health research (1-12).",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  200Thiese MS. Study design types: an overview logical or interventional, lack one or more of these  elements and have limited application.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    201Thiese MS. Study design types: an overview Study design Measures of disease Measures of risk Temporality Ecological Prevalence (rough estimate) Prevalence ratio Retrospective Proportional mortalityProportional mortality Standardized mortalityProportional mortality ratio Standardized mortality ratioRetrospective Case-crossover None Odds ratio Retrospective Cross-sectionalPoint prevalence Period prevalenceOdds ratio Prevalence odds ratio Prevalence ratio Prevalence differenceRetrospective Case-control None Odds ratio Retrospective Retrospective and  prospective cohortPoint prevalence Period prevalence IncidenceOdds ratio Prevalence odds ratio Prevalence ratio Prevalence difference Attributable risk Incidence rate ratio Relative risk Risk ratio Hazard ratioRetrospective only Both retrospective and  prospective Prospective only Study design Strengths Weaknesses EcologicalVery inexpensive Fast Easy to assign exposure levelsInaccuracy of data Inability to control for confounders Difficulty identifying or quantifying denominator No demonstrated temporality Proportional mortalityVery inexpensive Fast Outcome (death) well capturedUtilize deaths only Inaccuracy of data (death certificates) Inability to control for confounders Case-crossoverReduces some types of bias Good for acute health outcomes with a  defined exposure Cases act as their own controlSelection of comparison time point difficult Challenging to execute Prone to recall bias No demonstrated temporality Cross-sectionalInexpensive Timely Individualized data Ability to control for multiple  confounders Can assess multiple outcomesNo temporality Not good for rare diseases Poor for diseases of short duration No demonstrated temporality Case-controlInexpensive Timely Individualized data Ability to control for multiple  confounders Good for rare diseases Can assess multiple exposuresCannot calculate prevalence Can only assess one outcome Poor selection of controls can introduce bias May be difficult to identify enough cases Prone to recall bias No demonstrated temporality Retrospective and  prospective cohortTemporality demonstrated Individualized data Ability to control for multiple  confounders Can assess multiple exposures Can assess multiple outcomesExpensive Time intensive Not good for rare diseasesTa b l e  1.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  202Thiese MS. Study design types: an overview Observational studies Ecological study design The most basic observational study is an ecologi - cal study.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    203Thiese MS. Study design types: an overview outcome are assessed at the same time, temporal - ity cannot be demonstrated, i.e.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  204Thiese MS. Study design types: an overview relationships that are assessed using case-crosso - ver designs should have health outcomes that do  not have a subclinical or undiagnosed period prior to becoming a “case” in the study (12).,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    205Thiese MS. Study design types: an overview diagnostic procedure, including accuracy, sensitiv - ity, specificity, positive predictive value, negative  predictive value, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio can be calculated.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  206Thiese MS. Study design types: an overview measuring compliance, controlling for co-inter - ventions, measuring dropout, analysing results by  intention to treat, and assessing each treatment arm at the same time point in the same manner.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    207Thiese MS. Study design types: an overview there may be a therapeutic difference between  the two treatment arms.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  208Thiese MS. Study design types: an overview Standard name Acronym Website Consolidated Standards Of Reporting Trials CONSORT www.consort-statement.org Strengthening the Reporting of Observational studies in Epidemiology STROBE www.strobe-statement.org Standards for Reporting Studies of Diagnostic Accuracy STARD www.stard-statement.org Quality assessment of diagnostic accuracy studies QUADAS www.bris.ac.uk/quadas Preferred Reporting Items for Systematic Reviews and Meta-Analyses PRISMA www.prisma-statement.org Consolidated criteria for reporting qualitative research COREQ Statistical Analyses and Methods in the Published Literature SAMPL Consensus-based Clinical Case Reporting Guideline Development CARE www.care-statement.org/ Standards for Quality Improvement Reporting Excellence SQUIRE www.squire-statement.org Consolidated Health Economic Evaluation Reporting Standards CHEERSwww.ispor.org/taskforces/ EconomicPubGuidelines.asp Enhancing transparency in reporting the synthesis of qualitative research ENTREQTa b l e  3.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.11613/BM.2014.022 Biochemia Medica 2014;24(2):199–210    209Thiese MS. Study design types: an overview Conclusion The appropriate selection of a study design is only  one element in successful research.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Research methods in occupational epidemiology: Oxford University Press; 2004. http://dx.doi.org/10.1093/acprof:oso/9780195092424.001.0001.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Handbook of Epi- demiology: Springer; 2005. p. 287-319. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"Meta-analysis, decision analysis, and cost-ef-fectiveness analysis: methods for quantitative synthesis in medicine: Oxford University Press; 1999. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
BMJ 1999;319:670-4. http://dx.doi.org/10.1136/ bmj.319.7211.670.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biometrika 1999;86:365-79. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
BMC Med Res  Methodol 2001;1:2. http://dx.doi.org/10.1186/1471-2288- 1-2.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
JAMA 2001;285:2000-3. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Biochemia Medica 2014;24(2):199–210  http://dx.doi.org/10.11613/BM.2014.022  210Thiese MS. Study design types: an overview 31.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
1996;17:1-12. http://dx.doi.org/10.1016/0197-2456- (95)00134-4.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
J Clinical Epi-demiol 2004;57:1232-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
http://dx.doi.org/10.1503/ cmaj.090449.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
Qual Saf Health Care 2003;12:18-23. http://dx.doi.org/10.1136/ qhc.12.1.18.,Non-OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
J Occup Environ Med 2008;50:282-95. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/47/biomd-24-2-199-1.PMC4083571.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.023 Biochemia Medica 2014;24(2):211–6    211Abstract Despite the fact that there are more than twenty thousand biomedical journals in the world, research into the work of editors and publication pro - cess in biomedical and health care journals is rare.",Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Biochemia Medica 2014;24(2):211–6  http://dx.doi.org/10.11613/BM.2014.023  212Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
http://dx.doi.org/10.11613/BM.2014.023 Biochemia Medica 2014;24(2):211–6    213Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Biochemia Medica 2014;24(2):211–6  http://dx.doi.org/10.11613/BM.2014.023  214Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
http://dx.doi.org/10.11613/BM.2014.023 Biochemia Medica 2014;24(2):211–6    215Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Available at: http://www.icmje.,Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Biochemia Medica 2014;24(2):211–6  http://dx.doi.org/10.11613/BM.2014.023  216Marušić A. et al.,OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Availa-ble at: http://www.rcuk.ac.uk/research/outputs/.,Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
Available at: http://beta.congress.gov/bill/113th-congress/senate-bill/350/text?q=s350.,Non-OADS,/arxiv_data1/oa_pdf/c7/99/biomd-24-2-211-2.PMC4083572.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Research integrity corner Abstract This evidence-based opinion piece gives a short overview of the increase in retractions of publications in scientific journals and discusses various  reasons for that increase.",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"Key words : accountability; retraction of publication as topic; scientific misconduct Received: March 30, 2014 Accepted: May 19, 2014Retractions of scientific publications: responsibility and accountability Vedran Katavić Department of Anatomy, University of Zagreb School of Medicine, Zagreb, Croatia Corresponding author: vkatavic@mef.hr http://dx.doi.org/10.11613/BM.2014.024 Biochemia Medica 2014;24(2):217–22    217Disclaimer I‘d like to start this opinion piece with a disclaimer  – I am going to do something not entirely com - mon in a scientific journal, and NOT cite those arti - cles I mention in this manuscript!",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"Biochemia Medica 2014;24(2):217–22  http://dx.doi.org/10.11613/BM.2014.024  218Katavić V. Retractions of scientific publications: responsibility and accountability editor’s toolbox are, also, expressions of concern  that draw the attention of the public to possible problems in a published article, without, actually, correcting or retracting it (8).",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.11613/BM.2014.024 Biochemia Medica 2014;24(2):217–22    219Katavić V. Retractions of scientific publications: responsibility and accountability Authors with multiple retractions The surprising thing in the analyses of retracted  publications is the number of researchers with multiple retracted publications and the number of retracted publications (or publications found to be fraudulent that are awaiting retraction) they pub - lished (15).,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"Biochemia Medica 2014;24(2):217–22  http://dx.doi.org/10.11613/BM.2014.024  220Katavić V. Retractions of scientific publications: responsibility and accountability (Ir)reproducibility of published research Out of all the reasons for retractions (9), irrepro - ducibility of results inhabits its own troubling  niche.",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"http://dx.doi.org/10.11613/BM.2014.024 Biochemia Medica 2014;24(2):217–22    221Katavić V. Retractions of scientific publications: responsibility and accountability (at the time of writing this opinion piece, both pa - pers are under investigation for fraud).",Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Curr Med Res Opin 2010;26:843-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Science 2006;312:40-1. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1007/ s11948-014-9532-1.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
J Med Libr  Assoc2012;100:184-9.http://dx.doi.org/10.3163/1536-5050.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
J Med Ethics 2011;37:567-70. http://dx.doi.org/10.1136/ jme.2010.040964.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Biochem Med 2010;20:282-7. http://dx.doi.org/10.11613/ BM.2010.035.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nature 2011;478:26-8. http://dx.doi.org/10.1038/  478026a.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
EMBO Rep 2008;9:2. http://dx.doi.org/10.1038/ sj.embor.7401143.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/jo - urnal.pmed.1001563.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/journal.pone.0068397.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Proc Natl Acad Sci USA 2012;109:17028-33. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Biochemia Medica 2014;24(2):217–22  http://dx.doi.org/10.11613/BM.2014.024  222Katavić V. Retractions of scientific publications: responsibility and accountability 16.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Croat Med J 2014;55:61-72. http://dx.doi.org/10.3325/ cmj.2014.55.61.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
EMBO Rep 2007;8:422-3. http://dx.doi.org/10.1038/sj.embor.7400970.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nature 2005;435:737-8. http://dx.doi.org/10.1038/  435737a.,OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Infect Immun 2011;79:3855-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Scientometri-cs 2014;98:337-45. http://dx.doi.org/10.1007/s11192-013- 1033-5.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Science 2009; 325: 813-4. http://dx.doi.org/10.1126/science.325_813c .25.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nature 2012;483:531-3. http://dx.doi.org/10.1038/483531a.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1371/jour - nal.pmed.0020124.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Nat Rev Drug Discov 2011;10:712. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
Ava-ilable at: http://www.nature.com/nature/focus/reproduci- bility/index.html.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
http://dx.doi.org/10.1136/medethics-2013- 101822.,Non-OADS,/arxiv_data1/oa_pdf/87/33/biomd-24-2-217-3.PMC4083573.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    223Abstract Efficiently managing laboratory test utilization requires both ensuring adequate utilization of needed tests in some patients and discouraging su - perfluous tests in other patients.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  224Baird G. Utilization management panel of tests, perhaps only a blood count and  electrolytes, but possibly also any one of a myriad of large so-called “wellness” panels offered by commercial laboratories that have financial incen - tives to drive frequent, high-cost testing.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    225Baird G. Utilization management when it is extremely likely that the diagnosis in  question is present.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  226Baird G. Utilization management and newborn screening are exceptions to Rule 2 is  that there exists evidence demonstrating a benefit of the testing, when coupled with appropriate downstream therapeutic interventions.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    227Baird G. Utilization management A second problem with too-frequent testing de - rives from the statistics of repetitive applications  of a single test.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  228Baird G. Utilization management drive unnecessary and costly downstream activi - ties.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    229Baird G. Utilization management tions, meaning that large relational healthcare in - formation databases(35), although expensive, will  be very valuable in future utilization studies.",Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  230Baird G. Utilization management Ta b l e  1.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    231Baird G. Utilization management Ta b l e  1.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  232Baird G. Utilization management were paid in “book money” on a scale commensu - rate with the size of their collective percentage re - ductions in laboratory and radiology test ordering.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.org/10.11613/BM.2014.025 Biochemia Medica 2014;24(2):223–34    233Baird G. Utilization management References  1.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Ann Clin Biochem 2012;49:323-36. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Ann Intern Med 1971;75:157-63. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Science 2013;340:1177-8. http://dx.doi.org/10.1126/scien- ce.1236536.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
JAMA 1989;262:89-90. http://dx.doi.org/10.1001/jama.1989.03430010101039.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem Lab Med  2004;42:747-51. http://dx.doi.org/10.1515/CCLM.2004.126.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
J Am Coll Cardiol 2004;44:720-32. http://dx.doi.org/10.1016/j.jacc.2004.07.001.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Value Health 2012;15:613-21. http://dx.doi.org/10.1016/j.jval.2012.02.007.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Cost Eff Resour Alloc 2005;3:8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Pediatrics 2003;112:1005-15. http://dx.doi.org/10.1542/peds.112.5.1005.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Ann Intern Med 1979;90:85-91. http://dx.doi.org/10.7326/0003-4819-90-1-85.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Curr Opin Cardi-ol 2008;23:629-33. http://dx.doi.org/10.1097/HCO.0b013e  32830e6b4e .17.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Cardiol 2010;106:994-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Curr Opin Lipidol 2010;21:305-11. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Proceedings of the IRE 1949;37:10-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
J Diabetes Sci Technol 2009;3:411-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Neth J Med 1995;47:208-13. http://dx.doi.org/10.1016/0300-2977(95)00100-8.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Inten-sive Care Med 1985;11:304-8. http://dx.doi.org/10.1007/ BF00273541.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch In-tern Med 1974;134:1064-7. http://dx.doi.org/10.1001/ archinte.1974.00320240098012.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Int J  Technol Assess Health Care 1997;13:512-20. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
J Clin Pathol 2005;58:457-62. http://dx.doi.org/10.1136/ jcp.2004.021691.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Biochemia Medica 2014;24(2):223–34  http://dx.doi.org/10.11613/BM.2014.025  234Baird G. Utilization management 32.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2009;55:533-40.  http://dx.doi.org/10.1373/clinchem.2008.116707.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2003;49:1997-2005. http://dx.doi.org/10.1373/clinchem.2003.021220.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Available at: http://www.acb.org.uk/docs/default-sour - ce/guidelines/acb-mri-recommendations-a4-computer.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Med Care 1982;20:293- 301. http://dx.doi.org/10.1097/00005650-198203000-00006.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch In- tern Med 1997;157:2501-8. http://dx.doi.org/10.1001/ archinte.1997.00440420135015.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Postgrad Med J 2006;82:823-9.  http://dx.doi.org/10.1136/pgmj.2006.049551.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Available at: http://www.bcbsks.com/customerser - vice/providers/MedicalPolicies/policies/policies/Testing_VitaminDDeficiency_2011-12-21.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2013;139:289-97. http://dx.doi.org/10.1309/AJCP4- G6UAUXCFTQF .,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
JAMA 1998;280:2020-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2011;135:108-18. http://dx.doi.org/10.1309/AJCP4GS7KSBDBACF .46.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
BMJ 1990;301:1305-7. http://dx.doi.org/10.1136/ bmj.301.6764.1305.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch Pathol Lab Med 2014;138:189-203. http://dx.doi.org/10.5858/arpa.2013-0149-O A.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2006;126:200-6. http://dx.doi.org/10.1309/WP59YM73L6CEGX2F .,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2007;53:1016-22. http://dx.doi.org/10.1373/clinchem.2006.083360.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch Pa- thol Lab Med 2014;138:110-3. http://dx.doi.org/10.5858/ arpa.2012-0726-O A.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Arch Intern Med 2002;162:1885-90. http://dx.doi.org/10.1001/ archinte.162.16.1885.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Int J Med Inform 2009;78:639-44. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Blood Coagul Fibrinolysis 2011;22:688-95. http://dx.doi.org/10.1097/MBC.0b013e32834b8246.,Non-OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Clin Chem 2004;50:321-6. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
Am J Clin Pathol 2001;116:879-84. http://dx.doi.org/10.1309/WC83-ERLY-NEDF-471E .,OADS,/arxiv_data1/oa_pdf/9d/13/biomd-24-2-223-4.PMC4083574.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Abstract Environmental conditions and increased physical activity during scuba diving are followed by increased production of free radicals and disturbed  redox balance.",Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
"Antonija Perovic*1, Adriana Unic2, Jerka Dumic3 1Department of Biochemical and Hematological Laboratory Diagnostics, Dubrovnik General Hospital, Dubrovnik, Croatia 2Clinical Department of Laboratory Diagnostics, Dubrava University Hospital, Zagreb, Croatia 3University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Biochemistry and Molecular Biology, Zagreb, Croatia *Corresponding author: antonija.perovic@email.t-com.hrReview http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    235Introduction In the last few decades, diving with the self con - tained underwater breathing apparatus (scuba)  has become a popular recreational sport activity all around the world.",Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  236Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    237Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  238Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    239Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  240Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    241Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  242Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    243Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  244Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Available at:  http://www.cmas.org/technique/general-documents.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Oxid Med Cell Longev 2012;2012:756132. http://dx.doi.org/10.1155/2012/756132.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Int J Mol Sci 2013;14:3834-59. http://dx.doi.org/10.3390/ ijms14023834.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Free Radic Res 2007;41:274-81. http://dx.doi.org/10.1080/10715760601080371.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Med Sci Sports Exerc 2009;41:1271-6. http://dx.doi.org/10.1249/ MSS.0b013e3181951069.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Int  J Sports Med 2012;33:531-6. http://dx.doi.org/10.1055/s- 0031-1297957.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Clin Physi-ol Funct Imaging 2010;30:432-8. http://dx.doi.org/10.1111/ j.1475-097X.2010.00962.x.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    245Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2009;105: 507-13. http://dx.doi.org/10.1007/ s00421-008-0927-z.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Acta Physiol 2011;202:69-78. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Physiol 2007;578:859-70. http://dx.doi.org/10.1113/ jphysiol.2006.122218.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Aviat Space Envi-ron Med 2007;78:1114-20. http://dx.doi.org/10.3357/ ASEM.2039.2007.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2012;112:2131-7. http://dx.doi.org/10.1007/s00421-011- 2187-6.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Physiol 2005;566:901-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem Biophys Res Commun 2005;333:404-10. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Physiol 2004;555:637- 42. http://dx.doi.org/10.1113/jphysiol.2003.059360.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Med Sci Sports Exerc 2005;37:1319-23. http://dx.doi.org/10.1113/jphysiol.2003.059360.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell Biol 2012;32:704-16. http://dx.doi.org/10.1128/MCB.06448-11.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Cell  Physiol 2013;228:2262-70. http://dx.doi.org/10.1002/ jcp.24399.23.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell 2001;107:137-48. http://dx.doi.org/10.1016/ S0092-8674(01)00524-4.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Free Radic Biol Med 2012;52:281- 90. http://dx.doi.org/10.1016/j.freeradbiomed.2011.10.484.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell Signal 2013;25:1939-48. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochim Bi-ophys Acta 2010;1804:1626-34. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell Adh Migr 2010;4:163-5. http://dx.doi.org/10.4161/cam.4.2.10972.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Exp Mol Med 2007;39:8-13. http://dx.doi.org/10.1038/ emm.2007.2.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell 2007;28:91-106. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem Biophys Res Commun 2009;380:644-9. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Cell Biol 2009;185:203-11. http://dx.doi.org/10.1083/ jcb.200809167.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Annu Rev Pathol 2010;5:253-95. http://dx.doi.org/10.1146/annurev.pathol.4.110807.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochemia Medica 2014;24(2):235–47  http://dx.doi.org/10.11613/BM.2014.026  246Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Nat Med 2011;18:159-65. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell Biol 2009;29:1989-98. http://dx.doi.org/10.1128/ MCB.00552-08.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Handb Exp Pharmacol 2011;206:163-88. http://dx.doi.org/10.1128/MCB.00552-08.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
EMBO Rep 2011;12:534-41. http://dx.doi.org/10.1038/embor.2011.65.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Mol Biol 2008;382:790-801. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Biol Chem 2005;280:13560-7. http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem J  2012;444:1-10. http://dx.doi.org/10.1042/BJ20120030.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Tren- ds Cell Biol 2012;22:546-54. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Cell Mol Life Sci 2010;67:3073-87. http://dx.doi.org/10.1007/s00018-010-0402-y .,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
At-herosclerosis 2011;218:530-5. http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Metabolism 2008;57:986-98.  http://dx.doi.org/10.1016/j.metabol.2008.02.017.50.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2010;109:731-43. http://dx.doi.org/10.1007/s00421-010-1413-y .,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2009;107:419-27. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Free Radic Res 2012;46:799-808. http://dx.doi.org/10.3109/10715762.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
J Sports Sci 2009;27:49-58. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Circ Res 2007;100:1512-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Mol Cell Biol 2008;28:6384-401. http://dx.doi.org/10.1128/MCB.00426-08.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Am J Physiol Heart Circ Physiol 2011;301:H1255- 65. http://dx.doi.org/10.1152/ajpheart.01279.2010.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Aging Cell 2010;9:304-12. http://dx.doi.org/10.1111/j.1474-9726.2010.00557.x.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Int J Cardiol 2013;168:3160-72. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Genes Dev 2007;21:2644-58. http://dx.doi.org/10.1101/gad.435107.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Eur J Appl Physiol 2013;113:2637-45. http://dx.doi.org/10.1007/ s00421-013-2676-x.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.11613/BM.2014.026 Biochemia Medica 2014;24(2):235–47    247Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Aviat Spa-ce Environ Med 2009;80:716-9. http://dx.doi.org/10.3357/ ASEM.2544.2009.,Non-OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Life Sci 2001;69:1017- 21. http://dx.doi.org/10.1016/S0024-3205(01)01193-6.71.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
Biochem Med 2012;22:237-46. http://dx.doi.org/10.11613/BM.2012.026.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
http://dx.doi.org/10.1016/j.ahj.2006.03.022.,OADS,/arxiv_data1/oa_pdf/00/a3/biomd-24-2-235-5.PMC4083575.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  248Abstract Introduction : This study describes quality indicators for the pre-analytical process, grouping errors according to patient risk as critical or major, and  assesses their evaluation over a five-year period.",Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    249Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  250Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    251Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  252Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    253Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  254Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    255Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Biochemia Medica 2014;24(2):248–57  http://dx.doi.org/10.11613/BM.2014.027  256Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Ann Saudi Med 2011;31:223-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
"Available at: http://www.aacc.org/publicati- ons/cln/2011/november/Pages/ANewApproachtoQuali- tyControl.asp x. Accessed October 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
BMC Clin Pathol 2001;1:5. http://dx.doi.org/10.1186/1472-6890-1-5.,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem 2007;53:1338-42. http://dx.doi.org/10.1373/clinchem.2007.088344.,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2009;47:143-53. http://dx.doi.org/10.1515/ CCLM.2009.045.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
http://dx.doi.org/10.11613/BM.2014.027 Biochemia Medica 2014;24(2):248–57    257Giménez-Marín A. et al.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2007;45:708-11. http://dx.doi.org/10.1515/ CCLM.2007.169.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2006;44:150-60. http://dx.doi.org/10.1515/CCLM.2006.028.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Am J Clin Pathol 2009;131:418-31. http://dx.doi.org/10.1309/AJCPJF8JI4ZL - DQUE .,Non-OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2004;42:578- 82. http://dx.doi.org/10.1515/CCLM.2004.100.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2011;49:463-70. http://dx.doi.org/10.1515/ CCLM.2011.067.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem 2012;58:638-42. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2007;45:786-96. http://dx.doi.org/10.1515/CCLM.2007.135.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2011;49:835-44. http://dx.doi.org/10.1515/ CCLM.2011.128.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem 2006;52:1442-3. http://dx.doi.org/10.1373/ clinchem.2006.069534.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem Lab Med 2007;45:720-7. http://dx.doi.org/10.1515/CCLM.2007.167.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
Clin Chem  Lab Med 2013;51:187-95. http://dx.doi.org/10.1515/cclm- 2012-0582.,OADS,/arxiv_data1/oa_pdf/69/08/biomd-24-2-248-6.PMC4083576.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  258Abstract Introduction : We have previously shown that the concentrations of D-dimer are significantly elevated in saliva compared with plasma.",Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    259Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  260Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    261Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  262Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    263Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Biochemia Medica 2014;24(2):258–65  http://dx.doi.org/10.11613/BM.2014.028  264Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
World  Health Organization 2011; Available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
JAMA 2003;290:898-904. http://dx.doi.org/10.1001/jama.290.7.898.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Circulation 1997;95:2380-6. http://dx.doi.org/10.1161/01.CIR.95.10.2380.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
http://dx.doi.org/10.11613/BM.2014.028 Biochemia Medica 2014;24(2):258–65    265Zhang X. et al.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Bioanalysis 2013;5:2249-56. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Arterioscler Thromb Vasc Biol 1999;19:493-8. http://dx.doi.org/10.1161/01.ATV.19.3.493.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
J Hypertens 2013;31:2251-8; discussion 8. http://dx.doi.org/10.1097/ HJH.0b013e328363dcc c. 13.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
N Engl J Med 2006;355:2631-9. http://dx.doi.org/10.1056/NEJ- Moa055373.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
J Thromb Haemost 2005;3:1894-904. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Acta Physiol Scand 1992;145:287-93. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Eur J Oral Sci 2006;114:22-6. http://dx.doi.org/10.1111/j.1600-0722 .2006.00264.x.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Lan- cet 1987;2:3-9. http://dx.doi.org/10.1016/S0140-6736- (87)93050-9.18.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Lancet 1993;342:1076-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Stroke 2000;31:26-32.  http://dx.doi.org/10.1161/01.STR.31.1.26.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
N Engl J Med 2000;342:1792-801. http://dx.doi.org/10.1056/NEJM200006153422406.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Chem 2011;57:675-87. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Ce - llular oncology (Dordrecht) 2013;36:1-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Transl Oncol 2012;5:321-6. http://dx.doi.org/10.1593/ tlo.12232.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Transl Med 2012;1:19. http://dx.doi.org/10.1186/2001- 1326-1-19.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Chim Acta 2012;413:1066-70. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Ann N Y Acad Sci  1993;694:72-7. http://dx.doi.org/10.1111/j.1749-6632.1993.,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Clin Chim Acta  2007;382:15-9. http://dx.doi.org/10.1016/j.cca.2007.03.009 .,OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
J Immunol Methods 2012;377:62-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
Blood 2011;117:3172-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/biomd-24-2-258-7.PMC4083577.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original papers Abstract Introduction : Urinary tract infection (UTI) is one of the most common bacterial infectious diseases in children.",Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
"Key words : oxidative stress; inflammation; acute kidney injury Received: December 12, 2013 Accepted: April 12, 2014Oxidative status parameters in children with urinary tract infection Stanislava Petrovic1, Natasa Bogavac-Stanojevic*1, Jelena Kotur-Stevuljevic1, Amira Peco-Antic2,3, Ivana Ivanisevic2, Jasmina Ivanisevic1,  Dusan Paripovic3, Zorana Jelic-Ivanovic1 1Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia 2School of Medicine, University of Belgrade, Belgrade, Serbia 3Department of Nephrology, University Children’s Hospital, Belgrade, Serbia *Corresponding author: naca@pharmacy.bg.ac.rs Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  266Introduction Oxidative stress as a state of imbalance between  oxidant and antioxidant processes of the human body may be both the cause and the consequence of many diseases.",Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.org/10.11613/BM.2014.029 Biochemia Medica 2014;24(2):266–72    267Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  268Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.org/10.11613/BM.2014.029 Biochemia Medica 2014;24(2):266–72    269Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  270Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.org/10.11613/BM.2014.029 Biochemia Medica 2014;24(2):266–72    271Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biochemia Medica 2014;24(2):266–72  http://dx.doi.org/10.11613/BM.2014.029  272Petrovic S. et al.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Int J Nep - hrol 2012;2012:465897. http://dx.doi.org/10.1155/2012/  465897.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Mediators of Inflamma-tion 2005;4:242-4. http://dx.doi.org/10.1155/MI.2005.242.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pediatr Nephrol 1991;5:733-42. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
J Pineal Res 2006;41:220-7. http://dx.doi.org/10.1111/ j.1600-079X.2006.00357.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Kidney Int 1981;20:34-42. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Exp Mol Pat-hol 1981;34:34-42. http://dx.doi.org/10.1016/0014-4800- (81)90033-2.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pe - diatr Nephrol 1995;9:583-6. http://dx.doi.org/10.1007/ BF00860942.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pediatr Nephrol 2009;24:1533-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Clin Biochem 2004;37:277-85.  http://dx.doi.org/10.1016/j.clinbiochem.2003.11.015.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Clin Biochem 2005;38:1103-11. http://dx.doi.org/10.1016/j.clinbiochem.2005.08.008.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Circulation 2003;107:499-511. http://dx.doi.org/10.1161/01.CIR.0000052939.59093.45.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Biomed Papers 2001;145:81-3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
BMC  Nephrology 2012;13:136. http://dx.doi.org/10.1186/1471- 2369-13-136.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
J Urol 1991;161:1681-4.  http://dx.doi.org/10.1016/S0022-5347(05)69004-0.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Comp Im- munol Microbiol Infect Dis 2004;27:225-34. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
J Urol  1999;162:1396-8. http://dx.doi.org/10.1016/S0022-5347- (05)68319- X.,OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Eur Surg Res 2006;38:451-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
Pediatr Nephrol 2009;24:2375– 80. http://dx.doi.org/10.1007/s00467-009-1246-2.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/biomd-24-2-266-8.PMC4083578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    273Abstract Introduction : Postmenopausal women have higher risk of cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  274Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    275Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  276Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    277Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  278Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.11613/BM.2014.030 Biochemia Medica 2014;24(2):273–80    279Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Pathop - hysiol Haemost Thromb 2002;32:325-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Eur J Endocrinol 2008;159:233-41. http://dx.doi.org/10.1530/EJE-07-0848.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Athe - rosclerosis 2004;177:203-10. http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1007/s00210-003 -0833-1.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.atherosclero - sis.2004.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1161/01.ATV.19.9.2214.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1038/ ng1196-334.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1074/jbc.275.6.3957 .,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/S0006-2952(03)00401-5.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochemia Medica 2014;24(2):273–80  http://dx.doi.org/10.11613/BM.2014.030  280Butorac D. et al.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1042/CS20040187.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Clin Biochem 2010;43:1375-80. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
"Topçuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, Topçuoglu D. The effect of hormone replacement thera-py on oxidized low density lipoprotein levels and paraoxo - nase activity in postmenopausal women.Tohoku J Exp Med 2005;205:79-86. http://dx.doi.org/10.1620/tjem.205.79.23.",OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Dis Markers 2013;35:85-96. http://dx.doi.org/10.1155/2013/724706.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Obstet Gyne - col 1995;85:523-8. http://dx.doi.org/10.1016/0029-7844- (94)00452- J.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
Biochim Biophys Acta 2009;1790:155– 60. http://dx.doi.org/10.1016/j.bbagen.2008.11.009.,OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1007/s00109-003-0481-4.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/60/98/biomd-24-2-273-9.PMC4083579.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    281Abstract Introduction : The aim of this survey study was to assess the current practices and policies in use related to the various steps in the blood gas te - sting process, across hospital laboratories in Croatia.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  282Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    283Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  284Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    285Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  286Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    287Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  288Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    289Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  290Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"http://dx.doi.org/10.11613/BM.2014.031 Biochemia Medica 2014;24(2):281–92    291Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2003;333:141-5. http://dx.doi.org/10.1016/S0009-8981- (03)00178-5.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2003;333:185-9. http://dx.doi.org/10.1016/S0009-8981- (03)00184-0.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/ BM.2013.031.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Ann Lab Med 2012;32:5-16. http://dx.doi.org/10.3343/alm.2012.32.1.5.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"Biochemia Medica 2014;24(2):281–92  http://dx.doi.org/10.11613/BM.2014.031  292Dukić L, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2013;pii:S0009-8981(13)00331-8. http://dx.doi.org/10.1016/j.cca.2013.08.021.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Bi-ochem 2013;46:1170-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chim Acta 2013;pii:S0009-8981(13)00336-7.  http://dx.doi.org/10.1016/j.cca.2013.07.033.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2010;20:64-74. http://dx.doi.org/10.11613/BM.2010.008.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem Lab Med 2013;51:2099-107. http://dx.doi.org/10.1515/cclm- 2013-0183.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Respir Care 2013;58:1694-1703. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2012;22:189-201. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Biochem Med 2013;23:19-27. http://dx.doi.org/10.11613/ BM.2013.005.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin  Chem Lab Med 2011;49:931-2. http://dx.doi.org/10.1515/ CCLM.2011.136.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem Lab Med 2013;51:1651-4. http://dx.doi.org/10.1515/cclm- 2012-0802.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Int J Emerg Med 2009;2:117-20. http://dx.doi.org/10.1007/s12245-009- 0091-1.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
BMC Ane - sthesiol 2012;12:17. http://dx.doi.org/10.1186/1471-2253- 12-17.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
http://acutecaretesting.org/en/ar - ticles/the-importance-of-quality-control-qc-to-quality-blood-gas-testing.,Non-OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem Lab Med 2007;45:774-80. http://dx.doi.org/10.1515/CCLM.2007.163.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
Clin Chem 2011;57:1219-20. http://dx.doi.org/10.1373/clinchem.2011.171538.,OADS,/arxiv_data1/oa_pdf/e6/b9/biomd-24-2-281-10.PMC4083580.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.11613/BM.2014.032 Biochemia Medica 2014;24(2):293–8    293Abstract Introduction : Alpha-1-antitrypsin deficiency (AATD), genetic risk factor for premature chronic obstructive pulmonary disease (COPD), often remains  undetected.",Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochemia Medica 2014;24(2):293–8  http://dx.doi.org/10.11613/BM.2014.032  294Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.11613/BM.2014.032 Biochemia Medica 2014;24(2):293–8    295Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochemia Medica 2014;24(2):293–8  http://dx.doi.org/10.11613/BM.2014.032  296Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.11613/BM.2014.032 Biochemia Medica 2014;24(2):293–8    297Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochemia Medica 2014;24(2):293–8  http://dx.doi.org/10.11613/BM.2014.032  298Beletic A. et al.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Available at: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Can  Med Assoc J 2012;184:1365-71. http://dx.doi.org/10.1503/ cmaj.111749.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.1111/joim.12239.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Clin Chem  2006;52:2236-42. http://dx.doi.org/10.1373/clinchem.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Am J Clin Pathol 2007;128:482-90. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Eur Respir J 2010;35:960-8. http://dx.doi.org/10.1183/09031936.00069709.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
J Med Biochem 2014;33:88-96. http://dx.doi.org/10.2478/jomb- 2013-0038.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Available at: http://www.goldco - pd.org/uploads/users/files/GOLDReport_April112011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/ BM.2013.031.10.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
COPD 2013;10(S1):26-34. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Am J Clin Pathol 2012;138:398-405. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Resp Med 2007;101:1708-14. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Ther Adv Respir Dis 2012;6:79-85. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.2174/  138920310790848368.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
http://dx.doi.org/10.1373/ clinchem.2007.095125.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/biomd-24-2-293-11.PMC4083581.pdf
Available from: http://www.odermatol.com/odermatology/22013doi/ourd.20132.52.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/rt-2014-2-5343.PMC4083668.pdf
A vailable from: http://ispub.com/IJS/10/1/9804.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/rt-2014-2-5343.PMC4083668.pdf
Available from: http://www.cdc.gov /nchs/data/ nvsr/nvsr61/nvsr61_06.pdf.,OADS,/arxiv_data1/oa_pdf/29/a3/rt-2014-2-5389.PMC4083673.pdf
Available from: http://www.ohchr.,Non-OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available  from: http://www.ilo.org/global/topics/forced‑labour/Letter to Editor,Non-OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available from: http://www.state.gov/g/tip/ rls/tiprpt/2007.,OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available from: http://www.who.int/reproductivehealth/topics/ violence/vaw_series/en/.,Non-OADS,/arxiv_data1/oa_pdf/56/ad/AMHSR-4-61.PMC4083714.pdf
Available from: http://www.iadr.confex.com/ iadr/2005Balt/techprogram/abstract_61038.htm.,Non-OADS,/arxiv_data1/oa_pdf/57/b0/AMHSR-4-18.PMC4083724.pdf
"OTUs were picked using a closed-reference OTUpicking protocol against the Greengenes database 12_10release, http://greengenes.secondgenome.com/ (De Santiz et al.",OADS,/arxiv_data1/oa_pdf/5a/44/ele0017-0979.PMC4084827.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
"Direct link to deposited data Deposited data are available here: https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE34422 .Experimental design, materials and methods Cell line The human neuroblastoma cell line BE(2)-C was obtained from ATCC (CRL-2268, ATCC).",OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
"Speci ﬁcations Organism/cell line/tissueHomo sapiens Strain(s) Human neuroblastoma cell line BE(2)-C (CRL-2268, ATCC) Sequencer or array type Microarray: Affymetrix Human Gene 1.0 ST ChIP-seq: Illumina Genome Analyzer IIX Data format Microarray raw data: CEL ﬁles ChIP-seq raw data: FASTQ ﬁles Experimental factors BE(2)-C cells without or with HOXC9 overexpression Experimental features Micr oarray gene expression pro ﬁling to identify genes that are regulated by HOXC9ChIP-seq to map genomic sites that are bound byHOXC9 Consent N/ASample source location N/A http://dx.doi.org/10.1016/j.gdata.2014.04.0022213-5960/© 2014 The Authors.",OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/main.PMC4084856.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ .",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
Reprints and permissions information is available online at http://www.nature.com/reprints/index.html .,Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
"This year, Sage and DREAM (Dialogue for Reverse Engineering Assessments and Methods) are running four open challenges ( http://www.sagebase.org/challenges-overview/2013-dream- challenges/ ).",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
"Then, during the validation phase, each team will submit computer code, which the Sage- DREAM team ( http://www.sagebase.org/ ) will test in Synapse to establish whether it runs as expected to predict if a subject is an anti-TNF therapy responder or nonresponder on the basis of the GWAS data.",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
"2013 published online, http://dx.doi.org/10.1371/journal.pgen.",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/nihms590117.PMC4084858.pdf
© 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ *Correspondence: asood@mdanderson.org (A.K.S.,Non-OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six figures and one table and can be found with this article online at http://dx.doi.org/10.1016/ j.celrep.2014.02.014 .,OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
"A General Role for Complement in Cancer Growth To investigate whether complement proteins could be produced by other cancer cells besides ovarian cancer, we analyzed expression of C3 mRNA in different cancer cell lines using the Cancer Cell Line Encyclopedia (CCLE) database ( http://www.broadinstitute.org/ccle/home ) and identified a high level of C3 expression in liver, kidney, lung, endometrium, and ovarian cancer cell lines (Figure S6A).",OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
TCGA data portal ( http://tcga.cancer.gov ) was used to download information on clinically annotated information on patients with high- grade serous ovarian cancer and squamous cell lung cancer.,OADS,/arxiv_data1/oa_pdf/66/ba/nihms582020.PMC4084868.pdf
"To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-sa/3.0 Correspondence and requests for materials should be addressed to N.H.P.",Non-OADS,/arxiv_data1/oa_pdf/4c/e5/nihms587989.PMC4085046.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/cb/20/OpenMed-08-46.PMC4085085.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/3b/9d/OpenMed-08-54.PMC4085086.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/70/b5/OpenMed-08-67.PMC4085087.pdf
"Avail - able from: http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-21.html#docContBox 2 Controlled Drugs and Substances Act, section 5619  ➣The Minister may, on such terms and conditions as the Minister  deems necessary, exempt any person or class of persons or any controlled substance or precursor or any class thereof from the application of all or any of the provisions of this Act or the regulations if, in the opinion of the Minister, the exemption is necessary for a medical or scientifi  c purpose or is otherwise in the public interest.",Non-OADS,/arxiv_data1/oa_pdf/49/67/OpenMed-08-73.PMC4085088.pdf
"For more information, please see  http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/49/67/OpenMed-08-73.PMC4085088.pdf
Available from: http://hiru.mc - master.ca/hiru/HIRU_Hedges_home.aspx  (accessed 2012 Jun 23).,Non-OADS,/arxiv_data1/oa_pdf/af/68/OpenMed-08-01.PMC4085089.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/af/68/OpenMed-08-01.PMC4085089.pdf
Available   from: http://virtualmentor.ama-assn.org/2002/10/jdsc1-0210.html   (accessed 2013 Dec 10).,OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
Available from: http://en.wiki - pedia.org/wiki/Predictable_surprise  (2013 Dec 10).,Non-OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
Available from:  http://online.wsj.com/article/SB100008723963904434933045780388119 45287932.html  (accessed 2013 Dec 10).,Non-OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
Avail - able from: http://assembly.coe.int/asp/apfeaturesmanager/default   ArtView.asp?ID=918  (accessed 2013 Dec 10).,OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/75/73/OpenMed-08-10.PMC4085090.pdf
"When necessary, notices on  the MedEffect web site were supplemented by search - ing the product name in the Drug Product Database  (http://webprod5.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp ).",OADS,/arxiv_data1/oa_pdf/42/40/OpenMed-08-14.PMC4085091.pdf
Available  from: http://publications.gc.ca/collections/collection_2007/hc-sc/ H16448-2007E.pdf  (accessed 2013 Sep 26).,Non-OADS,/arxiv_data1/oa_pdf/42/40/OpenMed-08-14.PMC4085091.pdf
"For more information, please see   http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/42/40/OpenMed-08-14.PMC4085091.pdf
Available from: http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/list-eng.php  (accessed 2012 May 28).,OADS,/arxiv_data1/oa_pdf/45/96/OpenMed-08-20.PMC4085092.pdf
Available from: http://travel.gc.ca/travelling/health-safety/clinic  (accessed 2014 Feb 3).,Non-OADS,/arxiv_data1/oa_pdf/45/96/OpenMed-08-20.PMC4085092.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/45/96/OpenMed-08-20.PMC4085092.pdf
Available from: http://hdl.handle.net/10402/era.23788  (accessed 2012 Mar 20).,OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
Available from: http://hdl.handle.net/10402/era.23779  (accessed 2012 Mar  20).,OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
Available from: https://secure.cihi.ca/free_products/Hospitalizations%20for%20ADR-ENweb.pdf  (accessed 2013 Apr 21).,Non-OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/09/75/OpenMed-08-33.PMC4085093.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 205–212Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  205PERSPECTIVESopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6390 3Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"Or use: http://dvpr.es/1vOrUO nBeyond information retrieval and electronic  health record use: competencies in clinical  informatics for medical education William R Hersh1 Paul N Gorman1 Frances E Biagioli2 Vishnu Mohan1 Jeffrey A Gold3 George C Mejicano4 1Department of Medical Informatics  and Clinical Epidemiology,   2Department of Family Medicine,   3Department of Medicine,  4School of  Medicine, Oregon Health & Science  University, Portland, OR, USA Correspondence: William R Hersh   Department of Medical Informatics and  Clinical Epidemiology, School of Medicine,  Oregon Health & Science University,   3181 SW Sam Jackson Park Rd, BICC,  Portland, OR, USA   Tel +1 503 494 4563  Email hersh@ohsu.ed uAbstract:  Physicians in the  21st century will increasingly interact in diverse ways with  information systems, requiring competence in many aspects of clinical informatics.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"com) or medical (eg, PubMed, http://www.pubmed.go v)  search engines.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
gov) and the Centers for Disease Control and Prevention  travel site ( http://wwwnc.cdc.gov/trave l).,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/46/amep-5-205.PMC4085140.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 EDITOR’S NOTE – About This Supplement There are increasing cases of occupational diseases in industrial working places in Korea.",Non-OADS,/arxiv_data1/oa_pdf/79/63/jkms-29-S1.PMC4085167.pdf
"Sung-Tae Hong, MD Editor-in-Chief Journal of Korean Medical Science Department of Parasitology and Tropical Medicine, National University College of Medicine, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.S.S1  • J Korean Med Sci 2014; 29: S1EDITORIAL",Non-OADS,/arxiv_data1/oa_pdf/79/63/jkms-29-S1.PMC4085167.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Work-Related Cerebrocardiovascular Diseases The purpose of this study was to discuss the history of, and concerns regarding, the newly  amended criteria of occupational cerebrovascular or cardiovascular diseases (CCVDs).",Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
"Keywords:  Myocardial Infarction; Cardiovascular Diseases; Stroke; Overwork; Workers’  Compensation; KoreaJong-Uk Won1 and Inah Kim2 1Department of Preventive Medicine, College of  Medicine, Yonsei University, Seoul; 2Department of  Occupational and Environmental Health, Yonsei  University Graduate School of Public Health, Seoul,  Korea Received: 26 December 2013 Accepted: 2 May 2014 Address for Correspondence: Inah Kim, MD Department of Occupational and Environmental Health, Yonsei  University Graduate School of Public Health, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea  Tel: +82.32-260-3664, Fax: +82.32-260-3667 E-mail: ptdoctor@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.S.S12  • J Korean Med Sci 2014; 29: S12-17 INTRODUCTION On November 24, 1990, the Kyunghyang Shinmun  newspaper  printed the first report on karoshi  (death from overwork) in Ko - rea.",Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases http://jkms.org   S13 http://dx.doi.org/10.3346/jkms.2014.29.S.S12Table 1.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases S14  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S12Table 4.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases http://jkms.org   S15 http://dx.doi.org/10.3346/jkms.2014.29.S.S12are Japan and Taiwan.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases S16  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S12currence) for 12 weeks before CCVD occurrence.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
ORCID Jong-Uk Won http://orcid.org/0000-0002-9200-3297  Inah Kim http://orcid.org/0000-0003-3568-4484  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
• Compensation for Cerebro-cardiovascular Diseases http://jkms.org   S17 http://dx.doi.org/10.3346/jkms.2014.29.S.S12rea.,Non-OADS,/arxiv_data1/oa_pdf/70/07/jkms-29-S12.PMC4085168.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Work-Related Musculoskeletal Diseases and the Workers’  Compensation  The Industrial Accident Compensation Insurance Act (IACIA) regulates the workers’  compensation insurance system and the standards for the recognition of occupational  diseases (ODs).",Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
"Keywords:  Work-Related Musculoskeletal Disease (WMSD); Occupational Disease;  Workers’ Compensation; KoreaTae-Won Jang,1 Jung-Wan Koo,1   Soon-Chan Kwon,2 and Jaechul Song2 1Department of Occupational and Environmental  Medicine, College of Medicine, The Catholic  University of Korea, Seoul; 2Department of  Occupational and Environmental Medicine,  Hanyang University College of Medicine, Seoul,  Korea Received: 18 December 2013 Accepted: 12 May 2014 Address for Correspondence: Jaechul Song, MD Department of Occupational and Environmental Medicine,  Hanyang University College of Medicine, 222 Wangsimni-ro,  Seongdong-gu, Seoul 133-791, Korea Tel: +82.2-2220-0663, Fax: +82.2-2220-4663 E-mail: jsong@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.S.S18  • J Korean Med Sci 2014; 29: S18-23 INTRODUCTION In Korea, standards for the recognition of occupational diseases  (ODs) were stipulated in the Established Regulations of the  Ministry of Labor for the first time when the Ministry of Labor  was established in 1981.",Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
"• Work-Related Musculoskeletal Diseases in Korea http://jkms.org   S19 http://dx.doi.org/10.3346/jkms.2014.29.S.S18that a disease is associated with non-occupational factors rath - er than occupational factors, workers may not be approved for  compensation.",Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
• Work-Related Musculoskeletal Diseases in Korea S20  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S18Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
• Work-Related Musculoskeletal Diseases in Korea http://jkms.org   S21 http://dx.doi.org/10.3346/jkms.2014.29.S.S18degenerative musculoskeletal diseases related with work could  be considered compensable ODs.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
• Work-Related Musculoskeletal Diseases in Korea S22  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S18bor; and COMWEL should cooperate to narrow the differences  in the criteria for the approval of compensation in the cases of  WMSDs.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
ORCID Tae-Won Jang http://orcid.org/0000-0003-2624-3257  Jung-Wan Koo http://orcid.org/0000-0001-8306-0292  Soon-Chan Kwon http://orc id.org/000 0-0002-578 2-6087 Jaechul Song http://orcid.org/0000-0003-1265-0337  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
Available at http://www.kosha.or.kr/board.do?menuId=  554 [accessed on 10 Nov 2013].,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
• Work-Related Musculoskeletal Diseases in Korea http://jkms.org   S23 http://dx.doi.org/10.3346/jkms.2014.29.S.S18dustrial Accident Compensation insurance.,Non-OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
Available at http://www.cdc.gov/ niosh/docs/97-141/pdfs/97-141.pdf [accessed on 15 Nov 2013].,OADS,/arxiv_data1/oa_pdf/a5/00/jkms-29-S18.PMC4085169.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 PREFACE Korea has expanded the range of occupational diseases (ODs) to include occupational cancers.",Non-OADS,/arxiv_data1/oa_pdf/e5/4e/jkms-29-S2.PMC4085170.pdf
"Jaechul Song, MD Guest Editor Department of Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.S.S2  • J Korean Med Sci 2014; 29: S2EDITORIAL",Non-OADS,/arxiv_data1/oa_pdf/e5/4e/jkms-29-S2.PMC4085170.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Occupational Injuries and Diseases in Special  Populations: Farmers and Soldiers Some types of workers such as farmers and soldiers are at a higher risk of work-related  injury and illness than workers from other occupations.",Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
"Keywords:  Compensation; Occupational Diseases; Farmers; SoldiersYoung-Jun Kwon1 and Soo-Jin Lee2 1Department of Occupational and Environmental  Medicine, Hallym University Sacred Heart Hospital,  Anyang; 2Department of Occupational and  Environmental Medicine, Hanyang University  College of Medicine, Seoul, Korea Received: 18 December 2013 Accepted: 7 April 2014 Address for Correspondence: Soo-Jin Lee, MD Department of Occupational and Environmental Medicine,  Hanyang University College of Medicine, 222 Wangsimni-ro,  Seongdong-gu, Seoul 133-791, Korea Tel: +82.2-2290-9292, Fax: +82.2-2220-0664 E-mail:sjlee@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.S.S24  • J Korean Med Sci 2014; 29: S24-31 INTRODUCTION In Korea, almost all businesses and workplaces with one or  more workers have a comprehensive occupational safety and  health system (OSH system) for preventing industrial accidents  and establishing a healthy and safe work environment.",Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
• Occupational Diseases of Special Populations: Farmers and Soldiers   http://jkms.org   S25 http://dx.doi.org/10.3346/jkms.2014.29.S.S24Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
• Occupational Diseases of Special Populations: Farmers and Soldiers  S26  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S24Work-related injuries and diseases among farmers Agriculture is considered as one of the most hazardous indus - tries for workers all over the world.,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
"• Occupational Diseases of Special Populations: Farmers and Soldiers   http://jkms.org   S27 http://dx.doi.org/10.3346/jkms.2014.29.S.S24volved in these accidents were power tillers (0.82 per 100 ma - chines), followed by combine harvesters (0.37), and tractors  (0.31).",Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
• Occupational Diseases of Special Populations: Farmers and Soldiers  S28  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S24(1 case).,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
• Occupational Diseases of Special Populations: Farmers and Soldiers   http://jkms.org   S29 http://dx.doi.org/10.3346/jkms.2014.29.S.S24Table 5.,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
• Occupational Diseases of Special Populations: Farmers and Soldiers  S30  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S24Table 7.,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
"• Occupational Diseases of Special Populations: Farmers and Soldiers   http://jkms.org   S31 http://dx.doi.org/10.3346/jkms.2014.29.S.S24ly, many farmers suffer from work-related injuries and illnesses  leading to physical pain, financial hardship, and loss of work.",Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
ORCID Young-Jun Kwon http://orcid.org/0000-0002-2718-8870  Soo-Jin Lee http://orcid.org/0000-0002-4938-1700  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
Available at: http://ebook.mafra.go.kr/ 20121228_165810/ [accessed on 25 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
Available at: http://www.moel.go.kr/english/statistics/major_statistics.,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
Available at http://www.law.go.kr/admRulin - foPWah.do?admRulSeq=2000000024349 [accessed on 14 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
Available at http://www.prism.go.kr/homepage/research - Common/retrieveResearchDetailPopup.do?research_id=1290000- 201200031.,OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
Available at  http://www.mps.go.kr/milpen/renewal/ BoardView.do [accessed on 22  August 2013],Non-OADS,/arxiv_data1/oa_pdf/f6/4f/jkms-29-S24.PMC4085171.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Administrative Process for Recognition and Compensation  for Occupational Diseases in Korea In the Workers’ Compensation Insurance (WCI) system in Korea, occupational diseases (ODs)  are approved through deliberation meetings of the Committee on Occupational Disease  Judgment (CODJ) after disease investigations when workers or medical institutions  requested the Korea Workers’ Compensation and Welfare Service (COMWEL) for medical  care benefits.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
"Keywords:  Occupational Diseases; Workers’ Compensation; KoreaSoon-Chan Kwon,1 Hyoung-Ryoul Kim,2  and Young-Jun Kwon3 1Department of Occupational and Environmental  Medicine, Hanyang University College of Medicine,  Seoul; 2Department of Occupational and  Environmental Medicine, College of Medicine, The  Catholic University of Korea, Seoul; 3Department of  Occupational and Environmental Medicine, Hallym  University Sacred Heart Hospital, Anyang, Korea Received: 17 December 2013 Accepted: 2 May 2014 Address for Correspondence: Young-Jun Kwon, MD Department of Occupational and Environmental Medicine,  Hallym University Sacred Heart Hospital, 22 Gwanpyeong-ro  170beon-gil, Dongan-gu, Anyang 431-796, Korea Tel: +82.31-380-1591, Fax: +82.31-380-1583 E-mail: kwon5996@hallym.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.S.S3  • J Korean Med Sci 2014; 29: S3-11 INTRODUCTION The term “workers” refers to those who undertake paid employ - ment irrespective of occupation (1).",Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
"• Recognition Process for Occupational Diseases in Korea S4  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S3disease” refers to an occupational disease or work-related dis - ease, the term “occupational injury” refers to an injury by an  accident that occurred when working, and the term “work-re - lated accident” refers to an industrial accident as specified in  the IACIA.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
• Recognition Process for Occupational Diseases in Korea http://jkms.org   S5 http://dx.doi.org/10.3346/jkms.2014.29.S.S3cal investigations.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
"• Recognition Process for Occupational Diseases in Korea S6  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S3sonal information, cause of the accident, description and ex - planation of the event, whether compensation is to be received  other than benefits from WCI, the employer’s seal or signature,  and the victim’s seal or signature.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
• Recognition Process for Occupational Diseases in Korea http://jkms.org   S7 http://dx.doi.org/10.3346/jkms.2014.29.S.S3held that job are reviewed through personnel record books.,OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
"• Recognition Process for Occupational Diseases in Korea S8  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S3Advantages of the Committee on Occupational Disease Judgment Before the introduction of the CODJ, judgments on ODs were  made by individual opinions of the advisory doctors to individ - ual branches of COMWEL.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
"• Recognition Process for Occupational Diseases in Korea http://jkms.org   S9 http://dx.doi.org/10.3346/jkms.2014.29.S.S3not be evaluated with the first site investigation, a detailed bur - den evaluation should be requested of related experts.",Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
• Recognition Process for Occupational Diseases in Korea S10  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S3fit the reality of Korea through comparisons of these individual  elements among countries and should be steadily discussed  and studied.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
ORCID Soon-Chan Kwon http://orcid.org/0000-0002-5782-6087  Hyoung-Ryoul Kim http://orcid.org/0000-0001-7535-3140  Young-Jun Kwon http://orcid.org/0000-0002-2718-8870  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.lawnb.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Availble at: http://kosis.kr/statisticsList/statisticsList_01List.,OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://kosis.kr/statisticsList/statisticsList_01List.jsp?- vwcd=MT_ZTITLE&parentId=B [accessed on 4 November 2013].,OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at http://www.lawnb.com/lawinfo/contents_view.asp?cid=489D63 F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.lawnb.com/ lawinfo/contents_view.asp?cid=4375FD37B4024C389F28EC2C889B1560|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at: http://www.lawnb.com/lawinfo/contents_view.asp?cid=489D6 3F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at  http://www.lawnb.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at http://www.lawnb.com/lawinfo/contents_view.asp?cid=489D63 F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.lawnb.com/  lawinfo/contents_view.asp?cid=489D63F8A22E484285C5D1472BA9CD 89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.lawnb.com/lawinfo/contents_view.asp?cid=48 9D63F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 December  2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at  http://www.kli.re.kr/kli_home/isdata/vew.home-21010;jsession id=3D8D33D744F4731725C3E18C535218C6?pageNo=4&condition=&k eyword=&rowNum=&year=2002&seq=5498 [accessed on 27 December  2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at  http://www.prism.go.kr/homepage/researchCom - mon/retrieveResearchDetailPopup.do;jsessionid=DC24A0933E38518A CC94CFDE46D97D5E.node02?research_id=1490000-201200027 [Ac - cessed on 4 November 2013].,OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available  at http://www.lawnb.com/lawinfo/contents_view.asp?cid=6DC9B2484 45644E58EF29C8501852AF8|0|K [accessed on 27 December2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.law.go.kr/LSW/admRulInfoP - Wah.do?admRulSeq=2000000077866 [accessed on 27 December2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.law.go.kr/LSW/admRulInfoP - Wah.do?admRulSeq=2000000077866.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
• Recognition Process for Occupational Diseases in Korea http://jkms.org   S11 http://dx.doi.org/10.3346/jkms.2014.29.S.S38A22E484285C5D1472BA9CD89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at http://www.lawnb.com/lawinfo/contents_view.asp?cid=489D63 F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.lawnb.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.lawnb.com/lawinfo/contents_view.asp?c id=489D63F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 De - cember 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at http://www.lawnb.com/lawinfo/contents_view.asp?cid=489D63 F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at http://www.lawnb.com/lawinfo/contents_view.asp?cid=489D63 F8A22E484285C5D1472BA9CD89|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at https://www.molab.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at https://www.kcomwel.or.kr/download/ data/work/%EA%B5%AD%EB%82%B4%EC%99%B8%20%EC%82%B0 %EC%9E%AC%EB%B3%B4%ED%97%98%EC%A0%9C%EB%8F%84% EC%9D%98%20%EB%B9%84%EA%B5%90%20%EC%97%B0%EA%B5 %AC(%EA%B9%80%EC%9E%A5%EA%B8%B0).PDF [Accessed on 4  November 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.law.go.kr/LSW/admRulInfoP - Wah.do?admRulSeq=2000000077866 [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at: http://www.law.go.kr/LSW/admRulInfoP - Wah.do?admRulSeq=2000000077866 [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.law.go.kr/LSW/admRulIn - foPWah.do?admRulSeq=2000000077866 [accessed on 27 December  2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Avail - able at http://www.lawnb.com/lawinfo/contents_view.asp?cid=6DC9B 248445644E58EF29C8501852AF8|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://www.esdc.go.kr/bbs/viewbody.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at: http://search.ccourt.,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
"Available at http://search.ccourt.go.kr/ths/pr/se - lectThsPr0101List.do [Accessed on Nov 4, 2013].",OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
Available at http://search.ccourt.go.kr/ths/ pr/selectThsPr0101List.do [Accessed on 4 November 2013].,Non-OADS,/arxiv_data1/oa_pdf/3e/be/jkms-29-S3.PMC4085172.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Scope and Specific Criteria of Compensation for Occupational  Diseases in Korea The range of diseases covered by workers’ compensation is constantly expanding.",Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
"Keywords:  Workers’ Compensation; Occupational Diseases; KoreaJaechul Song,1 Inah Kim,2   and Byung-Soon Choi3 1Department of Occupational and Environmental  Medicine, Hanyang University College of Medicine,  Seoul; 2Graduate School of Public Health, Yonsei  University, Seoul; 3Occupational Lung Diseases  Institute, Ansan, Korea Received: 18 December 2013 Accepted: 10 April 2014 Address for Correspondence: Jaechul Song, MD Department of Occupational and Environmental Medicine,  Hanyang University College of Medicine, 222 Wangsimni-ro,  Seongdong-gu, Seoul 133-791, Korea Tel: +82.2-2220-0663, Fax: +82.2-2220-4663 E-mail: jsong@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.S.S32  • J Korean Med Sci 2014; 29: S32-39 INTRODUCTION Workers’ compensation is a form of social insurance providing  wage replacement and medical benefits to employees injured  at work.",Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
• Korean Scope and Specific Criteria of Compensation for Occupational Diseases http://jkms.org   S33 http://dx.doi.org/10.3346/jkms.2014.29.S.S32and to contribute to worker protection through accident pre - vention and other projects promoting workers’ welfare (4).,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
• Korean Scope and Specific Criteria of Compensation for Occupational Diseases S34  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S32on an analysis of the problems with the previous specific OD  recognition standards and on complementary studies.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
"• Korean Scope and Specific Criteria of Compensation for Occupational Diseases http://jkms.org   S35 http://dx.doi.org/10.3346/jkms.2014.29.S.S32The chemical causes include 108 organic chemicals, 19 metals,  8 acids and alkalis, 14 gases, 13 materials that must be licensed  for use, and 6 types of dusts containing materials that require a  specific medical examination (for workers).",Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
ORCID Jaechul Song http://orcid.org/0000-0003-1265-0337  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
Available  at http://law.go.kr/engLsSc.do?menuId=0&subMenu=5&query=constit,OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
• Korean Scope and Specific Criteria of Compensation for Occupational Diseases S36  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S32ution#liBgcolor0 [accessed on 11 December 2013] 3.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
Available  at http://law.go.kr/engLsSc.do?menuId=0&subMenu=5&query=constit ution#liBgcolor0 [accessed on 11 December 2013] 4.,OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
English version available at http://law.go.kr/engLsSc.do?m enuId=0&subMenu=5&query=%EA%B7%BC%EB%A1%9C%EA%B8%B 0%EC%A4%80%EB%B2%95#liBgcolor0 [accessed on 12 December 2013] 5.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
"English version available at  http://law.go.kr/engLsSc.do?menuId=0&subMenu=5&query=%EA%B7 %BC%EB%A1%9C%EA%B8%B0%EC%A4%80%EB%B2%95#liBgcolor0,  [accessed on 12 December 2013]  6. International labor office (ILO).",Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
English version available at http://law.go.kr/engLsSc.do?menuId=0&su bMenu=5&query=%EA%B7%BC%EB%A1%9C%EA%B8%B0%EC%A4% 80%EB%B2%95#liBgcolor4 [accessed on 12 December 2013] 14.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
English version available at http://law.go.kr/ engLsSc.do?menuId=0&subMenu=5&query=%EA%B7%BC%EB%A1%9 C%EA%B8%B0%EC%A4%80%EB%B2%95#liBgcolor3 [accessed on 12  December 2013] 16.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
Available at http://www.prism.go.kr/homepage/re - searchCommon/retrieveResearchDetailPopup.do?research_id=1490000- 201100029 [accessed on 12 December 2013] 18. International labor office (ILO).,OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
Available at http://www.ilo.org/dyn/normlex/en/f?p=NORMLEXPUB: 12100:0::NO::P12100_ILO_CODE:C130 [accessed on 10 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
• Korean Scope and Specific Criteria of Compensation for Occupational Diseases http://jkms.org   S37 http://dx.doi.org/10.3346/jkms.2014.29.S.S32Annexure 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
• Korean Scope and Specific Criteria of Compensation for Occupational Diseases S38  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S32Annexure 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
• Korean Scope and Specific Criteria of Compensation for Occupational Diseases http://jkms.org   S39 http://dx.doi.org/10.3346/jkms.2014.29.S.S32List of occupational diseases   9.,Non-OADS,/arxiv_data1/oa_pdf/dd/c4/jkms-29-S32.PMC4085173.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Occupational Cancer The legal scope and criteria for occupational cancer in Korea was out of date.",Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
"Keywords:  Occupational Cancer; Compensation; KoreaInah Kim,1 Eun-A Kim,2   and Jae Young Kim3 1Department of Occupational and Environmental  Health, Yonsei University Graduate School of Public  Health, Seoul; 2Occupational Safety and Health  Research Institute, Korea Occupational Safety and  Health Agency, Ulsan; 3Department of Occupational  and Environmental Medicine, Hanyang University  College of Medicine, Seoul, Korea Received: 19 December 2013 Accepted: 2 May 2014 Address for Correspondence: Eun-A Kim, MD Occupational Safety and Health Research Institute, Korea  Occupational Safety and Health Agency, 400 Jongga-ro,   Jung-gu, Ulsan 681-230, Korea  Tel: +82.52-703-0870, Fax:+82.52-703-0333  E-mail: toxneuro@kosha.nethttp://dx.doi.org/10.3346/jkms.2014.29.S.S40  • J Korean Med Sci 2014; 29: S40-46 INTRODUCTION The Korean public is highly concerned about the risk of occu - pation cancer as a result of exposure to carcinogens in the work - place.",Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
• Occupational Cancer Compensation http://jkms.org   S41 http://dx.doi.org/10.3346/jkms.2014.29.S.S40 The criteria determining whether or not an employee is enti - tled to compensation as a result of occupational cancer are a  major issue because the criteria is the only legal standard adapt - ed all processes of compensation for occupational disease from  COMWEL to the Administrative Court.,Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
• Occupational Cancer Compensation S42  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S40communal claims by metal union.,Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
• Occupational Cancer Compensation http://jkms.org   S43 http://dx.doi.org/10.3346/jkms.2014.29.S.S40Table 4.,Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
"• Occupational Cancer Compensation S44  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S40for recent amendment and directly participated in the policy  making process of amendments to the scope and criteria, se - lected 28 agents and 11 industries to extend the criteria of oc - cupational cancer according to the results the previously de - scribed review of the occupational cancer list of the ILO, the EU,  and the IARC classification, and the exposure possibility in Ko - rea to identified risk factors.",Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
"• Occupational Cancer Compensation http://jkms.org   S45 http://dx.doi.org/10.3346/jkms.2014.29.S.S40between countries is one of the main issues to consider, espe - cially an understanding of the compensation criteria or scope  of occupational cancer, because cancer usually develops post- exposure (5).",Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
ORCID Inah Kim http://orcid.org/0000-0003-3568-4484  Eun-A Kim http://orcid.org/0000-0002-8582-234X  Jae Young Kim http://orcid.org/0000-0002-9011-4209  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
• Occupational Cancer Compensation S46  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S40ma in semiconductor industry workers in Korea.,Non-OADS,/arxiv_data1/oa_pdf/68/f6/jkms-29-S40.PMC4085174.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Workers’ Compensation for Occupational Respiratory Diseases The respiratory system is one of the most important body systems particularly from the  viewpoint of occupational medicine because it is the major route of occupational exposure.",Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
"Keywords:  Respiratory Tract Diseases; Occupational Diseases; Workers’ Compensation;  KoreaSo-young Park,1 Hyoung-Ryoul Kim,2   and Jaechul Song3 1Occupational Lung Diseases Institute, Korea  Workers’ Compensation & Welfare Service, Ansan;  2Department of Occupational and Environmental  Medicine, College of Medicine, the Catholic  University of Korea, Seoul; 3Department of  Occupational and Environmental Medicine,  Hanyang University College of Medicine, Seoul,  Korea Received: 20 December 2013 Accepted: 6 April 2014 Address for Correspondence: Hyoung-Ryoul Kim, MD Department of Occupational and Environmental Medicine,  College of Medicine, the Catholic University of Korea,   222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82.2-2258-6269, Fax: +82.2-2258-6691 E-mail: cyclor@catholic.ac.kr This study was supported by the Ministry of Employment and  Labor, Korea (MOEL, Korea).http://dx.doi.org/10.3346/jkms.2014.29.S.S47  • J Korean Med Sci 2014; 29: S47-51 INTRODUCTION Standards for the recognition of occupational diseases (ODs)  have been little changed since their enactment in 1954.",Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
• Compensation for Occupational Respiratory Diseases in Korea S48  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S47ture was introduced (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
• Compensation for Occupational Respiratory Diseases in Korea http://jkms.org   S49 http://dx.doi.org/10.3346/jkms.2014.29.S.S47cal agents such as epoxy resin and acid anhydride were added.,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
• Compensation for Occupational Respiratory Diseases in Korea S50  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S47substances and agents (Table 4); the EC includes cancers of the  respiratory system in the same section.,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
ORCID So-young Park http://orcid.org/0000-0001-8034-8098  Hyoung-Ryoul Kim http://orcid.org/0000-0001-7535-3140  Jaechul Song http://orcid.org/0000-0003-1265-0337  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
Available at: http://www.lawnb.,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
• Compensation for Occupational Respiratory Diseases in Korea http://jkms.org   S51 http://dx.doi.org/10.3346/jkms.2014.29.S.S477.,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
Avail - able at http://iiac.independent.gov.uk/pdf/reports/Cm7253.pdf [accessed  on 14 November 2013] 8.,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
Avail - able at http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---pro- trav/---safework/documents/publication/wcms_125137.pdf [accessed  on 4February 2014].,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
Available at https://osha.europa.eu/data/links/in - formation-notices-on-occupational-diseases-a-guide-to-diagnosis [ac - cessed on 4February 2014].,Non-OADS,/arxiv_data1/oa_pdf/4d/09/jkms-29-S47.PMC4085175.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Occupational Skin Diseases The Korean list of occupational skin diseases was amended in July 2013.",Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
"Keywords:  Workers’ Compensation; Dermatitis, Occupational; KoreaHan-Soo Song1 and Hyun-chul Ryou2 1Department of Occupational and Environmental  Medicine, College of Medicine, Chosun University,  Gwangju; 2Teo Center of Occupational and  Environmental Medicine, Changwon, Korea  Received: 19 December 2013 Accepted: 2 May 2014 Address for Correspondence: Han-Soo Song, MD Department of Occupational and Environmental Medicine,  Chosun University Hospital, 365 Pilmun-daero, Dong-gu,  Gwangju 501-717, Korea Tel: +82.62-220-3689, Fax: +82.62-443-5035 E-mail: oemsong@chosun.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.S.S52  • J Korean Med Sci 2014; 29: S52-58 INTRODUCTION Occupational skin diseases (OSDs) are those resulting from or  aggravated by exposure to risk factors during work activity.",Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
"• Compensation for Occupational Skin Diseases http://jkms.org   S53 http://dx.doi.org/10.3346/jkms.2014.29.S.S52cial statistics totaled 179 people between 2006 and 2012, or ap - proximately 0.19 per 100,000 workers (Table 1).",OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
• Compensation for Occupational Skin Diseases S54  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S52and was revised in 1980.,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
• Compensation for Occupational Skin Diseases http://jkms.org   S55 http://dx.doi.org/10.3346/jkms.2014.29.S.S52diseases caused by exposure to vinyl chloride.,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
"• Compensation for Occupational Skin Diseases S56  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S52tivitis, asthma, and gastrointestinal symptoms; anaphylaxis may  occur in severe cases.",Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
"• Compensation for Occupational Skin Diseases http://jkms.org   S57 http://dx.doi.org/10.3346/jkms.2014.29.S.S52of their severity, the depth and width of burns and frostbite  should be considered.",Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
• Compensation for Occupational Skin Diseases S58  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S52ORCID Han-Soo Song http://orcid.org/0000-0001-6000-1572  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
Available at http://www.hse.gov.uk/statistics/causdis/der - matitis/skin.pdf [accessed on 16 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
Available at http://www.bls.gov/news.release/pdf/ osh.pdf [accessed on 16 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
Available at http://www.lawnb.com/lawinfo/ contents_view.asp?cid=680CBD452CF1476394D655C876959E33|0|K  [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
Available at http://www.lawnb.com/ lawinfo/contents_view.asp?cid=4375FD37B4024C389F28EC2C889B15 60|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
Available at http://www.ilo.org/safework/info/publica - tions/WCMS_125137/lang--en/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
Available at https://osha.europa.eu/data/links/in - formation-notices-on-occupational-diseases-a-guide-to-diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
Available at http://www.kosha.or.kr/www/boardView.,Non-OADS,/arxiv_data1/oa_pdf/9e/9c/jkms-29-S52.PMC4085176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Occupational Neurological and Mental  Disorders Standards for the recognition of occupational diseases (ODs) in Korea were established in  1954 and have been amended several times.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
"Keywords:  Neurological; Mental; Psychiatric; Occupational; Compensation; Korea;  Amendment; Standard; CriteriaDong-Mug Kang1 and Inah Kim2 1Department of Occupational and Environmental  Medicine, Pusan National University Yangsan  Hospital, Yangsan; 2Department of Occupational  and Environmental Health, Yonsei University  Graduate School of Public Health, Seoul, Korea Received: 26 December 2013 Accepted: 2 May 2014 Address for Correspondence: Inah Kim, MD Department of Occupational and Environmental Health,   Yonsei University Graduate School of Public Health,   50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  Tel: +82.32-260-3664, Fax: +82.32-260-3667 E-mail: ptdoctor@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.S.S59  • J Korean Med Sci 2014; 29: S59-65 INTRODUCTION Neurological disorders are disorders of the central and periph - eral nervous systems.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
• Compensation for Occupational Neurological and Mental Disorders  S60  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S59pensation system.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
• Compensation for Occupational Neurological and Mental Disorders  http://jkms.org   S61 http://dx.doi.org/10.3346/jkms.2014.29.S.S59described in Kim and Kang (8).,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
"• Compensation for Occupational Neurological and Mental Disorders  S62  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S59Details of current revision focusing on occupational  neurological disorders and occupational mental disorders   Problems of the Previous Version of Standards for the Recognition of  Occupational Neurological Disorders and Occupational Mental  Disorders Because the Korean occupational compensation system based  on the IACI Act relies on hazardous agents, from a clinician’s  point of view, it is difficult to determine ODs without knowing  the patient’s exposure to specific agents.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
• Compensation for Occupational Neurological and Mental Disorders  http://jkms.org   S63 http://dx.doi.org/10.3346/jkms.2014.29.S.S591.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
• Compensation for Occupational Neurological and Mental Disorders  S64  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S59Several neurotoxic agents were included in the amendment.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
• Compensation for Occupational Neurological and Mental Disorders  http://jkms.org   S65 http://dx.doi.org/10.3346/jkms.2014.29.S.S59included as an OMD.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
ORCID Dong-Mug Kang http://orcid.org/0000-0002-0657-0181  Inah Kim http://orcid.org/0000-0003-3568-4484  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
Available at http://www.who.int/classifications/icd/en [accessed on 9  October 2013].,OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
Avail - able at http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---pro- trav/---safework/documents/publication/wcms_125137.pdf [accessed  on 20 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
Available at https://osha.europa.eu/data/links/in - formation-notices-on-occupational-diseases-a-guide-to-diagnosis [ac - cessed on 20 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jkms-29-S59.PMC4085177.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Work-Related Hematologic, Liver, and  Infectious Diseases Occupational diseases may be defined only medically or scientifically, and even then, their  definition is not simple.",Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
"Keywords:  Workers’ Compensation; Hematologic Diseases; Liver Diseases; Infectious  Diseases; KoreaJung-Won Kim1 and Dong-Mug Kang2 1Department of Occupational and Environmental  Medicine, Kosin University College of Medicine,  Busan; 2Department of Preventive and Occupational  Medicine, School of Medicine, Pusan National  University, Yangsan, Korea Received: 17 December 2013 Accepted: 2 May 2014 Address for Correspondence: Dong-Mug Kang, MD Department of Preventive and Occupational Medicine,   Pusan National University, School of Medicine, 20 Geumo-ro,  Yangsan 626-770, Korea Tel: +82.55-510-8030, Fax: +82.55-360-3779 E-mail: kangdm@pusan.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.S.S66  • J Korean Med Sci 2014; 29: S66-71 INTRODUCTION Occupational diseases (ODs) can be defined only medically or  scientifically.",Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
"• Compensation for Work-Related Hematologic, Liver, and Infectious Diseases http://jkms.org   S67 http://dx.doi.org/10.3346/jkms.2014.29.S.S66scientific journals (5) and other related websites such as that of  the Korea Occupational Safety and Health Agency (KOSHA).",Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
"• Compensation for Work-Related Hematologic, Liver, and Infectious Diseases S68  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S66 Although myelodysplastic syndrome and aplastic anemia  can be classified as occupational cancers, the authors regarded  them as precancerous or non-cancerous conditions because of  their non-metastatic nature.",Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
"• Compensation for Work-Related Hematologic, Liver, and Infectious Diseases http://jkms.org   S69 http://dx.doi.org/10.3346/jkms.2014.29.S.S66particularly for resins and polar polymers, and for producing  synthetic fibers or synthetic leather.",Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
"• Compensation for Work-Related Hematologic, Liver, and Infectious Diseases S70  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S66eases have been retained.",Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
"• Compensation for Work-Related Hematologic, Liver, and Infectious Diseases http://jkms.org   S71 http://dx.doi.org/10.3346/jkms.2014.29.S.S66training.",Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
ORCID Dong-Mug Kang http://orcid.org/0000-0002-0657-0181  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
Avail - able at http://www.lawnb.com/lawinfo/contents_view.asp?cid=20FE34 414D0A4563A8507112C4D62FB6|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
Available at http://www.lawnb.com/lawinfo/ contents_view.asp?cid=4375FD37B4024C389F28EC2C889B1560|0|K  [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
Available at http://www.lawnb.com/lawinfo/ link_view.asp?cid=AA14082DC565417CA4872C0592886932|N  4.,Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
Available at http://safedu.org/pds1/23678  [accessed on 1 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
Available at http://kosis.kr/common/meta_onedepth.jsp?vwcd=MT_OTITLE&listid=380_38001  [accessed on 1 December 2013].,OADS,/arxiv_data1/oa_pdf/04/63/jkms-29-S66.PMC4085178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Physical Agents and Occupational Disease Compensation: Noise,  Vibration, Radiation, and Other Physical Agents The context of specific criteria for the recognition of occupational diseases (ODs) due to  physical agents in the Enforcement Decree of the Industrial Accident Compensation  Insurance Act (ED-IACIA) and the Labor Standard Act (LSA) does not describe definite  disease along with the agents but listed symptoms or obscure clinical conditions.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
"Keywords:  Physical Agents; Occupational Disease; Workers’ Compensation; Legislation;  Recognition CriteriaJiho Lee1 and Jungwon Kim2 1Department of Occupational and Environmental  Medicine, College of Medicine, University of Ulsan,  Ulsan; 2Department of Occupational and  Environmental Medicine, College of Medicine,  Koshin University, Busan, Korea Received: 19 December 2013 Accepted: 12 May 2014 Address for Correspondence: Jiho Lee, MD Department of Occupational and Environmental Medicine,  Ulsan University Hospital, 877 Bangeojinsunhwan-doro,   Dong-gu, Ulsan 682-714, Korea Tel: +82.52-250-7288, Fax: +82.52-250-7289 E-mail: oemdoc@naver.comhttp://dx.doi.org/10.3346/jkms.2014.29.S.S72  • J Korean Med Sci 2014; 29: S72-77 INTRODUCTION In general, physical agents workers are exposed to include noise,  vibration, radiation (ionizing and non-ionizing), pressure (com - pressed or decompressed), and extreme temperature.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
• Physical Agents and Occupational Disease Compensation http://jkms.org   S73 http://dx.doi.org/10.3346/jkms.2014.29.S.S72RESULTS History and present condition of occupational diseases  caused by physical agents Noise-induced hearing loss (NIHL) is the second common OD.,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
"• Physical Agents and Occupational Disease Compensation S74  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S72the workplace have any of the following disorders (symptoms  or signs), they could be considered to have work-related dis - ease: 1) facial disorders or skin diseases due to work-related ex - posure to ultraviolet radiation; 2) ocular disorders such as reti - nal burn and cataract due to work-related exposure to infrared  radiation; 3) ocular disorders such as retinal burn or skin disor - ders due to work-related exposure to a LASER; 4) ocular disor - ders such as cataract due to work-related exposure to micro - wave; 5) diseases caused by work-related exposure to ionizing  radiation, such as: radiation skin disorders (acute radio-epider - matitis and skin ulcers), radiation ocular disease (cataract), ra - diation pneumonitis, hematopoietic disorder (aplastic anemia),  and bone necrosis; 6) heat stroke due to work in a warm or hot  workplace; 7) skin burn (above 2nd degree) caused by dealing  with hot materials; and 8) frostbite (above 2nd degree) caused  by dealing with cold materials or work in the cold workplace.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
• Physical Agents and Occupational Disease Compensation http://jkms.org   S75 http://dx.doi.org/10.3346/jkms.2014.29.S.S72Table 3.,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
"• Physical Agents and Occupational Disease Compensation S76  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S72Agents        Exposure sources or conditions Diseases ICD-10* Vibration: hand-      arm vibration      (HAV)Vibration transmitted tools such as grinding,      spinning, fettling, using a grinding wheel,      chainsaw, high pressure water hose,      hammer drill, rammer, chisel, chipping      hammer or other pneumatic tools frequency      range 5-1,500 Hz, but usually 125-300 HzVi bration-induced white fingers (Raynaud’s phenomenon  of occupational origin) Peripheral sensorineural polyneu - ropathy Osteoarthrosis of the elbow and wrist Osteone - crosis of the semilunate bone (Kienböck’s disease)  Pseudoartrosis of the scaphoid bone contracture of the  palmar aponeurosis (Dupuytren’s disease)      T7 5.2 (Effects of vibration, Pneumatic hammer  syndrome, Traumatic vasospastic syndrome,  Vertigo from infrasound) M93.1 (Kienböck’s disease) M72.0 (Dupuytren’s disease) Ex treme temper - ature (high  temperature)W orkers at risk are steel workers, oven and  furnace operators, glassblowers, farmers,  ranchers, fishermen, and construction work - ersHeat stroke, heat exhaustion, heat clamps, heat syncope,      and skin disordersT67 (T67.0-T67.9) T6 7.0 (Heatstroke), T67.3 (Heat exhaustion, anhy - drotic), T67.4 (Heat exhaustion due to salt de - pletion), T67.5 (Heat exhaustion, unspecified)  T67.2 (Heat cramp), T67.1 (Heat syncope) Ex treme temper - ature (low  temperature)W orkers exposed to cold such as meat pack - ers, work with freezers, construction work - ers, cold room personnel, fishermen, wood - men, drivers, mail carriers, fire-fighters, and  road maintains workers Hypothermia, frostbite, immersion foot T68 (Hypothermia), T33-35 (Frostbite), T69.0      (Immersion hand and foot) *International Classification of Diseases-Version 10.Table 3.",Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
ORCID Jiho Lee http://orcid.org/0000-0001-8027-835X  REFERNCES 1.,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
Available at http://www.acgih.org [accessed on 1 Decem - ber 2013].,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
• Physical Agents and Occupational Disease Compensation http://jkms.org   S77 http://dx.doi.org/10.3346/jkms.2014.29.S.S72for occupational diseases in Korea.,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
Available at http://laborstat.moel.go.kr/  [accessed on 1 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
13.04.3 Available at http://www.ilo.org/global/publi - cations/books/WCMS_150323/lang--en/index.htm [accessed on 1 De - cember 2013].,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
Available at http://europa.eu [accessed on 1 De - cember 2013].,Non-OADS,/arxiv_data1/oa_pdf/83/6f/jkms-29-S72.PMC4085179.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Compensation for Occupational Diseases by Chemical Agents in  Korea Investigation into the frequency of compensation for occupational diseases (ODs) caused  by hazardous chemicals revealed an important opportunity for the improvement and  further development of occupational health and safety systems in Korea.",Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
"Keywords:  Industrial Accident Compensation Insurance Act; Chemical Agents; Workers’  Compensation and Welfare Service; Labor Standard Act, Occupational Diseases; KoreaSoon-Chan Kwon,1 Soo-Yong Roh,1   Ji-Hoon Lee,1 and Eun-A Kim2  1Department of Occupational and Environmental  Medicine, Hanyang University College of Medicine,  Seoul; 2Occupational Safety and Health Research  Institute, Korea Occupational Safety and Health  Agency, Ulsan, Korea Received: 17 December 2013 Accepted: 19 May 2014 Address for Correspondence: Eun-A Kim, MD Center for Occupational Disease Research, Occupational Safety  and Health Research Institute, Korea Occupational Safety and  Health Agency, 400 Jongga-ro, Jung-gu, Ulsan 681-230, Korea Tel: +82.52-703-0870, Fax: +82.52-703-0335   E-mail: toxneuro@kosha.nethttp://dx.doi.org/10.3346/jkms.2014.29.S.S78  • J Korean Med Sci 2014; 29: S78-84 INTRODUCTION Since the implementation of five, 5-yr economic development  plans beginning in the early 1960s, Korea has undergone sub - stantial industrialization.",Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
• Compensation for Occupational Diseases by Chemicals in Korea http://jkms.org   S79 http://dx.doi.org/10.3346/jkms.2014.29.S.S78other countries were noted.,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
"• Compensation for Occupational Diseases by Chemicals in Korea S80  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S78tors, and related symptoms, signs, and diseases (5).",Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
• Compensation for Occupational Diseases by Chemicals in Korea http://jkms.org   S81 http://dx.doi.org/10.3346/jkms.2014.29.S.S78cleaner who had worked for several different companies over  the previous 8 yr (26).,OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
• Compensation for Occupational Diseases by Chemicals in Korea S82  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S78the ED-IACIA.,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
• Compensation for Occupational Diseases by Chemicals in Korea http://jkms.org   S83 http://dx.doi.org/10.3346/jkms.2014.29.S.S78sentative example of this is the criteria for central nervous sys - tem disorders.,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
ORCID Soon-Chan Kwon http://orcid.org/0000-0002-5782-6087  Soo-Yong Roh http://orcid.org/0000-0003-1826-9780  Ji-Hoon Lee http://orcid.org/0000-0003-4259-2158  Eun-A Kim http://orcid.org/0000-0002-8582-234X  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
Available at http://kosis.kr/statisticsList/statisticsList_01List.,OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
• Compensation for Occupational Diseases by Chemicals in Korea S84  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.S.S785.,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
Available  at http://www.lawnb.com/lawinfo/contents_view.asp?cid=20FE34414 D0A4563A8507112C4D62FB6|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
Available at http://www.lawnb.com/ lawinfo/contents_view.asp?cid=4375FD37B4024C389F28EC2C889B15 60|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
Available at: http://www.lawnb.com/lawinfo/ contents_view.asp?cid=6DC9B248445644E58EF29C8501852AF8|0|K  [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
Available at: http://www.lawnb.com/lawinfo/ contents_view.asp?cid=6DC9B248445644E58EF29C8501852AF8|0|K  [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
Available at http://www.lawnb.com/lawinfo/ contents_view.asp?cid=4375FD37B4024C389F28EC2C889B1560|0|K  [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
Avail - able at  http://www.lawnb.com/lawinfo/contents_view.asp?cid=20FE3 4414D0A4563A8507112C4D62FB6|0|K [accessed on 27 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/fe/02/jkms-29-S78.PMC4085180.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f8/29/jpts-26-797.PMC4085194.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/92/3c/jpts-26-801.PMC4085195.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/04/17/jpts-26-805.PMC4085196.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/59/3e/jpts-26-807.PMC4085197.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fb/b3/jpts-26-813.PMC4085198.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/74/cf/jpts-26-817.PMC4085199.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/aa/36/jpts-26-821.PMC4085200.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/36/3e/jpts-26-825.PMC4085201.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b4/0d/jpts-26-831.PMC4085202.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/8f/32/jpts-26-833.PMC4085203.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a3/b3/jpts-26-841.PMC4085204.pdf
http://www.health.gov.au/ internet/main/publishing.nsf/ Content/ BC3101B1FF200CA4CA256F970 0154958/$File/adults_phys.pdf (Accessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/a3/b3/jpts-26-841.PMC4085204.pdf
"28) Statistics Canada: Canadian Health Measures Survey: Directly measured  physical activity of Canadians, 2007 to 2011 http://www.statcan.gc.ca/ daily-quotidien/130530/dq130530d-eng.html (Accessed Feb. 10, 2013) 29) The Canadian Society for Exercise Physiology: Canadian Physical Activi - ty Guidelines and Canadian Sedentary Behaviour Guidelines.",Non-OADS,/arxiv_data1/oa_pdf/a3/b3/jpts-26-841.PMC4085204.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/jpts-26-845.PMC4085205.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f8/db/jpts-26-849.PMC4085206.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d5/47/jpts-26-855.PMC4085207.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/92/96/jpts-26-857.PMC4085208.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/dc/97/jpts-26-861.PMC4085209.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/31/72/jpts-26-865.PMC4085210.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9b/58/jpts-26-873.PMC4085211.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9b/37/jpts-26-877.PMC4085212.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/dd/f5/jpts-26-881.PMC4085213.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d1/ae/jpts-26-885.PMC4085214.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/89/65/jpts-26-889.PMC4085215.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3a/a7/jpts-26-895.PMC4085216.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/87/0f/jpts-26-899.PMC4085217.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f0/44/jpts-26-905.PMC4085218.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3a/8b/jpts-26-909.PMC4085219.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d7/ca/jpts-26-911.PMC4085220.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/58/ba/jpts-26-915.PMC4085221.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d6/61/jpts-26-921.PMC4085222.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/7d/a5/jpts-26-925.PMC4085223.pdf
REFERENCES 1) http://www.police.go.kr/portal/main/contents.do?menuNo=200188.,Non-OADS,/arxiv_data1/oa_pdf/7d/a5/jpts-26-925.PMC4085223.pdf
6) http://www.law.go.kr/lsInfoP.do?lsiSeq=133242&efYd=20130701#0000.,Non-OADS,/arxiv_data1/oa_pdf/7d/a5/jpts-26-925.PMC4085223.pdf
7) http://www.kosha.or.kr/www/boardView.do?contentId=343906&menuId=554&boardType=A2.,Non-OADS,/arxiv_data1/oa_pdf/7d/a5/jpts-26-925.PMC4085223.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/db/0d/jpts-26-931.PMC4085224.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/db/72/jpts-26-937.PMC4085225.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case	Study,Non-OADS,/arxiv_data1/oa_pdf/ec/da/jpts-26-941.PMC4085226.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/3d/e8/jpts-26-945.PMC4085227.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/c2/5f/jpts-26-951.PMC4085228.pdf
[J Adv Prosthodont 2014;6:151-6] KEY WORDS: Zirconia; Lithium disilicate; Microtensile; Glass-ceramic; Bond strength; Ceramichttp://dx.doi.org/10.4047/jap.2014.6.3.151 http://jap.or.kr J Adv Prosthodont 2014;6:151-6 INTRODUCTION  All-ceramic restorations have been introduced to fixed prosthodontics according to the increasing demand for  esthetic restorations.,Non-OADS,/arxiv_data1/oa_pdf/64/8f/jap-6-151.PMC4085237.pdf
"66814445111: e-mail, Chuchai.anu@mahidol.eduReceived August 10, 2013 / Last Revision March 20, 2014 / Accepted  May 15, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/8f/jap-6-151.PMC4085237.pdf
[J Adv Prosthodont 2014;6:157-64] KEY WORDS: Magnesium; Ion implantation; Titanium surface; MC3T3-E1; Mouse bone marrow-derived macrophages (BMMs)http://dx.doi.org/10.4047/jap.2014.6.3.157 http://jap.or.kr J Adv Prosthodont 2014;6:157-64  INTRODUCTION There has been considerable effort to enhance osseointe- gration between bone and implant material.,Non-OADS,/arxiv_data1/oa_pdf/bd/fb/jap-6-157.PMC4085238.pdf
"8224407500: e-mail, verycutebear@khu.ac.kr Received July 16, 2013 / Last Revision March 5, 2014 / Accepted March  10, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/fb/jap-6-157.PMC4085238.pdf
"[J Adv Prosthodont 2014;6:165-70] KEY WORDS: Tooth erosion; Adhesives; Tensile strength; Lasers; Gluma dentin desensitizerhttp://dx.doi.org/10.4047/jap.2014.6.3.165 http://jap.or.kr J Adv Prosthodont 2014;6:165-70 INTRODUCTION Dentin hypersensitivity (DH) is a painful and chronic dental condition, and it occurs when dentinal tubules on the den- tin surface are open and patent to vital pulp, which is prob-ably related to erosion.",Non-OADS,/arxiv_data1/oa_pdf/d5/c0/jap-6-165.PMC4085239.pdf
"[J Adv Prosthodont 2014;6:171-6] KEY WORDS: Root/Crown ratio; Prognosis of teeth; Ethnic differences; Panoramic radiographhttp://dx.doi.org/10.4047/jap.2014.6.3.171 http://jap.or.kr J Adv Prosthodont 2014;6:171-6 INTRODUCTION In oral rehabilitation procedures using prosthetic restora- tions, it is mandatory, yet difficult, to determine the prog-nostic factors for an individual tooth in order to predict its longevity and select the most clinically appropriate pros-thetic abutments.",Non-OADS,/arxiv_data1/oa_pdf/92/b1/jap-6-171.PMC4085240.pdf
"82222288980: e-mail, jby1004 @yuhs.ac Received September 4, 2013 / Last Revision March 31, 2014 / Accepted  May 15, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/b1/jap-6-171.PMC4085240.pdf
"Zirconia; Resin cement; Surface treatment; Marjinal gap; Internal gaphttp://dx.doi.org/10.4047/jap.2014.6.3.177 http://jap.or.kr J Adv Prosthodont 2014;6:177-84 INTRODUCTION During the past few years, partially stabilized zirconia has  been integrated into restorative dentistry.1 Yttrium-oxide  partially stabilized zirconia (Y-TZP) has mechanical proper - ties that are attractive for restorative dentistry; namely, its chemical and dimensional stability, high mechanical strength, and fracture-toughness.",Non-OADS,/arxiv_data1/oa_pdf/9f/c6/jap-6-177.PMC4085241.pdf
"+902122319120 (ext 301): e-mail, begumturker@hotmail.comReceived September 11, 2013 / Last Revision February 13, 2014 /  Accepted March 5, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/c6/jap-6-177.PMC4085241.pdf
[J Adv  Prosthodont 2014;6:185-93] KEY WORDS: Computer-aided design; Convergence angle; Prosthodontic tooth preparation; Validation studies;  Dental abutmentshttp://dx.doi.org/10.4047/jap.2014.6.3.185 http://jap.or.kr J Adv Prosthodont 2014;6:185-93 INTRODUCTION The retention of  cast metal restorations has been an inter - esting research topic in the field of fixed prosthodontics  for many years.,Non-OADS,/arxiv_data1/oa_pdf/b7/18/jap-6-185.PMC4085242.pdf
"82220722661: e-mail, pros53@snu.ac.kr Received October 17, 2013 / Last Revision March 11, 2014 / Accepted  March 14, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/18/jap-6-185.PMC4085242.pdf
"[J Adv Prosthodont 2014;6:194-9] KEY WORDS: Light transmission; Degree of conversion; Depth of cure; Translucent post; Resin compositehttp://dx.doi.org/10.4047/jap.2014.6.3.194 http://jap.or.kr J Adv Prosthodont 2014;6:194-9 INTRODUCTION In recent years, the prefabricated fiber-reinforced compos- ite post has become popularly used for the direct post and core restoration due to their good esthetics and relatively low elastic modulus.",Non-OADS,/arxiv_data1/oa_pdf/d8/9d/jap-6-194.PMC4085243.pdf
"6622007817: e-mail, s.urapepon@gmail.comReceived November 18, 2013 / Last Revision April 14, 2014 / Accepted  April 25, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/9d/jap-6-194.PMC4085243.pdf
[J Adv  Prosthodont 2014;6:200-6] KEY WORDS: Endodontically treated premolar; Intracoronal direct restoration; Silorane-based composite; Polyethylene fiber; Nano-ionomer; Fracture resistancehttp://dx.doi.org/10.4047/jap.2014.6.3.200 http://jap.or.kr J Adv Prosthodont 2014;6:200-6 INTRODUCTION The choice of an optimal restoration for endodontically  treated (ET) teeth that guarantee the success of  endodontic treatment remains controversial.,Non-OADS,/arxiv_data1/oa_pdf/ca/4c/jap-6-200.PMC4085244.pdf
"987116263193: e-mail, tavangarm@yahoo.comReceived November 22, 2013 / Last Revision March 11, 2014 / Accepted  March 17, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/4c/jap-6-200.PMC4085244.pdf
"[J Adv Prosthodont 2014;6:207-14] KEY WORDS: Platinum nanoparticles; Denture acrylic resin; Nanocomposite; Anti-adherent effecthttp://dx.doi.org/10.4047/jap.2014.6.3.207 http://jap.or.kr J Adv Prosthodont 2014;6:207-14 INTRODUCTION A denture base seated on oral cavity leads to changes in  weakening the natural hygienic effect of  tongue and salivary flow, especially, by inducing formation and deposit of  bio-films on both prosthetics and adjacent mucosa.",Non-OADS,/arxiv_data1/oa_pdf/c3/25/jap-6-207.PMC4085245.pdf
"82532507807: e-mail, nkyp@dsmc.or.kr Received December 1, 2013 / Last Revision March 3, 2014 / Accepted  March 11, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/25/jap-6-207.PMC4085245.pdf
[J Adv Prosthodont 2014;6:215-23] KEY WORDS: Cu-Al-Ni alloy; Copper alloy; Dental alloy; Post and corehttp://dx.doi.org/10.4047/jap.2014.6.3.215 http://jap.or.kr J Adv Prosthodont 2014;6:215-23 INTRODUCTION Dental post and core are usually fabricated from a cast alloy  as a single unit from a lost-wax technique.,Non-OADS,/arxiv_data1/oa_pdf/32/28/jap-6-215.PMC4085246.pdf
"66814933887: e-mail, somchai.ura@mahidol.ac.thReceived December 12, 2013 / Last Revision March 31, 2014 / Accepted  April 7, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/28/jap-6-215.PMC4085246.pdf
"[J Adv Prosthodont 2014;6:224-32] KEY WORDS: Ce-TZP/AL2O3; Y -TZP; Phase transformation; Thermocycling; Mechanical loading; Characteristic  strengthhttp://dx.doi.org/10.4047/jap.2014.6.3.224 http://jap.or.kr J Adv Prosthodont 2014;6:224-32 INTRODUCTION Y-TZP (yttria stabilized tetragonal zirconia polycrystals) are  commonly used core materials that are manufactured from fine zirconia (ZrO 2) particles and 1.75-3.5 mol.% yttrium  oxide (Y2O3).1-3 Y2O3 is commonly used for stabilizing zir - conia-based ceramics at room temperature.3,4 However,  cerium oxide can also be used to stabilize the tetragonal phase of zirconia.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/jap-6-224.PMC4085247.pdf
"903122034196: e-mail, hozkula@gmail.comReceived December 19, 2013 / Last Revision April 30, 2014 / Accepted  May 7, 2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/jap-6-224.PMC4085247.pdf
[J Adv Prosthodont 2014;6:233-40] KEY WORDS: Implant abutments; Zirconia copings; CAD/CAM; Temporary cementation; Semi-permanent  cementation; Cleaning methodhttp://dx.doi.org/10.4047/jap.2014.6.3.233 http://jap.or.kr J Adv Prosthodont 2014;6:233-40 INTRODUCTION Titanium has been used as standard material in dental  implantology for implants and abutments due to its excel-lent mechanical and biological properties.,Non-OADS,/arxiv_data1/oa_pdf/f8/a1/jap-6-233.PMC4085248.pdf
"49551399697: e-mail, nikolaus.gersdorff@med.uni-goettingen.de Received May 7, 2014 / Last Revision June 3, 2014 / Accepted June 11,  2014 © 2014  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/a1/jap-6-233.PMC4085248.pdf
[J Adv Prosthodont 2014;6:241-4] KEY WORDS: Partial removable dental prosthesis; Metal ceramic crown; Ceramic press-on metal techniquehttp://dx.doi.org/10.4047/jap.2014.6.3.241 http://jap.or.kr J Adv Prosthodont 2014;6:241-4 INTRODUCTION An abutment tooth on partial removable dental prosthesis  (PRDP) can be carious as much as it requires additional res-toration.,Non-OADS,/arxiv_data1/oa_pdf/d3/b7/jap-6-241.PMC4085249.pdf
"If standard Korean  assessment instruments for pain and its associated health status,  symptoms, and problems are made to be easily “intertranslated”  between Korean and English and are distributed in every clinic,  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 415-416  http://dx.doi.org/10.4097/kjae.2014.66.6.415 Editorial",Non-OADS,/arxiv_data1/oa_pdf/3a/72/kjae-66-415.PMC4085260.pdf
"Re-evaluation and integration of the individual  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 417-418  http://dx.doi.org/10.4097/kjae.2014.66.6.417 Editorial",Non-OADS,/arxiv_data1/oa_pdf/09/49/kjae-66-417.PMC4085261.pdf
"Tel: 82-2-6299-2571, Fax: 82-2-6299-2585, E-mail: roman00@naver.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 419-432  http://dx.doi.org/10.4097/kjae.2014.66.6.419",Non-OADS,/arxiv_data1/oa_pdf/3f/be/kjae-66-419.PMC4085262.pdf
The search was performed in March 2014 through: do - mestic databases including Koreamed (http://www.koreamed.,OADS,/arxiv_data1/oa_pdf/3f/be/kjae-66-419.PMC4085262.pdf
"org), KMBASE (http://kmbase.medric.or.kr), KISS (http://kiss.",OADS,/arxiv_data1/oa_pdf/3f/be/kjae-66-419.PMC4085262.pdf
"Tel: 82-2-970-8084, Fax: 82-2-970-8350, E-mail: anesthjin@hanmail.net     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 433-438  http://dx.doi.org/10.4097/kjae.2014.66.6.433",Non-OADS,/arxiv_data1/oa_pdf/bb/31/kjae-66-433.PMC4085263.pdf
"Tel: 82-31-560-2390, Fax: 82-31-563-1731, E-mail: yeomjh@hanyang.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 439-443  http://dx.doi.org/10.4097/kjae.2014.66.6.439",Non-OADS,/arxiv_data1/oa_pdf/9f/c5/kjae-66-439.PMC4085264.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 444-450  http://dx.doi.org/10.4097/kjae.2014.66.6.444",Non-OADS,/arxiv_data1/oa_pdf/99/9d/kjae-66-444.PMC4085265.pdf
"Tel: 82-2-2290-8680, Fax: 82-2-2299-0742, E-mail: kimks@hanyang.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 451-456  http://dx.doi.org/10.4097/kjae.2014.66.6.451",Non-OADS,/arxiv_data1/oa_pdf/96/94/kjae-66-451.PMC4085266.pdf
"Tel: 90-464-213049, Fax: 90-464-217036, E-mail:  ahmetsenau@gmail.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 457-461  http://dx.doi.org/10.4097/kjae.2014.66.6.457",Non-OADS,/arxiv_data1/oa_pdf/41/9a/kjae-66-457.PMC4085267.pdf
"This case was clinically diagnosed as SCLS because of hypo - tension, pulmonary edema and hemoconcentration that oc - curred suddenly during elective surgery, and it is a very rare dis - Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 462-466  http://dx.doi.org/10.4097/kjae.2014.66.6.462 Case Report",Non-OADS,/arxiv_data1/oa_pdf/d1/a1/kjae-66-462.PMC4085268.pdf
"Severe hemodynamic instability and significant metabolic  disturbances during graft reperfusion have been reported in  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 467-471  http://dx.doi.org/10.4097/kjae.2014.66.6.467 Case Report",Non-OADS,/arxiv_data1/oa_pdf/aa/9a/kjae-66-467.PMC4085269.pdf
"We report a case of an 8-month-old OI patient who under - went liver transplantation due to progressive familial intrahepat - Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 472-475  http://dx.doi.org/10.4097/kjae.2014.66.6.472 Case Report",Non-OADS,/arxiv_data1/oa_pdf/5e/2f/kjae-66-472.PMC4085270.pdf
"Abdominopelvic computed  tomography and endoscopic findings indicated the presence of  partial gastric outlet obstruction but the patient did not com - Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 476-480  http://dx.doi.org/10.4097/kjae.2014.66.6.476 Case Report",Non-OADS,/arxiv_data1/oa_pdf/28/4a/kjae-66-476.PMC4085271.pdf
"Therefore, minimizing  the complement overactivity that is induced by CFHD during  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 481-485  http://dx.doi.org/10.4097/kjae.2014.66.6.481 Case Report",Non-OADS,/arxiv_data1/oa_pdf/12/a6/kjae-66-481.PMC4085272.pdf
"In addition, the inspired oxygen concentration  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 June 66(6): 486-487  http://dx.doi.org/10.4097/kjae.2014.66.6.486 Opinion Fig.",Non-OADS,/arxiv_data1/oa_pdf/02/a0/kjae-66-486.PMC4085273.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dc/75/dmso-7-255.PMC4085289.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 255–264Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  255Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5051 6Management of adult diabetic ketoacidosis Aidar R Gosmanov1 elvira O Gosmanova2 erika Dillard-Cannon3 1Division of endocrinology, Diabetes  and Metabolism,  2Division of  Nephrology, Department of Medicine,   3Department of Microbiology,   immunology, and Biochemistry,   University of Tennessee Health  Science Center, Memphis, TN, USA Correspondence: Aidar R Gosmanov   Division of endocrinology,   Diabetes and Metabolism, University   of Tennessee Health Science Center,   920 Madison Avenue, Suite  300A,   Memphis, TN  38163, USA   Fax +1 901 448 5940  email agosmano@uthsc.ed uAbstract:  Diabetic ketoacidosis (DKA) is a rare yet potentially fatal hyperglycemic crisis that  can occur in patients with both type  1 and 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/dc/75/dmso-7-255.PMC4085289.pdf
"Available from: http://www.cdc.gov/ diabetes/pubs/factsheet11.ht m. Accessed April  7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/dc/75/dmso-7-255.PMC4085289.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/dc/75/dmso-7-255.PMC4085289.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/75/dmso-7-255.PMC4085289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/99/ccid-7-207.PMC4085290.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 207–214Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  207OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S5566 9genetic polymorphisms and skin aging:   the identification of population genotypic groups   holds potential for personalized treatments Jordi naval1 Vicente alonso1,2 Miquel Angel Herranz1 1genocosmetics lab, Barcelona,    spain;  2Dermatology Unit,    hospital nisa 9 de Octubre,    Valencia, spain Correspondence: Jordi naval   genocosmetics lab, rambla Catalunya  91, 8th Floor, suite 3,   08008 Barcelona, spain   Tel +34 6 7851 0344  email jnaval@genocosmetics.co mIntroduction:  Skin changes are among the most visible signs of aging.",Non-OADS,/arxiv_data1/oa_pdf/ff/99/ccid-7-207.PMC4085290.pdf
"Moreover, in order to study SNPs that are frequent in  Caucasian populations, we checked the previously described  population frequencies for these SNPs in NCBI database (http://www.ncbi.nlm.nih.gov /) in a Caucasian population.",OADS,/arxiv_data1/oa_pdf/ff/99/ccid-7-207.PMC4085290.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/ff/99/ccid-7-207.PMC4085290.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/99/ccid-7-207.PMC4085290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/b5/ppa-8-933.PMC4085291.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 933–937Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  933OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6613 3Acceptance of orthodontic miniscrews   as temporary anchorage devices Khalid h Zawawi Department of Orthodontics,   Faculty of Dentistry, King Abdulaziz  University, Jeddah, saudi Arabia correspondence: Khalid h Zawawi   Department of Orthodontics, Faculty   of Dentistry, King Abdulaziz University,  PO Box 80209, Jeddah 21589,   saudi Arabia   T el +966-2 640 2000, ext 20388   Fax +966-2 640 3316   email kzawawi@kau.edu.s aObjective:  To study the patient’s acceptance, expectation, and experience of pain with   orthodontic temporary miniscrews.",Non-OADS,/arxiv_data1/oa_pdf/10/b5/ppa-8-933.PMC4085291.pdf
"Even though the added cost is not an issue to patients, the possibility of additional  discomfort together with fear could change their decision when choosing between Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Zawawi Running head recto: Orthodontic miniscrews as temporary anchorage devices DOI: http://dx.doi.org/10.2147/PPA.S66133",Non-OADS,/arxiv_data1/oa_pdf/10/b5/ppa-8-933.PMC4085291.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/10/b5/ppa-8-933.PMC4085291.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/20/ott-7-1169.PMC4085292.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1169–1175OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6378 5Modeling pegylated liposomal doxorubicin-   induced hand-foot syndrome and intestinal   mucositis in zebrafish Yau-hung chen1 Ya-Ting lee1 chi-chung Wen2 Yun-chen chen3 Yu-Jen chen4,5 1Department of chemistry,   2Department of Mathematics,   3Department of chemical and  Materials engineering, Tamkang  University, new Taipei city, Taiwan;   4graduate institute of Pharmacology,   Taipei Medical University, Taipei,   Taiwan;  5Department of radiation  Oncology, Mackay Memorial   hospital, Taipei, Taiwan correspondence: Yu-Jen chen   92, section  2, chung shan north road,   Taipei  10449, Taiwan   email chenmdphd@gmail.co m    Yau-hung chen   151 Yingzhuan road, Danshui Dist,   new Taipei city  25137, Taiwan   Tel +886 2 2621 5656 ext  3009  Fax +886 2 2620 9924  email yauhung@mail.tku.edu.t wAbstract:  Pegylated liposomal doxorubicin (PLD) has been widely used to treat cancer.",Non-OADS,/arxiv_data1/oa_pdf/46/20/ott-7-1169.PMC4085292.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/46/20/ott-7-1169.PMC4085292.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/20/ott-7-1169.PMC4085292.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/28/ndt-10-1141.PMC4085293.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1141–1153Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1141OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6005 8A failure to confirm the effectiveness of a brief  group psychoeducational program for mothers  of children with high-functioning pervasive  developmental disorders: a randomized   controlled pilot trial Masako suzuki1 atsurou Yamada1 Norio Watanabe1 Tatsuo akechi1 Fujika Katsuki2 Takeshi Nishiyama3 Masayuki imaeda4 Taishi Miyachi4 Kazuo Otaki5 Yumiko Mitsuda6 akino Ota6 T oshi a Furukawa7 1Department of Psychiatry and cognitive- Behavioral Medicine, Nagoya city  University graduate school of Medical  sciences, Nagoya, Japan; 2Department of  Psychiatric and Mental health Nursing,   Nagoya city University school of Nursing,   Nagoya, Japan; 3clinical Trial Management  center, Nagoya city University  hospital, Nagoya, Japan; 4Department of  Neonatology and Pediatrics, Nagoya city  University graduate school of Medical  sciences, Nagoya, Japan; 5Kazuo Mental  clinic, T oyohashi, Japan; 6Toyokawa sakura  hospital, T oyokawa Japan; 7Department of  health Promotion and human Behavior,   Kyoto University graduate school of  Medicine/School of Public Health,    Kyoto, Japan correspondence: Masako suzuki   Department of Psychiatry and cognitive- Behavioral Medicine, Nagoya city  University graduate school of Medical  sciences, Mizuho-cho, Mizuho-ku,  Nagoya, 467-8601, Japan   email masako8886@yahoo.co.j pObjective:  The purpose of this study was to examine the effectiveness of group  psychoeducation  to relieve the psychological distress of mothers of children with high-functioning pervasive  developmental disorders (HFPDD) and to improve the behaviors of the children.",Non-OADS,/arxiv_data1/oa_pdf/69/28/ndt-10-1141.PMC4085293.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/69/28/ndt-10-1141.PMC4085293.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/28/ndt-10-1141.PMC4085293.pdf
Available at: http://store.samhsa.,Non-OADS,/arxiv_data1/oa_pdf/69/28/ndt-10-1141.PMC4085293.pdf
Available at: http://jnpf.net /.,Non-OADS,/arxiv_data1/oa_pdf/69/28/ndt-10-1141.PMC4085293.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/06/41/ijn-9-3175.PMC4085294.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3175–3182International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3175OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6157 0stepwise encapsulation and controlled two-stage  release system for cis-Diamminediiodoplatinum Yun chen1,*  Qian li1,2,* Qingsheng Wu1 1Department of chemistry,    Key laboratory of Yangtze river  Water environment, Ministry of  education, T ongji University, shanghai;   2shanghai Institute of Quality  Inspection and T echnical research,   shanghai, People’s republic of china *These authors contributed equally   to this workAbstract:  cis-Diamminediiodoplatinum (cis-DIDP) is a cisplatin-like anticancer drug with  higher anticancer activity, but lower stability and price than cisplatin.",Non-OADS,/arxiv_data1/oa_pdf/06/41/ijn-9-3175.PMC4085294.pdf
"For example, polyamidoamine dendrimers can improve intracellular  delivery and reduce undesirable side effects.6 Encapsulation in solid lipid nanopar - ticles (SLNs), which are drug carriers made from physiological or synthetic lipids, correspondence: Qingsheng Wu 1239 siping road, Department of  chemistry, T ongji University, shanghai,  People’s republic of china 200092 T el +86 21 6598 2620 Fax +86 21 6598 1097 email qswu@tongji.edu.c nJournal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Chen et al Running head recto: Stepwise encapsulation and two-stage release of cis-DIDP DOI: http://dx.doi.org/10.2147/IJN.S61570",Non-OADS,/arxiv_data1/oa_pdf/06/41/ijn-9-3175.PMC4085294.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/06/41/ijn-9-3175.PMC4085294.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3182chen et al number 11nm0501300); and the Fundamental Research  Funds for the Central Universities and the Shanghai Key  Laboratory of Molecular Catalysis and Innovative Materials  (grant number 2012MCIMKF03).,Non-OADS,/arxiv_data1/oa_pdf/06/41/ijn-9-3175.PMC4085294.pdf
"Available from:   http://www.cnki.net/KCMS/detail/detail.aspx?QueryID =16&CurRec =4 9&dbcode =CJFQ&dbname =CJFD7993&filename =DBSZ19930303 0&urlid =&yx=&uid =WEEvREcwSlJHSldTTGJhYlJRZTdBc0FGcT BDZG11MkZEQmZRZkpadE1CTHRMaGxtM2FCRzRHaG5jOG - FvSXRXRQ ==&v=MTI4OTZVTDNOSVMvWWRMS3hGOUxNck k5R1pJUjhlWDFMdXhZUzdEaDFUM3FUcldNMUZyQ1VSTDZm - WXVScEZ5cm s. Accessed June 11, 2014.",OADS,/arxiv_data1/oa_pdf/06/41/ijn-9-3175.PMC4085294.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/d1/dddt-8-869.PMC4085295.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 869–873Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  869CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/DDDT .S6534 9Virologic breakthrough in a patient with chronic  hepatitis B by combination treatment with  tenofovir disoproxil fumarate and entecavir Fumitaka Suzuki1,2 Hitomi Sezaki1 Norio Akuta1 Y oshiyuki Suzuki1 Yusuke Kawamura1 T etsuya Hosaka1 Masahiro Kobayashi1 Satoshi Saitoh1 Yasuji Arase1 Kenji Ikeda1 Mariko Kobayashi3 Sachiyo Watahiki3 Rie Mineta3 Yukiko Suzuki3 Hiromitsu Kumada1 1Department of Hepatology,   T oranomon Hospital, T okyo, Japan;    2Okinaka Memorial Institute for  Medical Research, T okyo, Japan;   3Research Institute for Hepatology,   T oranomon Branch Hospital,   Kawasaki, Japan Correspondence: Fumitaka Suzuki   Toranomon Hospital, Department  of Hepatology,  2-2-2 Toranomon,  Minato-ku, Tokyo  105-8470, Japan   Tel +81 44 877 5111  Fax +81 44 860 1623  Email fumitakas@toranomon.gr.j pAbstract:  Tenofovir disoproxil fumarate (TDF) is widely used to treat hepatitis B virus (HBV)  patients in the USA and Europe.",Non-OADS,/arxiv_data1/oa_pdf/05/d1/dddt-8-869.PMC4085295.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/05/d1/dddt-8-869.PMC4085295.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/d1/dddt-8-869.PMC4085295.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/ijn-9-3193.PMC4085296.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3193–3201International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3193OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5980 7Novel flower-shaped albumin particles   as controlled-release carriers for drugs   to penetrate the round-window membrane Zhan Yu1,* Min Yu2,* Zhimin Zhou3 Zhibao Zhang3 Bo Du3 Qingqing Xiong3 1second artillery general hospital,   Beijing, 2Department of Cell Biology,   Key Laboratory of Cell Biology,   Ministry of Public Health, College  of Basic Medicine, China Medical  University, Shenyang, 3Institute   of Biomedical Engineering, Chinese  academy of Medical sciences,   Peking Union Medical College, Key  Laboratory of Biomedical Material   of Tianjin, Tianjin, People’s Republic  of China *These authors contributed equally   to this work Correspondence: Zhan Yu second artillery general hospital,   16 Xinjiekou Outer Avenue, Beijing  100088, People’s Republic of China T el +86 10 2421 3139 Fax +86 10 2421 3139 email yuzhandz@126.co m Min Yu  China Medical University, 92 Beier Road,  Shenyang, 110001, People’s Republic   of China T el +86 24 2326 1056 Fax +86 24 2326 1056 email ym77@163.co mAbstract:  Controlled-release carriers for local drug delivery have attracted increasing   attention for inner-ear treatment recently.",Non-OADS,/arxiv_data1/oa_pdf/7e/a0/ijn-9-3193.PMC4085296.pdf
"In  1998, Balough et al reported that fibrin-based vehicles  impregnated with gentamicin were successfully injected into the middle ear of  chinchillas, and allowed for a prolonged effect without absorption in the untreated  ear or blood.4 In 2010, Horie et al reported that drug-loaded poly(lactic- co-gly- colic acid) (PLGA) microparticles were capable of delivering lidocaine into the  cochlea in a sustained manner.5 The PLGA nanoparticles (NPs) were found to be Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Yu et al Running head recto: Flower-shaped BSA particles as carriers to inner ear DOI: http://dx.doi.org/10.2147/IJN.S59807",OADS,/arxiv_data1/oa_pdf/7e/a0/ijn-9-3193.PMC4085296.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7e/a0/ijn-9-3193.PMC4085296.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3201Flower-shaped BSA particles as carriers to inner ear  7.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/ijn-9-3193.PMC4085296.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/eb/ott-7-1185.PMC4085297.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1185–1193OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1185Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6366 5correlation between EGFR mutation status  and response to first-line platinum-based  chemotherapy in patients with advanced   non-small cell lung cancer shu Fang1 Zhehai Wang2 Jun guo2 Jie liu2 changzheng li2 lin liu2 huan shi2 liyan liu2 huihui li2 chao Xie2 Xia Zhang2 Wenwen sun1 Minmin li1 1school of Medicine and life sciences,   University of Jinan-Shandong Academy  of Medical sciences,  2Department of  Oncology, shandong cancer hospital,   Jinan, shandong Province, People’s  republic of china correspondence: Zhehai Wang   Department of Oncology, shandong  cancer hospital,  440 Jiyan road,   Jinan, shandong  250117, People’s   republic of china   Tel +86 531 6762 6331  Fax +86 531 6762 6331  email wzhai8778@sina.co mBackground:  The purpose of this research was to investigate the relationship between epidermal  growth factor receptor ( EGFR ) mutations and the response to first-line chemotherapy in patients  with advanced non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/57/eb/ott-7-1185.PMC4085297.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/57/eb/ott-7-1185.PMC4085297.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/eb/ott-7-1185.PMC4085297.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/be/jmdh-7-259.PMC4085298.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 259–265Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  259Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S6226 9The effects of shared situational awareness on  functional and hospital outcomes of hospitalized  older adults with heart failure Joo H lee1 sun J Kim2,3 Julia lam4 sulgi Kim5 shunichi nakagawa6 Ji W Y oo7,8 1Department of Media and  communication, Hanyang University  college of social sciences, seoul,   Korea;  2Department of Public  Health, 3institute of Health services  research, Yonsei University college  of Medicine, seoul, Korea;  4University  of Wisconsin school of Medicine  and Public Health, Madison, Wi, Usa;   5Department of epidemiology and  Biostatistics, case Western reserve  University, cleveland, OH, Usa;   6Department of Medicine, columbia  University college of Physicians and  surgeons, new Y ork, nY, Usa;  7center  for senior Health and longevity,   aurora Health care,  8Department  of Medicine, University of Wisconsin  school of Medicine and Public Health,   Milwaukee, Wi, Usa correspondence: Ji Won Yoo   Department of Medicine, University of  Wisconsin school of Medicine and Public  Health center for senior Health and  longevity, aurora Health care,   1020 n,  12th st, #  301, Milwaukee,   Wi 53233, Usa   Tel +1 414 219 7300  Fax +1 414 219 7632  email yoo36@wisc.ed uBackground:  Functional decline of hospitalized older adults is common and triggers health  care expenditures.",Non-OADS,/arxiv_data1/oa_pdf/25/be/jmdh-7-259.PMC4085298.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/25/be/jmdh-7-259.PMC4085298.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/be/jmdh-7-259.PMC4085298.pdf
Or use: http://dvpr.es/1tXekF C 23.,Non-OADS,/arxiv_data1/oa_pdf/25/be/jmdh-7-259.PMC4085298.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/d5/dddt-8-887.PMC4085299.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 887–896Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  887Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org /10.2147/DDDT .S42708New approaches to the management of  schizophrenia: focus on aberrant hippocampal  drive of dopamine pathways Stephanie M Perez   Daniel J Lodge Department of Pharmacology and  Center for Biomedical Neuroscience,   University of Texas Health Science  Center, San Antonio, TX, USA Correspondence: Daniel J Lodge   Department of Pharmacology and Center  for Biomedical Neuroscience, University  of Texas Health Science Center,   7703 Floyd Curl Drive, MC  7764,   San Antonio, TX,  78229, USA   Tel +1 210 567 4188  email lodged@uthscsa.ed uAbstract:  Schizophrenia is a disease affecting up to  1% of the population.",Non-OADS,/arxiv_data1/oa_pdf/35/d5/dddt-8-887.PMC4085299.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/35/d5/dddt-8-887.PMC4085299.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/d5/dddt-8-887.PMC4085299.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ndt-10-1191.PMC4085300.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1191–1197Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1191OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6164 0Katharina Dannehl1 Winfried rief1 Markus J schwarz2 annika hennings1 sabine riemer1 Verena selberdinger3 Theresa stapf3 Frank euteneuer1 1Division of clinical Psychology and  Psychotherapy, Philipps Universität  Marburg, Marburg, germany; 2institute  for laboratory Medicine, ludwig- Maximilian Universität, Munich,   germany; 3Department of Psychiatry,   ludwig-Maximilian Universität,   Munich, germany correspondence: Katharina Dannehl   Division of clinical Psychology and  Psychotherapy, Philipp University of  Marburg, gutenbergstrasse 18, Marburg,  germany   T el +49 6421 282 3347 Fax +49 6421 282 8904 email dannehl@staff.uni-marburg.deThe predictive value of somatic and cognitive  depressive symptoms for cytokine changes   in patients with major depression Context:  Elevated concentrations of proinflammatory cytokines have been hypothesized as  an important factor in the pathophysiology of depression.",Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ndt-10-1191.PMC4085300.pdf
Current findings sug - gest that “cognitive” and “somatic” symptom dimensions are related in different ways Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Dannehl et al Running head recto: Depressive symptoms and cytokine changes DOI: http://dx.doi.org/10.2147/NDT.S61640,Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ndt-10-1191.PMC4085300.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ndt-10-1191.PMC4085300.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1197Depressive symptoms and cytokine changes  41.,Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ndt-10-1191.PMC4085300.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/5f/ijn-9-3151.PMC4085301.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3151–3161International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3151OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6259 9chitosan gel containing polymeric nanocapsules:   a new formulation for vaginal drug delivery correspondence: silvia s guterres Faculdade de Farmácia, Universidade  Federal do rio grande do sul,   av Ipiranga, 2752/405 ceP 90610-000,  Porto alegre, rs, Brazil T el +55 51 3308 5500 Fax +55 51 3308 5247 email silvia.guterres@ufrgs.b rluiza a Frank1 giuseppina sandri2 Francesca D´autilia2 renata V contri1 Maria cristina Bonferoni2 carla caramella2 alejandro g Frank3 adriana r Pohlmann1 silvia s guterres1 1Pharmaceutical science graduate  Program, Federal University of rio  grande do sul, Porto alegre, rs,   Brazil; 2Department of Drug sciences,   University of Pavia, Pavia, PV, Italy;   3Department of Industrial engineering,   Federal University of rio grande do  sul, Porto alegre, rs, BrazilAbstract:  The vaginal route of administration is an alternative for several treatments for  either local or systemic pharmacological effects.",Non-OADS,/arxiv_data1/oa_pdf/83/5f/ijn-9-3151.PMC4085301.pdf
Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Frank et al Running head recto: A new formulation for vaginal drug delivery DOI: http://dx.doi.org/10.2147/IJN.S62599,Non-OADS,/arxiv_data1/oa_pdf/83/5f/ijn-9-3151.PMC4085301.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/83/5f/ijn-9-3151.PMC4085301.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3161a new formulation for vaginal drug delivery  18.,Non-OADS,/arxiv_data1/oa_pdf/83/5f/ijn-9-3151.PMC4085301.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/c1/opth-8-1221.PMC4085302.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1221–1226Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1221Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6249 4intensity of side effects of topical glaucoma  medication and its influence on adherence  behavior in patients with glaucoma alice l Yu1 stefanie Weise2 Ulrich Welge-lussen3 1Department of Ophthalmology,   ludwig-Maximilians-University,   Munich, 2Department of  Ophthalmology, University of  Cologne, Cologne, 3Department of  Ophthalmology, Friedrich-alexander- University, erlangen, germanyBackground:  The aim of this study was to investigate the intensity of side effects that patients  attribute to their topical glaucoma medication and their relationship to adherence behavior.",Non-OADS,/arxiv_data1/oa_pdf/a7/c1/opth-8-1221.PMC4085302.pdf
"Few studies have examined Correspondence: alice l Yu ludwig-Maximilians-University,  Department of Ophthalmology,  Mathildenstrasse 8, 80336 Munich,  germany Tel +49 89 5160 3811 Fax +49 89 5160 5160 email alice.yu@med.uni-muenchen.d eJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Yu et al Running head recto: Intensity of side effects and adherence behavior in patients with glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S62494",Non-OADS,/arxiv_data1/oa_pdf/a7/c1/opth-8-1221.PMC4085302.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a7/c1/opth-8-1221.PMC4085302.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1226Yu et al The authors have no financial or proprietary interest in any  material or method used in this study.,Non-OADS,/arxiv_data1/oa_pdf/a7/c1/opth-8-1221.PMC4085302.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 339–343International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  339OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJGM.S6441 9Efficacy and tolerability of carbamazepine   for the treatment of painful diabetic neuropathy   in adults: a  12-week, open-label, multicenter study Tariq saeed1 Muhammad nasrullah2 adnan Ghafoor3 Riaz Shahid4 nadeem Islam5 Mohammad Usman  Khattak6 Neeta Maheshwary7 ahson siddiqi7 Muhammad athar Khan8 1Pakistan Telecommunication  Company Ltd, Karachi, Pakistan;   2Cavalary Hospital, Gulberg, Lahore,   Pakistan;  3Fauji Foundation hospital,   Rawalpindi, Pakistan;  4Dr Riaz Shahid  clinic, Peshawar cantt, Peshawar,   Pakistan;  5Punjab Employs Social  Security Institution, Islamabad,   Pakistan;  6Medical B Unit, Hayat Abad  Medical Complex, Peshawar, Pakistan;   7novartis Pharma Pakistan, Karachi,   Pakistan;  8Department of Medical  Education, King Saud bin Abdulaziz  University, Riyadh, Kingdom of   Saudi Arabia Correspondence: Neeta Maheshwary   Medical Scientific Liaison,   15 West Wharf road, novartis   Pharma Pakistan, Karachi, Pakistan   Tel +92 322 824 7773  Fax +92 213 437 6210  email neeta.maheshwary@novartis.co mObjective:  Anticonvulsants are increasingly being used in the symptomatic management of  several neuropathic pain disorders.",Non-OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
"Available from: http://diabetes.niddk.nih.gov/dm/pubs/ statistics/#Nervou s. Accessed October  30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
Available from: http://www.pakneurology.net/images/ Neuropathic_pain_guidelines_detailed_versio n.pdf.,Non-OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
Available from: http://www.theacpa.org/uploads/ documents/Quality_of_Life_Scale.pdf.,OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
"Available from: http://www.theacpa.org/uploads/ Life_Scale_3.pd f. Accessed March  19, 2014.",OADS,/arxiv_data1/oa_pdf/eb/54/ijgm-7-339.PMC4085303.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/15/ott-7-1195.PMC4085304.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1195–1204OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1195Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S6403 3Expression profiles and initial confirmation   of long noncoding rnas in chinese patients   with pulmonary adenocarcinoma Xin Zhao* Wen Zhu* Wangjian Zha Feifei chen Zhenzhen Wu Yanan liu Mao huang Department of respiratory Medicine,   The First affiliated hospital, nanjing  Medical University, nanjing, People’s  republic of china *These authors contributed equally to  this study and share first authorship correspondence: Mao huang   Department of respiratory Medicine, The  First Affiliated Hospital, Nanjing Medical  University,  300 guangzhou road, nanjing   210029, People’s republic of china   Tel +86 25 6813 6269  Fax +86 25 8367 3567  email hm6114@126.co mBackground:  The purpose of this study was to investigate differentially expressed long  noncoding RNAs (lncRNAs) in pulmonary adenocarcinoma tissue and adjacent noncancerous  tissue from Chinese patients using lncRNA expression microarray and preliminary analysis.",Non-OADS,/arxiv_data1/oa_pdf/d0/15/ott-7-1195.PMC4085304.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/15/ott-7-1195.PMC4085304.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/15/ott-7-1195.PMC4085304.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 687–695International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  687RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S4779 2Differential pharmacology and clinical   utility of emerging combination treatments   in the management of COPD – role   of umeclidinium/vilanterol Mario Malerba1  Jaymin Bhagwanji Morjaria2 Alessandro Radaeli3 1Department of Internal Medicine,   University of Brescia, Brescia, Italy;   2Department of Academic Respiratory  Medicine, Hull York Medical  School, University of Hull, Castle  Hill Hospital, Cottingham, United  Kingdom;  3Department of emergency,   Spedali Civili di Brescia, Brescia, Italy Correspondence: Mario Malerba   Department of Internal Medicine,  University of Brescia and AOU   Spedali Civili, Brescia, Italy   Tel +39 030 399 5250  email malerba@med.unibs.i tAbstract:  Chronic obstructive pulmonary disease (COPD) is a preven table  and trea table  disease  characterized by airflow limitation that is not fully reversible.",Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
"Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/   UCM367414.pd f.46 Accessed May 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
"Available from: http://www.fda.gov/newsevents/newsroom/   pressannouncements/ucm379057.ht m. Accessed May 18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
Available  from: http://clinicaltrials.gov/show/NCT01376388.,Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/a6/43/copd-9-687.PMC4085305.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/ae/dmso-7-265.PMC4085306.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 265–275Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  265Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DMSO.S5878 6combination of the sodium-glucose  cotransporter-2 inhibitor empagliflozin with  orlistat or sibutramine further improves the  body-weight reduction and glucose homeostasis  of obese rats fed a cafeteria diet Steven P Vickers1 Sharon c cheetham1 Katie r headland1 Keith Dickinson1 rolf grempler2 eric Mayoux2 Michael Mark2 Thomas Klein2 1renaSci, Bio city nottingham,   nottingham, UK; 2Boehringer  ingelheim Pharma, Biberach an der  riss, germany correspondence: eric Mayoux   Boehringer ingelheim Pharma,  Birkendorfer Strasse 65, 88400   Biberach an der riss, germany   email eric.mayoux@boehringer- ingelheim.co mAbstract:  The present study assessed the potential of the sodium glucose-linked transporter  (SGLT)-2 inhibitor empagliflozin to decrease body weight when administered alone or in  combination with the clinically effective weight-loss agents orlistat and sibutramine in obese  rats fed a cafeteria diet.",Non-OADS,/arxiv_data1/oa_pdf/85/ae/dmso-7-265.PMC4085306.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs311/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/85/ae/dmso-7-265.PMC4085306.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/85/ae/dmso-7-265.PMC4085306.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/ae/dmso-7-265.PMC4085306.pdf
Available from: http://pa2online.org/abstract/abstract.,OADS,/arxiv_data1/oa_pdf/85/ae/dmso-7-265.PMC4085306.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/22/ott-7-1177.PMC4085307.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1177–1184OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1177Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6373 9a single-institution experience with bevacizumab  in the treatment of metastatic colorectal cancer  and in conjunction with liver resection Pia Osterlund1,2 reetta Peltonen2,3 T uomo alanko1 Petri Bono1,2 helena isoniemi2,3 1Department of Oncology, helsinki  University central hospital, helsinki,   2institute of clinical Medicine,   University of helsinki, helsinki,   3Department of surgery, helsinki  University central hospital, helsinki,   Finland correspondence: Pia Osterlund   Department of Oncology, helsinki  University central hospital, PO Box 180,  00029 hUs (helsinki), Finland   Tel +358 9 4711   Fax +358 9 471 74202   email pia.osterlund@hus.fiBackground:  Bevacizumab is active in the treatment of metastatic colorectal cancer (mCRC).",Non-OADS,/arxiv_data1/oa_pdf/c4/22/ott-7-1177.PMC4085307.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c4/22/ott-7-1177.PMC4085307.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/22/ott-7-1177.PMC4085307.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/e0/dddt-8-875.PMC4085308.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 875–885Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  875ExpEr T OpiniO nopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6490 7Treatment of pulmonary hypertension   in idiopathic pulmonary fibrosis: shortfall   in efficacy or trial design?",Non-OADS,/arxiv_data1/oa_pdf/99/e0/dddt-8-875.PMC4085308.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/99/e0/dddt-8-875.PMC4085308.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/e0/dddt-8-875.PMC4085308.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Related Outcome Measures 2014:5 43–62Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  43Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S4273 5Nonadherence with antipsychotic   medication in schizophrenia: challenges   and management strategies Peter M Haddad1,2 Cecilia Brain3,4 Jan Scott5,6 1Neuroscience and Psychiatry Unit,   University of Manchester, Manchester,   2Greater Manchester west Mental  Health NHS Foundation Trust, Salford,   UK; 3institute of Neuroscience and  Physiology, Department of Psychiatry  and Neurochemistry, Sahlgrenska  Academy, University of Gothenburg,   4Nå Ut-teamet, Psychosis Clinic,   Sahlgrenska University Hospital,   Gothenburg, Sweden; 5Academic  Psychiatry, institute of Neuroscience,   Newcastle University, 6Centre for  Affective Disorders, institute of  Psychiatry, London, UK Correspondence: Peter M Haddad   Greater Manchester west Mental Health  NHS Foundation Trust, Cromwell House,  eccles, Salford, M30 0GT, UK   Tel +44 161 787 6007   email peter.haddad@gmw.nhs.u kAbstract:  Nonadherence with medication occurs in all chronic medical disorders.",Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
http://ukcatalogue.oup.com/product/9780199586042.d o.,Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
"For permission to reuse this material, please visit http://www.oup.co.uk/academic/rights/ permission s.146 Abbreviation:  QoL, Quality of life.",Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
Avail - able from: http://www.nice.org.uk/guidance/CG76.,Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
"Available from: http://www.nice.org.uk/nicemedia/ live/14382/66529/66529.pd f. Accessed April 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
"Available from: http://psychrights.org/research/Digest/ OutPtCmmtmnt/UKRptonCTO.pd f. Accessed March 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fa/2a/prom-5-043.PMC4085309.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/e5/cia-9-1031.PMC4085310.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1031–1038Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1031OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6592 1Correspondence: Daye Cheng Department of Transfusion, First hospital  of China Medical University, 155 north  nanjing street, shenyang, liaoning  110001, People’s republic of China Tel/fax +86 24 8328 3039 email dayecheng_cmu@yeah.ne tEstrogen receptor  α gene polymorphisms   and risk of Alzheimer’s disease: evidence   from a meta-analysis Daye Cheng1 Bin liang2 Yiwen hao1 Wenling Zhou1 1Department of Transfusion, First  hospital of China Medical University,   shenyang, 2Department of Clinical  laboratory, high Vocational  Technological College, China Medical  University, shenyang, People’s  republic of ChinaObjective:  Human estrogen receptor α (ESR1) , a member of the nuclear receptor superfamily   of ligand-activated transcription factors, is one of the key mediators of hormonal response in  estrogen-sensitive tissues.",Non-OADS,/arxiv_data1/oa_pdf/9e/e5/cia-9-1031.PMC4085310.pdf
"Genetic, metabolic, and environmental factors play a role in the development and  progression of AD.5 Recent genome-wide association studies have identified many  genetic variances and single-nucleotide polymorphisms (SNPs) that are associated with Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Cheng et al Running head recto: ESR1  and AD risk DOI: http://dx.doi.org/10.2147/CIA.S65921",Non-OADS,/arxiv_data1/oa_pdf/9e/e5/cia-9-1031.PMC4085310.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/9e/e5/cia-9-1031.PMC4085310.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9e/e5/cia-9-1031.PMC4085310.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/07/ott-7-1205.PMC4085311.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1205–1214OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1205Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6471 4Histological type-specific prognostic factors   of cervical small cell neuroendocrine carcinoma,   adenocarcinoma, and squamous cell carcinoma suthida intaraphet1 nongyao Kasatpibal2 Mette søgaard3 surapan Khunamornpong4 Jayanton Patumanond5 anchalee chandacham6 imjai chitapanarux7 sumalee siriaunkgul4 1Boromarajonani College of Nursing,   KhonKaen, Thailand and Clinical  Epidemiology Unit, Faculty of  Medicine,  Chiang Mai University,   Chiang Mai, Thailand; 2Faculty of  Nursing, Chiang Mai University,   Chiang Mai, Thailand;  3Department  of Clinical Epidemiology, Institute  of Clinical Medicine, Aarhus  University Hospital, Aarhus, Denmark;   4Department of Pathology, Faculty  of Medicine, Chiang Mai University,   Chiang Mai, Thailand;  5clinical  Research Center, Faculty of Medicine,   Thammasat University, PathumThani,   Thailand;  6Department of Gynecology  and Obstetrics, Nakornping Hospital,   Chiang Mai, Thailand;  7Department of  Radiology, Faculty of Medicine, Chiang  Mai University, Chiang Mai, Thailand correspondence: sumalee siriaunkgul   Department of Pathology, Faculty of   Medicine, Chiang Mai University,   chiang Mai  50200, Thailand   Tel +66 53 945 4424  Fax +66 53 217 144  email sumalee.cmu@gmail.co mBackground:  The study aimed to determine the prognostic impact of clinical and pathological  factors on survival among patients with small cell neuroendocrine carcinoma (SNEC), adeno - carcinoma (ADC), and squamous cell carcinoma (SCC).",Non-OADS,/arxiv_data1/oa_pdf/52/07/ott-7-1205.PMC4085311.pdf
Available from: http://www.nci.,Non-OADS,/arxiv_data1/oa_pdf/52/07/ott-7-1205.PMC4085311.pdf
Available from: http://globocan.iarc.fr/old/sum - mary_table_pop-html.asp?selection=194764&title=Thailand&sex=2 &type=1&window=1&sort=0&submit=%C2%A0Execute%C2%A 0.,Non-OADS,/arxiv_data1/oa_pdf/52/07/ott-7-1205.PMC4085311.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/52/07/ott-7-1205.PMC4085311.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/07/ott-7-1205.PMC4085311.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/b7/ijgm-7-319.PMC4085312.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 319–323International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  319OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S6660 9cardiac arrest teams and time of day: effects   on surviving in-hospital resuscitation Martin christ Wolfgang Dierschke Katharina Isabel von  auenmueller Marc van Bracht Martin Grett hans-Joachim Trappe Department of cardiology and  angiology, Marienhospital herne,   ruhr – University Bochum, herne,   Germany correspondence: Martin christ   Department of cardiology and angiology,  Marienhospital herne, ruhr – University  Bochum, hoelkeskampring  40,   44625 herne, Germany   Tel +49 2323 499 5620  Fax +49 2323 499 301  email martin.christ@marienhospital- herne.d eObjectives:  Little is known about the factors that influence survival following in-hospital  resuscitation, but previous investigations have suggested that in-hospital resuscitations outside  of regular working hours are associated with worse survival rates.",Non-OADS,/arxiv_data1/oa_pdf/72/b7/ijgm-7-319.PMC4085312.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/72/b7/ijgm-7-319.PMC4085312.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/b7/ijgm-7-319.PMC4085312.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/9b/cmar-6-291.PMC4085313.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 291–300Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  291Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CMAR.S3882 7Prognostic stratification of colorectal cancer  patients: current perspectives Nora i Schneider Cord Langner Institute of Pathology, Medical  University of Graz, Graz, Austria Correspondence: Cord Langner   Institute of Pathology, Medical University  of Graz,  25 Auenbruggerplatz, Graz,  Styria  8036, Austria   Tel +43 316 385 13665   Fax +43 316 385 13432   email cord.langner@medunigraz.a tAbstract:  Tumor staging according to the American Joint Committee on Cancer/Union for  International Cancer Control tumor, node, metastasis (TNM) system is currently regarded as  the standard for staging of patients with colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/b8/9b/cmar-6-291.PMC4085313.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/b8/9b/cmar-6-291.PMC4085313.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/9b/cmar-6-291.PMC4085313.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1057–1068Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1057OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5995 8T owards horizon 2020: challenges and advances  for clinical mental health research – outcome   of an expert survey christina M van der   Feltz-cornelis1–3 Jim van Os4,6 susanne Knappe5 gunter schumann6 eduard Vieta7 hans-Ulrich Wittchen5 shôn W lewis8 iman elfeddali2,9 Kristian Wahlbeck10,11 Donald linszen4 carla Obradors-Tarragó12,13 Josep Maria haro12–14 1Trimbos instituut, Utrecht, 2Tilburg  University, Tranzo Department, Tilburg, 3ggz  Breburg, Tilburg, 4Department of Psychiatry  and Psychology, south limburg Mental  health research and T eaching Network,  euron, Maastricht University Medical center,  Maastricht, the Netherlands; 5institute of  clinical Psychology and Psychotherapy and  center for epidemiology and longitudinal  studies, T echnische Universität Dresden,  Dresden, germany; 6institute of Psychiatry,  King’s college london, london, UK;  7institute of Neuroscience, hospital clinic,  University of Barcelona, iDiBaPs, ciBersaM,  Barcelona, catalonia, spain; 8institute  of Brain, Behaviour and Mental health,  University of Manchester, Manchester, UK;  9Department of health Promotion/ school of  Public health and Primary care, Maastricht  University, Maastricht, the Netherlands;  10The Nordic school of Public health,  gothenburg, sweden; 11National institute  for health and Welfare, helsinki, Finland;  12centro de investigación Biomédica en red  de salud Mental, Madrid, 13research and  Development Unit, Parc sanitari sant Joan  de Déu, Fundació sant Joan de Déu, sant  Boi de llobregat, 14Universitat de Barcelona,  Barcelona, spain correspondence: christina M van der   Feltz-cornelis   Tilburg University, Tranzo Department,   Tias Building T307, PO Box 725,   5000 le Tilburg, the Netherlands   email c.m.vdr feltz@ tilburguniversity.ed uBackground:  The size and increasing burden of disease due to mental disorders in Europe  poses substantial challenges to its population and to the health policy of the European Union.",Non-OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
"They were selected by the members  of the ROAMER Clinical Research Task Force according to  one of the following criteria:  •	minimum h-index of 10 in Web of Science,22 or more  than 50 publications in the field in Web of Knowledge •	experts who had been consulted in the Grand Challenges  in Global Mental Health survey,23 who were scrutinized in  duplicate (RK, CMFC) in order to identify all European  experts involved in clinical research •	principal investigators carrying out clinical research in  Europe were selected (RK, SK) from several databases  for clinical research, such as the http://www.trialregister.",OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
"Available from: http://www.who.int/nmh/publications/ncd_report_full_ en.pd f. Accessed March 27, 2014.",OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
Available from:  http://www.webropol.com /.,Non-OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
"Available from: http://www.kingsfund.org.uk/publications/ long-term-conditions-and-mental-healt h. Accessed March 27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/8a/ndt-10-1057.PMC4085314.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/7b/opth-8-1233.PMC4085315.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1233–1239Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1233Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S5575 1assessment of β-zone peripapillary atrophy by   optical coherence tomography and scanning laser   ophthalmoscopy imaging in glaucoma patients Florian seidensticker1,* lukas reznicek2,* Thomas Mann2 irene hübert2 anselm Kampik2 Michael Ulbig2 Christoph hirneiss2 aljoscha s neubauer2 Marcus Kernt2 1Department of Ophthalmology,   hannover Medical school,   hannover, germany; 2Department of  Ophthalmology, ludwig-Maximilians- University, Munich, germany *These authors have contributed  equally to this work Correspondence: Marcus Kernt   ludwig-Maximilians-University,   Department of Ophthalmology,   Klinikum der Universität München,   Campus innenstadt, Mathildenstrasse 8,   D-80336 Munich, germany   Tel +49 89 5160 3821   Fax +49 9131 5160 5160   email marcus.kernt@med.uni-muenchen.",Non-OADS,/arxiv_data1/oa_pdf/eb/7b/opth-8-1233.PMC4085315.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/eb/7b/opth-8-1233.PMC4085315.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/7b/opth-8-1233.PMC4085315.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/3d/opth-8-1241.PMC4085316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1241–1252Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1241Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6458 4Efficacy and safety of benzalkonium chloride-free  fixed-dose combination of latanoprost and timolol  in patients with open-angle glaucoma or ocular  hypertension Purvi Bhagat1 Kalyani sodimalla2 Chandrima Paul3 surinder s Pandav4 ganesh V raman5 Rengappa Ramakrishnan6 Abhijeet Joshi7 atul raut7 1Glaucoma Clinic, M & J Western  regional institute of Ophthalmology,   Civil Hospital, Ahmedabad, Gujarat,   india; 2glaucoma Department, PBM a’s  h.V.",Non-OADS,/arxiv_data1/oa_pdf/55/3d/opth-8-1241.PMC4085316.pdf
"Keywords:  open-angle glaucoma, ocular hypertension, pharmaceutical preservatives,   benzalkonium chloride, latanoprost, timolol Introduction Control of elevated intraocular pressure (IOP) remains the principal goal in the  treatment of glaucoma and ocular hypertension (OHT).1 The evidence suggests that  achieving low IOP with treatment is associated with reduced progression of visual field Correspondence: atul raut Clinical research, sun Pharma advanced  Research Company Ltd, 17-B Mahal  Industrial Estate, Mahakali Caves  Road, Andheri (E), Mumbai 400093,  Maharashtra, india Tel +91 22 6645 5752 Fax +91 22 6645 5685 email atul.raut@sparcmail.co m Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Bhagat et al Running head recto: BAK-free latanoprost/timolol fixed-dose combination in OAG and OHT DOI: http://dx.doi.org/10.2147/OPTH.S64584",Non-OADS,/arxiv_data1/oa_pdf/55/3d/opth-8-1241.PMC4085316.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/55/3d/opth-8-1241.PMC4085316.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1252Bhagat et al  19.,Non-OADS,/arxiv_data1/oa_pdf/55/3d/opth-8-1241.PMC4085316.pdf
Available from: http://bi.adisinsight.com.,Non-OADS,/arxiv_data1/oa_pdf/55/3d/opth-8-1241.PMC4085316.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/71/ijn-9-3069.PMC4085317.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3069–3076International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3069OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6567 4a new approach for noninvasive transdermal  determination of blood uric acid levels correspondence:   congo Tak-shing ching   Department of electrical engineering,  National chi Nan University,  1 University rd, Puli, Nantou county  54561, Taiwan, republic of china   T el +88 64 9291 0960 ext 4774   email tsching@ncnu.edu.t w Kok-Khun Y ong   Puli christian hospital, T eh-shan rd,   Puli, Nantou county 54546, Taiwan,   republic of china   email khun1110@mail.pch.org.t wcongo Tak-shing ching1,2 Kok-Khun Y ong3 Yan-Dong Yao4 huan-Ting shen3 shiu-Man hsieh5 Deng-Yun Jheng1 Tai-Ping sun1,6 hsiu-li shieh1 1Department of electrical engineering,   National chi Nan University, Nantou,   2Department of Photonics and  communication engineering, asia  University, Taichung, 3Department  of Internal Medicine, Puli christian  hospital, Nantou, Taiwan, republic  of china; 4Division of science and  T echnology, hong Kong community  college, hong Kong; 5Department of  Orthopedic surgery, Puli christian  hospital, 6Department of electronic  engineering, Nan Kai University of  Technology, Nantou, Taiwan, republic  of chinaAbstract:  The aims of this study were to investigate the most effective combination of physical  forces from laser, electroporation, and reverse iontophoresis for noninvasive transdermal extrac - tion of uric acid, and to develop a highly sensitive uric acid biosensor (UAB) for quantifying  the uric acid extracted.",Non-OADS,/arxiv_data1/oa_pdf/69/71/ijn-9-3069.PMC4085317.pdf
"Laser perforation is a technique whereby micropores are created in the skin by  pulsed laser to promote transport of molecules.7,8 RI refers to the technique of pass - ing a small current through a section of skin to promote transport of both charged  and neutral molecules.16 Electroporation refers to the process of creating transient  micropores across cell membranes by injecting a brief high voltage pulse to per - mit movement of exogenous molecules.17 Several papers have reported the use of Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Ching et al Running head recto: Noninvasive transdermal determination of blood uric acid levels DOI: http://dx.doi.org/10.2147/IJN.S65674",Non-OADS,/arxiv_data1/oa_pdf/69/71/ijn-9-3069.PMC4085317.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/71/ijn-9-3069.PMC4085317.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3076ching et al Taiwan, Republic of China (TCVGH-NCNU1027901), and  the National Chi Nan University and Puli Christian Hospital,  Taichung, Taiwan, Republic of China (102A038).",Non-OADS,/arxiv_data1/oa_pdf/69/71/ijn-9-3069.PMC4085317.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/46/ijn-9-3163.PMC4085318.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3163–3174International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3163OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6046 5glial cell line-derived neurotrophic factor   gene delivery via a polyethylene imine grafted  chitosan carrier Yu-shiang Peng1,* Po-liang lai2,* sydney Peng1 his-chin Wu3 siang Yu1 Tsan-Yun Tseng4 li-Fang Wang5 I-Ming chu1 1Department of chemical engineering,   National Tsing hua University,   hsinchu, 2Department of Orthopedic  surgery, chang gung Memorial  hospital at linkou, chang gung  University college of Medicine,   Taoyuan, 3Department of Materials  engineering, Tatung University, Taipei,   4graduate school of Biotechnology  and Bioengineering, college of  engineering, Yuan Ze University,   chung-li, 5Department of Medicinal  and applied chemistry, Kaohsiung  Medical University, Kaohsiung, Taiwan *Yu-shiang Peng and Po- liang lai  contributed equally to this work correspondence: li-Fang Wang   Department of Medicinal and applied  chemistry, Kaohsiung Medical University,  100 shih-chuan 1st road, Kaohsiung city  80708, Taiwan   T el +886 7 312 1101 ext 2217   Fax +886 7 312 5339   email lfwang@kmu.edu.t w I-Ming chu   National Tsing hua University,  Department of chemical engineering,   101 section 2, Kuang-Fu road, hsinchu  city 30013, Taiwan   T el +886 3 571 3704   Fax +886 3 571 5408   email chuiming456@gmail.co mAbstract:  Parkinson’s disease is known to result from the loss of dopaminergic neurons.",Non-OADS,/arxiv_data1/oa_pdf/54/46/ijn-9-3163.PMC4085318.pdf
"However, the acid  dissociation Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Peng et al Running head recto: Glial cell line-derived neurotrophic factor gene delivery DOI: http://dx.doi.org/10.2147/IJN.S60465",Non-OADS,/arxiv_data1/oa_pdf/54/46/ijn-9-3163.PMC4085318.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/54/46/ijn-9-3163.PMC4085318.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3174Peng et al 34.,Non-OADS,/arxiv_data1/oa_pdf/54/46/ijn-9-3163.PMC4085318.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/1e/dhps-6-089.PMC4085319.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2014:6 89–92Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  89SHort rePortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/DHPS.S6368 0Joint medicine-information and pharmacovigilance  services could improve detection and  communication about drug-safety problems Jan Schjøtt1–3 Jenny Bergman3 1Section of Clinical Pharmacology,   Laboratory of Clinical Biochemistry,   Haukeland University Hospital,   2Institute of Clinical Science, Faculty  of Medicine and Dentistry, University  of Bergen,  3regional Medicines  Information and Pharmacovigilance  Centre ( reLIS Vest), Haukeland  University Hospital, Bergen, Norway Correspondence: Jan Schjøtt   Section of Clinical Pharmacology,   Laboratory of Clinical Biochemistry,   Haukeland University Hospital, 5021   Bergen, Norway   tel +47 55 973 093  Fax +47 55 290 718  email jan.didrik.schjott@helse-bergen.n oBackground:  RELIS is a Norwegian network of four regional medicine-information and  pharmacovigilance centers where pharmacists and clinical pharmacologists provide feedback  to health care professionals in spontaneous drug-related questions and adverse drug-reaction  (ADR) reports published in a question–answer pair (QAP) database (the RELIS database) and  the Norwegian ADR database, respectively.",Non-OADS,/arxiv_data1/oa_pdf/fb/1e/dhps-6-089.PMC4085319.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/fb/1e/dhps-6-089.PMC4085319.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/1e/dhps-6-089.PMC4085319.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/66/idr-7-177.PMC4085320.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 177–182Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  177ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IDR.S6592 8safety and feasibility of antibiotic de-escalation   in bacteremic pneumonia Faisal a Khasawneh1 adnanul Karim2 Tashfeen Mahmood3 subhan ahmed4 sayyed F Jaffri3 Mansoor Mehmood2 1section of Infectious Diseases,   2Department of Internal Medicine,   T exas T ech University health sciences  center, amarillo, TX,  3Department  of Internal Medicine, Deaconess  hospital, evansville, In , 4section of  nephrology, Department of Internal  Medicine, University of Oklahoma,   T ulsa, OK, Usa correspondence: Faisal a Khasawneh   Department of Internal Medicine,   Texas Tech University health sciences   center,  1400 s coulter street,   amarillo, TX  79106, Usa   Tel +1 806 414 9110  Fax +1 806 354 5765  email faisal.khasawneh@ttuhsc.ed uBackground:  Antibiotic de-escalation is a potential strategy advocated to conserve the   effectiveness of broad-spectrum antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/98/66/idr-7-177.PMC4085320.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/98/66/idr-7-177.PMC4085320.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/66/idr-7-177.PMC4085320.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/26/cia-9-1011.PMC4085321.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1011–1019Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1011RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4892 6Hiroyuki Umegaki Department of Community  Healthcare and Geriatrics, Nagoya  University Graduate School   of Medicine, Nagoya, Japan Correspondence: Hiroyuki Umegaki   Department of Community Healthcare  and Geriatrics, Nagoya University  Graduate School of Medicine   65 Tsuruma-cho, Showa-ku, Nagoya,    Aichi, 466-8550, Japan   email umegaki@med.nagoya-u.ac.j pType 2 diabetes as a risk factor for cognitive  impairment: current insights Abstract:  Type 2 diabetes mellitus (T2DM) is a risk factor for cognitive dysfunction and demen - tia in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/2c/26/cia-9-1011.PMC4085321.pdf
"IR  is defined as an inadequate response by insulin target tissues, such as skeletal muscle, Journal name: Clinical Interventions in Aging Journal Designation: Review Y ear: 2014 Volume: 9 Running head verso: Umegaki Running head recto: T2DM and cognitive impairment DOI: http://dx.doi.org/10.2147/CIA.S48926",Non-OADS,/arxiv_data1/oa_pdf/2c/26/cia-9-1011.PMC4085321.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2c/26/cia-9-1011.PMC4085321.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2c/26/cia-9-1011.PMC4085321.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/d1/jpr-7-379.PMC4085322.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 379–387Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  379ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6379 6health care utilization and expenditures among   Medicaid beneficiaries with neuropathic   pain following spinal cord injury Jay M Margolis1 Paul Juneau1 alesia sadosky2 Joseph c cappelleri3 Thomas n Bryce4 edward c nieshoff5 1Truven health analytics, Bethesda,   MD, Usa;  2Pfizer inc., new Y ork, nY,    Usa;  3Pfizer inc., groton, cT, Usa;   4Department of Rehabilitation  Medicine, The icahn school of  Medicine at Mount sinai, new Y ork,   nY, Usa;  5Department of Physical  Medicine and Rehabilitation, Wayne  state University school of Medicine,    Detroit, M i, Usa correspondence: Jay M Margolis   Truven health analytics,  332 Bryn Mawr   ave, Bala cynwyd, Pa  19004, Usa   Tel +1 610 667 4718  Fax +1 610 667 4718  email jay.margolis@truvenhealth.co mBackground:  The study aimed to evaluate health care resource utilization (HRU) and costs for  neuropathic pain (NeP) secondary to spinal cord injury (SCI) among Medicaid beneficiaries.",Non-OADS,/arxiv_data1/oa_pdf/c6/d1/jpr-7-379.PMC4085322.pdf
"Available from: https://www.nscisc.uab.edu/ PublicDocuments/fact_ figures_docs/Facts%202013.pd f. Accessed  August  22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c6/d1/jpr-7-379.PMC4085322.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/c6/d1/jpr-7-379.PMC4085322.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/d1/jpr-7-379.PMC4085322.pdf
Available from: https://www.cms.gov/Research- Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare - ProgramRatesStats/downloads/MedicareMedicaidSummaries2011.pdf.,OADS,/arxiv_data1/oa_pdf/c6/d1/jpr-7-379.PMC4085322.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/32/sar-5-063.PMC4085323.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 63–73Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  63ORiginAl ReSeARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/SAR.S6212 7Program- and service-level costs of seven  screening, brief intervention, and referral   to treatment programs Jeremy W Bray1 erin Mallonee2 William Dowd2 Arnie Aldridge2 Alexander J cowell2 Janice Vendetti3 1Department of economics, Bryan  School of Business and economics,   University of north carolina at  greensboro, greensboro, nc, USA;   2RTi international, Research Triangle  Park, nc, USA; 3Department of  community Medicine and health  care, School of Medicine, U cOnn  health, Farmington, cT, USA correspondence: Jeremy W Bray   Department of economics, Bryan School  of Business and economics, 462 Bryan  Building, PO Box 26170, University  of north carolina at greensboro,  greensboro, nc 27402-6170, USA   Tel +1 336 334 3910   Fax +1 336 334 5463   email jwbray@uncg.ed uAbstract:  This paper examines the costs of delivering screening, brief intervention, and referral  to treatment (SBIRT) services within the first seven demonstration programs funded by the US  Substance Abuse and Mental Health Services Administration.",Non-OADS,/arxiv_data1/oa_pdf/f4/32/sar-5-063.PMC4085323.pdf
Available at: http://www.grubb-ellis.com/Research /.,Non-OADS,/arxiv_data1/oa_pdf/f4/32/sar-5-063.PMC4085323.pdf
Available at: https://www.samhsa-gpra.,Non-OADS,/arxiv_data1/oa_pdf/f4/32/sar-5-063.PMC4085323.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/f4/32/sar-5-063.PMC4085323.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/32/sar-5-063.PMC4085323.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/34/ijgm-7-333.PMC4085324.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 333–337International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  333OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJGM.S5580 6lung cancer trends: smoking, obesity,   and sex assessed in the staten Island   University’s lung cancer patients shilpi Gupta1 samer hassan1 Vijaya r Bhatt2 houssein abdul sater1 asma Dilawari3 1hematology-Oncology, staten Island  University hospital, staten Island,   nY, Usa;  2hematology-Oncology,   nebraska Medical ctr, Omaha, ne,   Usa;  3hematology-Oncology, Med star  Georgetown University hospital,   Olney, Maryland, Usa correspondence: houssein abdul sater   hematology-Oncology, staten Island   University hospital,  177 clifton avenue,   staten Island, nY  10305, Usa   Tel +1 64 6204 4559  email houssein.md@gmail.co m, hus_ tas@hotmail.co mIntroduction:  The incidence of lung cancer in the United States decreased by  1.8% from  1991  to 2005 while it increased by  0.5% in females.",Non-OADS,/arxiv_data1/oa_pdf/ee/34/ijgm-7-333.PMC4085324.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/ee/34/ijgm-7-333.PMC4085324.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/34/ijgm-7-333.PMC4085324.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/ac/ceg-7-205.PMC4085325.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2014:7 205–214Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  205REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CEG.S4345 3S1pping fire: Sphingosine-1-phosphate signaling   as an emerging target in inflammatory bowel   disease and colitis-associated cancer Emilie Degagné Julie D Saba Children’s Hospital Oakland Research  Institute, Oakland, CA, USA Correspondence: Julie D Saba   Children’s Hospital Oakland Research  Institute, 5700 Martin Luther King Jr  Way, Oakland, CA  94609, USA   Tel +1 510 450 7690  Fax +1 510 450 7910  Email jsaba@chori.or gAbstract:  Inflammatory bowel disease (IBD) is a complex disease that involves unpredic table   and destructive inflammation in the gastrointestinal tract resulting in gastrointestinal symp - toms, infection, and tissue destruction, and which can be associated with an increased risk  of colon cancer.",Non-OADS,/arxiv_data1/oa_pdf/78/ac/ceg-7-205.PMC4085325.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/78/ac/ceg-7-205.PMC4085325.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/ac/ceg-7-205.PMC4085325.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/cd/copd-9-675.PMC4085326.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 675–683International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  675OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6348 5extent and prevalence of cognitive dysfunction   in chronic obstructive pulmonary disease, chronic  non-obstructive bronchitis, and in asymptomatic  smokers, compared to normal reference values roberto W Dal negro1 luca Bonadiman1 silvia T ognella2 Fernanda P Bricolo3 Paola T urco3 1national Center for respiratory  Pharmacoeconomics and  Pharmacoepidemiology (CesF ar),   Verona, Italy; 2lung Division,   Bussolengo general hospital,   Bussolengo, Italy; 3research and  Clinical governance, Verona, Italy Correspondence: roberto W Dal negro   national Center for respiratory  Pharmacoeconomics and  Pharmacoepidemiology (CesF ar), Via  gabriele rossetti 4, Verona, Italy   email robertodalnegro@gmail.co mBackground:  Chronic obstructive pulmonary disease (COPD) can affect cognition.",Non-OADS,/arxiv_data1/oa_pdf/b1/cd/copd-9-675.PMC4085326.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b1/cd/copd-9-675.PMC4085326.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/cd/copd-9-675.PMC4085326.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/e1/tcrm-10-517.PMC4085332.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 517–525Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  517Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6196 7Anti-N-methyl- d-aspartate-receptor encephalitis:  diagnosis, optimal management, and challenges Andrea P Mann1 elena Grebenciucova2 Rimas v Lukas2 1Department of Psychiatry  and Behavioral Neuroscience,   2Department of Neurology,    University of Chicago, Chicago,    iL, USA Correspondence: Andrea P Mann   Department of Psychiatry and Behavioral  Neuroscience,  5841 South Maryland  Avenue – MC  3077, University of  Chicago, Chicago, iL  60637, USA   email andrea.mann7@gmail.co mObjective:  Anti- N-methyl- d-aspartate-receptor (NMDA-R) encephalitis is a new autoimmune  disorder, often paraneoplastic in nature, presenting with complex neuropsychiatric symptoms.",Non-OADS,/arxiv_data1/oa_pdf/cb/e1/tcrm-10-517.PMC4085332.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/cb/e1/tcrm-10-517.PMC4085332.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/e1/tcrm-10-517.PMC4085332.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/3d/tcrm-10-513.PMC4085333.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2014:10 513–516Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  513Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/TCRM.S6611 7severe complications after negative pressure  wound therapy in burned wounds: two case  reports Haitao Ren1 Yuan Li2 1Department of Burns and Wound  Center, the second affiliated Hospital,   school of Medicine, Zhejiang  University, Hangzhou, People’s  Republic of China;  2Department of  Ultrasound, Women’s Hospital, school  of Medicine, Zhejiang University,   Hangzhou, People’s Republic of China Correspondence: Yuan Li   Department of Ultrasound, Women’s  Hospital, school of Medicine, Zhejiang  University, Xue shi Road1#, Hangzhou   310006, People’s Republic of China   email d ocliyuan@126.co mAbstract:  We present two typical cases of severe complications (sepsis and hemorrhage) after  negative pressure wound therapy (NPWT) in burned patients.",Non-OADS,/arxiv_data1/oa_pdf/4e/3d/tcrm-10-513.PMC4085333.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4e/3d/tcrm-10-513.PMC4085333.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/3d/tcrm-10-513.PMC4085333.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/ce/vhrm-10-399.PMC4085334.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 399–401Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  399Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/ 10.2147/VHRM.S6428 6Cardiac angiosarcoma: utility   of [18F]fluorodeoxyglucose positron   emission tomography–computed tomography   in evaluation of residue, metastases,   and treatment response Handan tokmak1 Nurhan Demir2 Mehmet onur Demirkol3 1Department of Nuclear Medicine and  Molecular Imaging, american Hospital,   Nişantaşi, Istanbul, 2Internal Medicine  Department, Cerrahpasa Medical  Faculty, Istanbul University, Istanbul,   3Department of Nuclear Medicine and  Molecular Imaging, Koç University,   Istanbul, T urkey Correspondence: Handan tokmak   Department of Nuclear Medicine and  Molecular Imaging, american Hospital,   20 Güzelbahçe Sokak, Nişantaşi,   Istanbul 34365, Turkey   tel +90 212 444 3777 ext 2586   Fax +90 212 311 2190   email handantokmak@gmail.co mAbstract:  Cardiac angiosarcomas are a rare form of malignancy.",Non-OADS,/arxiv_data1/oa_pdf/a7/ce/vhrm-10-399.PMC4085334.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/a7/ce/vhrm-10-399.PMC4085334.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/ce/vhrm-10-399.PMC4085334.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/dd/tcrm-10-505.PMC4085335.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 505–511Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  505Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5036 2Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/b6/dd/tcrm-10-505.PMC4085335.pdf
"Or use: http://dvpr.es/1l9diW HSafety and efficacy of acarbose in the treatment   of diabetes in Chinese patients Ke He* Jun-Cheng Shi* Xiao-Ming Mao Department of endocrinology, Nanjing  First Hospital Affiliated to Nanjing  Medical University, Nanjing, People’s  Republic of China *These authors contributed equally to  this work Correspondence: XM Mao   Department of endocrinology, Nanjing  First Hospital Affiliated to Nanjing  Medical University,  68 ChangLe St,  Nanjing,  210006, People’s Republic of  China   email maoxming@163.co mAbstract:  Acarbose is an α-glucosidase inhibitor that is commonly used to control postprandial  blood glucose.",Non-OADS,/arxiv_data1/oa_pdf/b6/dd/tcrm-10-505.PMC4085335.pdf
"Available from: http://www.fao.org/docrep/007/y5736e/ y5736e00.ht m. Accessed January  15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/b6/dd/tcrm-10-505.PMC4085335.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b6/dd/tcrm-10-505.PMC4085335.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/dd/tcrm-10-505.PMC4085335.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/b0/ijn-9-3183.PMC4085336.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3183–3192International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3183OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6528 9Novel gramicidin formulations in cationic lipid   as broad-spectrum microbicidal agents correspondence: ana M carmona- ribeiro   Departamento de Bioquímica, Instituto  de Química, Universidade de são Paulo,   PO Box 26077, são Paulo   05513-970, Brazil   Tel +55 11 3091 1887   Fax +55 11 3815 5579   email amcr@usp.b rDanielle aMT ragioto letícia DM carrasco ana M carmona-ribeiro Departamento de Bioquímica,   Instituto de Química, Universidade   de são Paulo, são Paulo, Brazil Abstract:  Dioctadecyldimethylammonium bromide (DODAB) is an antimicrobial lipid that  can be dispersed as large closed bilayers (LV) or bilayer disks (BF).",Non-OADS,/arxiv_data1/oa_pdf/40/b0/ijn-9-3183.PMC4085336.pdf
"AMPs have been known for many years, yet very few have been  used extensively in the clinic due to their considerable toxicity and high manufacturing  costs.2 Further, the development of resistance by pathogenic bacteria requires multiple  lines of urgent action, such as the design and synthesis of model peptides with potent  antimicrobial activity and low toxicity3 and the invention of novel supramolecular  assemblies for the available peptides, allowing combination of different mechanisms  of action.4–6 For example, small cationic peptides were recently shown to delocalize  peripheral membrane proteins, thereby impacting important cellular processes such as  respiration and cell wall biosynthesis.7 Lipid bilayer disks8 have been used as carriers  for AMPs, leading to novel, nontoxic, and efficacious formulations which fully protect  the peptide against degradation but preserve its activity against bacteria.9 Some poly - saccharides have also been evaluated as suitable vehicles for AMPs, with confirmation  of the advantages of prolonged retention of peptides at the site of application due to  bioadhesion and slowing of proteolytic degradation.10,11 Gramicidin A (Gr) is an antimicrobial peptide with a unique mechanism of ham - pering the function of bacterial plasma membranes, thereby preventing development Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Ragioto et al Running head recto: Microbicidal gramicidin formulations in cationic lipid DOI: http://dx.doi.org/10.2147/IJN.S65289",Non-OADS,/arxiv_data1/oa_pdf/40/b0/ijn-9-3183.PMC4085336.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/40/b0/ijn-9-3183.PMC4085336.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3192ragioto et al  3.,Non-OADS,/arxiv_data1/oa_pdf/40/b0/ijn-9-3183.PMC4085336.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
Coho salmon is one of the most valuedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.05.007 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Please cite this article as: T. Nakano, et al., Effect of severe environmental thermal stress on redox state in salmon, Redox Biology (2014), http://dx.doi.org/10.1016/j.redox.2014.05.007 iRedox Biology 2 (2014) 772 –776",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"/ Redox Biology 2 (2014) 772 –776 773 Please cite this article as: T. Nakano, et al., Effect of severe environmental thermal stress on redox state in salmon, Redox Biology (2014), http://dx.doi.org/10.1016/j.redox.2014.05.007 i",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"/ Redox Biology 2 (2014) 772 –776 774 Please cite this article as: T. Nakano, et al., Effect of severe environmental thermal stress on redox state in salmon, Redox Biology (2014), http://dx.doi.org/10.1016/j.redox.2014.05.007 i",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[5] A.D. Pickering, Growth and stress in ﬁsh production, Aquaculture 111 (1993) 51–63,http://dx.doi.org/10.1016/j.redox.2014.05.007 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[6] P. Prunet, Ø. Øverli, J. Doux ﬁls, G. Bernardini, P. Kestemont, D. Baron, Fish welfare and genomics, Fish Physiology and Biochemistry 38 (2012) 43 –60, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Barton, G.K. Iwama, Physiological changes in ﬁsh from stress in aqua- culture with emphasis on the response and effects of corticosteroids, Annual Review of Fish Diseases 1 (1991) 3 –26, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"/ Redox Biology 2 (2014) 772 –776 775 Please cite this article as: T. Nakano, et al., Effect of severe environmental thermal stress on redox state in salmon, Redox Biology (2014), http://dx.doi.org/10.1016/j.redox.2014.05.007 i",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Bibeau, K. Nakano, P.M. Schulte, G.K. Iwama, Heat shock protein genes and their functional signi ﬁcance in ﬁsh, Gene 295 (2002) 173 –183, http://dx.doi.org/10.1016/j.redox.2014.05.007 12354651 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Hofmann, Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology, Annual Review of Physiology 61 (1999) 243 –282, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Beckman, G.K. Iwama, R.H. Devlin, Acute physiological stress down-regulates mRNA expressions of growth-related genes in coho salmon, PLoS One 8 (2013) e71421, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Woo, Modulation of ﬁsh growth hormone levels by salinity, temperature, pollutants and aquaculture related stress: a review, Reviews in Fish Biology and Fisheries 19 (2009) 97 –120, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[14] S. Moriyama, F.G. Ayson, H. Kawauchi, Growth regulation by insulin-like growth factor-I in ﬁsh, Bioscience, Biotechnology, and Biochemistry 64 (2000) 1553 –1562, http://dx.doi.org/10.1016/j.redox.2014.05.007 10993139 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[16] M. Reinecke, In ﬂuences of the environment on the endocrine and paracrine ﬁsh growth hormone-insulin-like growth factor-I system, Journal of Fish Biology 76 (2010) 1233 –1254, http://dx.doi.org/10.1016/j.redox.2014.05.007 20537012 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Grau, G.K. Iwama, The effects of cortisol on heat shock protein 70 levels in two ﬁsh species, General and Comparative Endocrinology 124 (2001) 97 –105, http://dx.doi.org/10.1016/j.redox.2014.05.007 11703075 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Lushchak, Environmentally induced oxidative stress in aquatic animals, Aquatic Toxicology 101 (2011) 13 –30,http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[24] T. Nakano, M. Tosa, M. Takeuchi, Improvement of biochemical features in ﬁsh health by red yeast and synthetic astaxanthin, Journal of Agricultural and Food Chemistry 43 (1995) 1570 –1573, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[27] T. Nakano, T. Kanmuri, M. Sato, M. Takeuchi, Effect of astaxanthin rich red yeast ( Phafﬁa rhodozyma ) on oxidative stress in rainbow trout, Biochimica et Biophysica Acta 1426 (1999) 119 –125, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Mayhew, R. Myklebust, E. Ringø, Acute stress alters intestinal function of rainbow trout, Oncorhynchus mykiss (Walbaum), Aqua- culture 250 (2005) 480 –495, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[30] A.-P. Arrigo, Gene expression and the thiol redox state, Free Radical Biology and Medicine 27 (1999) 936 –944, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[32] H. Sies, Glutathione and its role in cellular functions, Free Radical Biology and Medicine 27 (1999) 916 –921, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[33] T. Nakano, M. Sato, M. Takeuchi, Glutathione peroxidase of ﬁsh, Journal of Food Science 57 (1992) 1116 –1119, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[35] S.A. Ploch, Y.-P. Lee, E. MacLean, R.T. Di Giulio, Oxidative stress in liver of brown bullhead and channel cat ﬁsh following exposure to tert-butyl hydro- peroxide, Aquatic Toxicology 46 (1999) 231 –240, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[41] T. Nakano, M. Sato, M. Takeuchi, Superoxide dismutase activity in the skin of ﬁsh, Journal of Fish Biology 43 (1993) 492 –496, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Zelko, T.J. Mariani, R.J. Folz, Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression, Free Radical Biology and Medicine 33 (2002) 337 –349, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Pörtner, D. Abele, Seasonality of energetic functioning and production of reactive oxygen species by lugworm ( Arenicola marina ) mitochondria exposed to acute temperature changes, Journal of Experimental Biology 207 (2004) 2529 –2538, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Ji, Oxidative stress during exercise: implication of antioxidant nutrients, Free Radical Biology and Medicine 18 (1995) 1079 –1086, http://dx.doi.org/ 10.1016/j.redox.2014.05.007 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[47] A. Mujahid, Y. Yoshiki, Y. Akiba, M. Toyomizu, Superoxide radical production in chicken skeletal muscle induced by acute heat stress, Poultry Science 84 (2005) 307 –314, http://dx.doi.org/10.1016/j.redox.2014.05.007 15742968 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Jones, K. Watson, Stress proteins as biomarkers of oxidative stress: effects of antioxidant supplements, Free Radical Biology and Medicine 28 (2000) 1598 –1606, http://dx.doi.org/10.1016/j.redox.2014.05.007 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Allen, M. Tresini, Oxidative stress and gene regulation, Free Radical Biology and Medicine 28 (2000) 463 –499, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Willetts, A. Devitt, Redox regulation of protein damage in plasma, Redox Biology 2 (2014) 430 –435, http://dx.doi.org/10.1016/ j.redox.2014.05.007 24624332 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Mak, Modulation of oxidative stress as an anticancer strategy, Nature Reviews Drug Discovery 12 (2013) 931 –947, http://dx.doi.org/ 10.1016/j.redox.2014.05.007 .",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"[58] I. Milisav, B. Poljsak, D. Suput, Adaptive response, evidence of cross-resistance and its potential clinical use, International Journal of Molecular Sciences 13 (2012) 10771 –10806, http://dx.doi.org/10.1016/j.redox.2014.05.007 23109822 .",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Chandel, Physiological roles of mitochondrial reactive oxygen species, Molecular Cell 48 (2012) 158 –167, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"Yan, Positive oxidative stress in aging and aging-related disease tolerance, Redox Biology 2 (2014) 165 –169, http://dx.doi.org/10.1016/j.redox.2014.05.007 .T.",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
"/ Redox Biology 2 (2014) 772 –776 776 Please cite this article as: T. Nakano, et al., Effect of severe environmental thermal stress on redox state in salmon, Redox Biology (2014), http://dx.doi.org/10.1016/j.redox.2014.05.007 i",OADS,/arxiv_data1/oa_pdf/b9/4d/main.PMC4085342.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
6Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.06.008 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AKT, serine/threonine protein kinase (v-akt murine thimoma viral oncogene homolog1); apoB48, apolipoprotein B48; CD, Crohns disease; COX-2, cyclooxygenase-2; Cys, cysteine; DSS, dextran sodium sulfate; ERK, extracellular signal-regulated kinase; GRP, grape reaction product; GSH, red uced glutathione; IBD, inﬂammatory bowel disease; IKB, inhibitor of NF- κB; IL, interleukin; iNOS, inducible nitric oxide synthase; IFN, interferon; LPS, lipopolysaccharide; MAPK, mitogen-activated protein kinase; NADPH, nicotinamide adenine dinucleotide phosphate reduced; NF- κB, nuclear factor- κB; Nrf2, nuclear factor erythroid-2-related factor 2; PGE-2, prostaglandin E-2; ROS, reactive oxygen species; SIRT-1, silent mating type information regulation-1; TNF- α, tumor necrosis factor alpha; UC, Ulcerative Colitis nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Dignass, Intestinal barrier function, Current Opinion in Clinical Nutrition and Metabolic Care 5 (2002) 685 –694, http://dx.doi.org/ 10.1016/j.redox.2014.06.008 12394645 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Oteiza, G. Poli, In ﬂammatory bowel disease: mechanisms, redox considerations, and therapeutic targets, Antioxidants & Redox Signaling 19 (2013) 1711 –1747, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Covas, P. Gambert, M. Fitó, R. de la Torre, Wine and oxidative stress: up-to- date evidence of the effects of moderate wine consumption on oxidative damage in humans, Atherosclerosis 208 (2010) 297 –304, http://dx.doi.org/ 10.1016/j.redox.2014.06.008 19660752 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Scollary, Chemistry of ascorbic acid and sulfur dioxide as an antioxidant system relevant to white wine, Analytica Chimica Acta 732 (2012) 186 –193, http://dx.doi.org/10.1016/j.redox.2014.06.008 22688051 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Stappenbeck, Autophagy and intestinal homeostasis, Annual Review of Physiology 75 (2013) 241 –262, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[ 7 ]G .L e o n a r d u z z i ,B .S o t t e r o ,G .T e s t a ,F .B i a s i ,G .P o l i ,N e wi n s i g h t si n t o redox-modulated cell signaling, Current Pharmaceutical Design 17 (2011)3994 –4006, http://dx.doi.org/10.1016/j.redox.2014.06.008 22188450 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[8] M. Pasparakis, Role of NF- κB in epithelial biology, Immunological Reviews 246 (2012) 346 –358, http://dx.doi.org/10.1016/j.redox.2014.06.008 22435565 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Aw, Intestinal redox biology and oxidative stress, Seminars in Cell & Developmental Biology 23 (2012) 729 –737, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Waterhouse, Wine phenolics, Annals of the New York Academy of Sciences 957 (2002) 21 –36,http://dx.doi.org/10.1016/j.redox.2014.06.008 12074959 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Teissedre, M. Boban, C. Di Lorenzo, P. Restani, Bioavailability of wine-derived phenolic compounds in humans: a review, Food & Function 3 (2012) 995 –1007, http://dx.doi.org/10.1016/j.redox.2014.06.008 22728778 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[12] F. Pelsy, Molecular and cellular mechanisms of diversity within grapevine varieties, Heredity 104 (2010) 331 –340, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Teissedre, Tannin composition of cabernet- sauvignon and merlot grapes from the Bordeaux area for different vintages (2006 –2009) and comparison to tannin pro ﬁle of ﬁve 2009 vintage Mediter- ranean grapes varieties, Molecules (Basel, Switzerland) 16 (2011) 1519 –1532, http://dx.doi.org/10.1016/j.redox.2014.06.008 21317842 .F.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Spranger, Evolution of phenolic composition of red wine during vini ﬁcation and storage and its contribution to wine sensory properties and antioxidant activity, Journal of Agricultural and Food Chemistry 59 (2011) 6550 –6557, http://dx.doi.org/10.1016/j.redox.2014.06.008 21561162 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Teissedre, Impact of concentration of ellagitannins in oak wood on their levels and organoleptic in ﬂuence in red wine, Journal of Agricultural and Food Chemistry 59 (2011) 5677 –5683, http://dx.doi.org/10.1016/j.redox.2014.06.008 21480590 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Kauffmann, Determination of aminothiols by liquid chromatography with amperometricdetection at a silver electrode: application to white wines, Analytica Chimica Acta 786 (2013) 22 –28,http://dx.doi.org/10.1016/j.redox.2014.06.008 23790287 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Pérez-Coello, I. Hermosín-Gutiérrez, Identi ﬁcation of new derivatives of 2-S-glutathionylcaftaric acid in aged white wines by HPLC-DAD-ESI-MS(n.), Journal of Agricultural and Food Chemistry 58 (2010) 11483 –11492, http://dx.doi.org/10.1016/j.redox.2014.06.008 20942401 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[21] S. Marchand, G. de Revel, A HPLC ﬂuorescence-based method for glutathione derivatives quanti ﬁcation in must and wine, Analytica Chimica Acta 660 (2010) 158 –163, http://dx.doi.org/10.1016/j.redox.2014.06.008 20103157 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Changes in concentration in dry white wines during alcoholic fermentation and aging, Journal of Chromatography A 1139 (2007) 130 –135, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Dessì, E. Straface, W. Malorni, R. Masella, Apop- tosis induced by oxidized lipids is associated with up-regulation of p66Shc in intestinal Caco-2 cells: Protective effects of phenolic compounds, Journal of Nutritional Biochemistry 19 (2008) 118 –128, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Garcia-Parrilla, Intake of alcohol-free red wine modulates antioxidant enzyme activities in a human intervention study, Pharmacological Research: The Of ﬁcial Journal of the Italian Pharmacological Society 65 (2012) 609 –614, http://dx.doi.org/10.1016/ j.redox.2014.06.008 22484523 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"García-Parrilla, Simulated digestion and antioxidant activity of red wine fractions separated by high speed countercurrent chromatography, Journal of Agricultural and Food Chemistry 56 (2008) 8879 –8884, http://dx.doi.org/ 10.1016/j.redox.2014.06.008 18778068 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Weaver, The metabolism and analysis of iso ﬂavones and other dietary polyphenols in foods and biological systems, Food & Function 2 (2011) 235–244, http://dx.doi.org/10.1016/j.redox.2014.06.008 21779561 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Clifford, Dietary phenolics: chemistry, bioavail- ability and effects on health, Natural Product Reports 26 (2009) 1001 –1043, http://dx.doi.org/10.1016/j.redox.2014.06.008 19636448 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Wightman, A. Crozier, Colonic catabolism of dietary phenolic and polyphenolic compounds from Concord grape juice, Food & Function 4 (2013) 52 –62,http://dx.doi.org/10.1016/j.redox.2014.06.008 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Quintanilla-López, C. Gómez-Cordovés, B. Bartolomé, R. Lebrón-Aguilar, MALDI-TOF MS analysis of plant proanthocyanidins, Journal of Pharmaceutical and Biomedical Analysis 51 (2010) 358 –372, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Lean, A. Crozier, The bioavailability of raspberry anthocyanins and ellagitannins in rats, Molecular Nutrition & Food Research 51 (2007) 714 –725, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Tomás- Barberán, Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans, Journal of Agricultural and Food Chemistry 55 (2007) 10476 –10485, http://dx.doi.org/10.1016/j.redox.2014.06.008 17990850 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Tomás-Barberán, Identi ﬁcation of urolithin A as a metabolite produced by human colon micro ﬂora from ellagic acid and related compounds, Journal of Agricultural and Food Chemistry 53 (2005) 5571 –5576, http://dx.doi.org/10.1016/j.redox.2014.06.008 15998116 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"McDougall, S. Fyffe, P. Dobson, D. Stewart, Anthocyanins from red wine — Their stability under simulated gastrointestinal digestion, Phytochemistry 66 (2005) 2540 –2548, http://dx.doi.org/10.1016/j.redox.2014.06.008 16242736 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Reynolds, The jejunum is the main site of absorption for anthocyanins in mice, Journal of Nutritional Biochemistry 17 (2006) 31 –36,http://dx.doi.org/10.1016/j.redox.2014.06.008 16098729 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"O ’Leary, G. Williamson, in vitro metabolism of anthocyanins by human gut micro ﬂora, European Journal of Nutrition 44 (2005) 133 –142, http://dx.doi.org/10.1016/j.redox.2014.06.008 15309431 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Waterhouse, Identi ﬁcation of Cabernet Sauvignon anthocya- nin gut micro ﬂora metabolites, Journal of Agricultural and Food Chemistry 56 (2008) 9299 –9304, http://dx.doi.org/10.1016/j.redox.2014.06.008 18767860 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[40] S. Dragoni, J. Gee, R. Bennett, M. Valoti, G. Sgaragli, Red wine alcohol promotes quercetin absorption and directs its metabolism towards isorhamnetin and tamarixetin in rat intestine in vitro, British Journal of Pharmacology 147(2006) 765 –771, http://dx.doi.org/10.1016/j.redox.2014.06.008 16444288 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Dessì, Wine extracts from Sardinian grape varieties attenuate membrane oxidative damage in Caco-2 cell monolayers, Food Chemistry 134 (2012) 2105 –2113, http://dx.doi.org/10.1016/ j.redox.2014.06.008 23442662 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[43] C. Starp, B. Alteheld, P. Stehle, Characteristics of ( þ)-catechin and ( /C0)-epica- techin transport across pig intestinal brush border membranes, Annals of Nutrition & Metabolism 50 (2006) 59 –65, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[44] A. Takagaki, F. Nanjo, Catabolism of ( þ)-catechin and ( /C0)-epicatechin by rat intestinal microbiota, Journal of Agricultural and Food Chemistry 61 (2013) 4927 –4935, http://dx.doi.org/10.1016/j.redox.2014.06.008 23621128 .",OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[45] R. Tabasco, F. Sánchez-Patán, M. Monagas, B. Bartolomé, M. Victoria Moreno- Arribas, C. Peláez, T. Requena, Effect of grape polyphenols on lactic acidbacteria and bi ﬁdobacteria growth: Resistance and metabolism, Food Micro- biology 28 (2011) 1345 –1352, http://dx.doi.org/10.1016/j.redox.2014.06.008 21839384 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Femia, L. Giovannelli, G. Caderni, C. Cecchini, S. Silvi, C. Orpianesi, A. Cresci, Red wine polyphenols in ﬂuence carcinogenesis, intestinal micro ﬂora, oxidative damage and gene expression proﬁles of colonic mucosa in F344 rats, Mutation Research 591 (2005) 237– 246, http://dx.doi.org/10.1016/j.redox.2014.06.008 16293270 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Vaughan, T. van de Wiele, in vitro bioconversion of polyphenols from black tea and red wine/grape juice by human intestinal microbiota displays strong interindivi- dual variability, Journal of Agricultural and Food Chemistry 58 (2010) 10236 –- 10246, http://dx.doi.org/10.1016/j.redox.2014.06.008 20726519 .",OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[51] C. Zhou, J. Zhao, J. Li, H. Wang, C. Tang, Acute ethanol administration inhibits Toll-like receptor 4 signaling pathway in rat intestinal epithelia, Alcohol (Fayette- ville, N.Y.) 47 (2013) 231 –239, http://dx.doi.org/10.1016/j.redox.2014.06.008 23428594 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[52] N. Boban, M. Tonkic, D. Budimir, D. Modun, D. Sutlovic, V. Punda-Polic, M. Boban, Antimicrobial effects of wine: separating the role of polyphenols, pH, ethanol, and other wine components, Journal of Food Science 75 (2010) M322 –M326, http://dx.doi.org/10.1016/j.redox.2014.06.008 20629891 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Jin, W. Namkung, T. Ma, J.R. Thiagarajah, A.S. Verkman, Chloride channel inhibition by a red wine extract and a synthetic small molecule prevents rotaviral secretory diarrhoea in neonatal mice, Gut 63 (2014)1120 –1129, http://dx.doi.org/10.1016/j.redox.2014.06.008 24052273 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Franzosi, A. Maggioni, G. L. Nicolosi, C. Schweiger, M. Silletta, L. Tavazzi, G. Tognoni, R. Marchioli, Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trial, International Journal of Cardiology163 (2013) 282 –287, http://dx.doi.org/10.1016/j.redox.2014.06.008 21737162 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[55] G. Farchi, F. Fidanza, S. Giampaoli, S. Mariotti, A. Menotti, Alcohol and survival in the Italian rural cohorts of the Seven Countries Study, International Journal of Epidemiology 29 (2000) 667 –671, http://dx.doi.org/10.1016/j.redox.2014.06.008 10922343 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Redman, Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols, Nutrition (Bur-bank, los Angeles County, Calif.) 27 (2011) 733 –744, http://dx.doi.org/10.1016/ j.redox.2014.06.008 21454053 .F.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Kirkham, Regulation of in ﬂammation and redox signaling by dietary polyphenols, Biochemical Pharmacology 72 (2006) 1439 –1452, http://dx.doi.org/10.1016/j.redox.2014.06.008 16920072 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[59] Y. Shukla, R. Singh, Resveratrol and cellular mechanisms of cancer prevention, Annals of the New York Academy of Sciences 1215 (2011) 1 –8,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Henry, Resveratrol oligomers isolated from Carex species inhibit growth of human colontumorigenic cells mediated by cell cycle arrest, Journal of Agricultural and Food Chemistry 59 (2011) 8632 –8638, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Panaro, V. Caro ﬁglio, A. Acquafredda, P. Cavallo, A. Cianciulli, Anti- inﬂammatory effects of resveratrol occur via inhibition of lipopolysaccharide- induced NF- κB activation in Caco-2 and SW480 human colon cancer cells, British Journal of Nutrition 108 (2012) 1623 –1632, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Gastrointestinal and Liver Physiology 302 (2012)G326 –G335, http://dx.doi.org/10.1016/j.redox.2014.06.008 22052016 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Barbosa, J. Laranjinha, Intestinal anti-in ﬂammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells, Food & Function 4 (2013) 373 –383, http://dx.doi.org/10.1016/j.redox.2014.06.008 23233037 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[66] G. Angel-Morales, G. Noratto, S. Mertens-Talcott, Red wine polyphenolics reduce the expression of in ﬂammation markers in human colon-derived CCD- 18Co myo ﬁbroblast cells: potential role of microRNA-126, Food & Function 3 (2012) 745 –752, http://dx.doi.org/10.1016/j.redox.2014.06.008 22572890 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Gessner, R. Ringseis, M. Siebers, J. Keller, J. Kloster, G. Wen, K. Eder, Inhibition of the pro-in ﬂammatory NF- κB pathway by a grape seed and grape marc meal extract in intestinal epithelial cells, Journal of Animal Physiology and Animal Nutrition 96 (2012) 1074 –1083, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Tuberoso, S. Calfapietra, E. Chiarpotto, B. Sottero, P. Gamba, S. Gargiulo, V. Brunetto, G. Testa, M. A. Dessì, G. Poli, G. Leonarduzzi, Phenolic compounds present in Sardinian wine extracts protect against the production of in ﬂammatory cytokines induced by oxysterols in CaCo-2 human enterocyte-like cells, Biochemical Pharmacology 86 (2013) 138 –145, http://dx.doi.org/10.1016/j.redox.2014.06.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[69] L. Tian, H. Wang, A.M. Abdallah, W. Prinyawiwatkul, Z. Xu, Red and white wines inhibit cholesterol oxidation induced by free radicals, Journal of Agricultural and Food Chemistry 59 (2011) 6453 –6458, http://dx.doi.org/ 10.1016/j.redox.2014.06.008 21563753 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[70] S. Pal, S.S. Ho, R. Takechi, Red wine Polyphenolics suppress the secretion of ApoB48 from human intestinal CaCo-2 cells, Journal of Agricultural and FoodChemistry 53 (2005) 2767 –2772, http://dx.doi.org/10.1016/j.redox.2014.06.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Peters, G. Jansen, F. Martel, C. Calhau, Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds, European Journal of Nutrition 46 (2007) 329 –336, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Selma, A. González-Sarrías, S. Toti, J.J. Cerón, F. Tomás-Barberán, P. Dolara, J.C. Espín, Effect of a low dose of dietary resveratrol on colon microbiota, in ﬂammation and tissue damage in a DSS-induced colitis rat model, Journal of Agricultural and Food Chemistry 57(2009) 2211 –2220, http://dx.doi.org/10.1016/j.redox.2014.06.008 19228061 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Nagarkatti, Resveratrol (trans-3,5,4 0-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcrip- tion factor-kappaB activation to abrogate dextran sulfate sodium-inducedcolitis, Journal of Pharmacology and Experimental Therapeutics 332 (2010) 829–839, http://dx.doi.org/10.1016/j.redox.2014.06.008 19940103 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Howarth, Grape seed extract reduces the severity of selected disease markers in the proximal colon of dextran sulphate sodium-induced colitis in rats, DigestiveDiseases and Sciences 58 (2013) 970 –977, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Pfaf ﬂ, The in ﬂuence of polyphenol rich apple pomace or red-wine pomace diet on the gut morphol- ogy in weaning piglets, Journal of Animal Physiology and Animal Nutrition 91(2007) 289 –296, http://dx.doi.org/10.1016/j.redox.2014.06.008 17614999 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[78] R. Canali, F. Vignolini, F. Nobili, E. Mengheri, Reduction of oxidative stress and cytokine-induced neutrophil chemoattractant (CINC) expression by red wine polyphenols in zinc de ﬁciency induced intestinal damage of rat, Free Radical Biology & Medicine 28 (2000) 1661 –1670, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Clifford, P. Dolara, Effect of complex polyphenols and tannins from red wine on DNA oxidativedamage of rat colon mucosa in vivo, European Journal of Nutrition 39 (2000) 207–212, http://dx.doi.org/10.1016/j.redox.2014.06.008 11131367 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Beck, A.G. Buret, Mechanisms by which inﬂammation may increase intestinal cancer risk in in ﬂammatory bowel disease, In ﬂammatory Bowel Diseases 16 (2010) 1411 –1420, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Lamuela-Raventos, R. Estruch, Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies, Alcohol and Alcoholism (Oxford, Oxfordshire) 48 (2013) 270–277, http://dx.doi.org/10.1016/j.redox.2014.06.008 23408240 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Digestion 84 (2011) 238 –244, http://dx.doi.org/10.1016/j.redox.2014.06.008 21876358 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"Vaughan, J. van Duynhoven, (1)H NMR metabolite pro ﬁling of feces as a tool to assess the impact of nutrition on the human microbiome, NMR inBiomedicine 21 (2008) 615 –626, http://dx.doi.org/10.1016/j.redox.2014.06.008 18085514 .",OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
"[88] H. Hey, A. Schmedes, A.A. Nielsen, P. Winding, H. Grønbaek, Effects of ﬁve different alcoholic drinks on patients with Crohn's disease, Scandinavian Journal of Gastroenterology 42 (2007) 968 –972, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/c2/main.PMC4085343.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Interestingly, it was recently shown that 2-Cys Prx reversible sul ﬁnylation is aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.06.001 2213-2317/ &2014 The Authors.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: CSE, cystathionine γ-lyase; DEA-NO, diethylamine NONOate; DETA-NO, diethylenetriamine NONOate; DMEM, Dulbecco ’s modi ﬁed Eagle ’s medium; Hcy, homocysteine nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
Monoisotopic peptide mass values extracted by Data Explorer (Applied Biosystems) were used for protein identi ﬁcation by searching against the UniProtKB/Swiss-Prot database using the on-line mascot search engine ( http://www.matrixscience.com ).,OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2014.06.001 .,OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Winterbourn, The high reactivity of peroxiredoxin 2 with H(2)O(2) is not re ﬂected in its reaction with other oxidants and thiol reagents, Journal of Biological Chem- istry 282 (2007) 11885 –11892, http://dx.doi.org/10.1016/j.redox.2014.06.001 17329258 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Bae, Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides, Journal of Biological Chemistry 287 (2012) 4403 –4410, http://dx.doi.org/10.1016/j.redox.2014.06.001 22147704 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Signaling 7 (2005) 619 –626, http://dx.doi.org/10.1016/j.redox.2014.06.001 15890005 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Ferrero, E. Pagano, R.A. Wolosiuk, Typical 2-Cys peroxiredoxins — modulation by covalent transformations and noncovalent interactions, FEBS Journal 276 (2009) 2478 –2493, http://dx.doi.org/10.1016/j.redox.2014.06.001 19476489 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Karplus, Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling, Science 300 (2003) 650 –653, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Veal, Inactivation of a peroxiredoxin by hydrogen peroxide is critical for thioredoxin-mediated repair of oxidized proteins and cell survival, Molecular Cell 45 (2012) 398 –408, http://dx.doi.org/10.1016/j.redox.2014.06.001 22245228 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[8] H. Sies, Role of metabolic H 2O2generation: redox signaling and oxidative stress, Journal of Biological Chemistry 289 (2014) 8735 –8741, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Lee, Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a mole-cular chaperone function, Cell 117 (2004) 625 –635, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[10] M. Chevallet, E. Wagner, S. Luche, A. van Dorsselaer, E. Leize-Wagner, T. Rabilloud, Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recoveryafter oxidative stress, Journal of Biological Chemistry 278 (2003) 37146 –37153, http://dx.doi.org/10.1016/j.redox.2014.06.001 12853451 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Kang, K. Kim, S.G. Rhee, Reversing the inactivation of peroxiredoxins caused by cysteine sul ﬁnic acid formation, Science (New York, N.Y.) 300 (2003) 653 –656, http://dx.doi.org/ 10.1016/j.redox.2014.06.001 12714748 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Toledano, S.G. Rhee, Role of sul ﬁredoxin as a regulator of peroxiredoxin function and regulation of its expression, Free RadicalBiology & Medicine 53 (2012) 447 –456, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Toledano, J.C. Drapier, Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages, Journal of Biological Chemistry 282 (2007)36199 –36205, http://dx.doi.org/10.1016/j.redox.2014.06.001 17921138 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Toledano, J.C. Drapier, Nitric oxide activates an Nrf2/sul ﬁredoxin anti- oxidant pathway in macrophages, Free Radical Biology and Medicine 51 (2011) 107–114, http://dx.doi.org/10.1016/j.redox.2014.06.001 21466852 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"53 (2011) 945 –953, http://dx.doi.org/10.1016/j.redox.2014.06.001 21319188 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[17] J. Fang, T. Nakamura, D.H. Cho, Z. Gu, S.A. Lipton, S-nitrosylation of peroxir- edoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson ’s disease, Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 18742 –18747, http://dx.doi.org/10.1016/j.redox.2014.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Forman, M. Torres, Redox signaling in macrophages, Molecular Aspects of Medicine 22 (2001) 189 –216, http://dx.doi.org/10.1016/j.redox.2014.06.001 11679166 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Immunology 13 (2013)349–361, http://dx.doi.org/10.1016/j.redox.2014.06.001 23618831 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Zmijewski, Q. Li, J.R. Lancaster Jr., Dinitro- syliron complexes and the mechanism(s) of cellular protein nitrosothiol formation from nitric oxide, Proceedings of the National Academy of Sciences of the United States of America 106 (2009) 4671 –4676, http://dx.doi.org/ 10.1016/j.redox.2014.06.001 19261856 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Winyard, Hydrogen sul ﬁde and in ﬂammation: the good, the bad, the ugly and the promising, Expert Review of Clinical Pharmacology 4 (2011) 13 –32,http://dx.doi.org/10.1016/j.redox.2014.06.001 22115346 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[22] S. Singh, R. Banerjee, PLP-dependent H(2)S biogenesis, Biochimica et Biophy- sica Acta 1814 (2011) 1518 –1527, http://dx.doi.org/10.1016/j.redox.2014.06.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Chung, Hydrogen sul ﬁde inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macro- phages stimulated with lipopolysaccharide, Free Radical Biology & Medicine 41 (2006) 106 –119, http://dx.doi.org/10.1016/j.redox.2014.06.001 16781459 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[25] J.K. Park, P. Kostka, Fluorometric detection of biological S-nitrosothiols, Analytical Biochemistry 249 (1997) 61 –66, http://dx.doi.org/10.1016/j.redox.2014.06.001 9193709 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[26] K. Abbas, S. Riquier, J.C. Drapier, Peroxiredoxins and sul ﬁredoxin at the crossroads of the NO and H 2O2signaling pathways, Methods in Enzymology 527 (2013) 113 –128, http://dx.doi.org/10.1016/j.redox.2014.06.001 23830628 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Winterbourn, Rapid reaction of hydrogen sul ﬁde with the neutrophil oxidant hypochlorous acid to generate polysul ﬁdes, Chemical Research in Toxicology 23 (2010) 1541 –1543, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Snyder, Hydrogen sul ﬁde-linked sulfhydration of NF- κB mediates its antiapoptotic actions, Molecular Cell 45 (2012) 13 –24, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Picot, V. Quesniaux, C. Bouton, J.C. Drapier, Signaling events leading to peroxiredoxin 5 up-regulation in immunostimulated macro-phages, Free Radical Biology & Medicine 47 (2009) 794 –802, http://dx.doi.org/ 10.1016/j.redox.2014.06.001 19540914 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Marks, HDAC6 is a speci ﬁc deacetylase of peroxiredoxins and is involved in redox regulation, Proceedings of the National Academy of Sciencesof the United States of America 105 (2008) 9633 –9638, http://dx.doi.org/ 10.1016/j.redox.2014.06.001 18606987 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[33] P.M. Watson, A. Riccio, Nitric oxide and histone deacetylases: a new relation- ship between old molecules, Communicative & Integrative Biology 2 (2009) 11–13,http://dx.doi.org/10.1016/j.redox.2014.06.001 19704855 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Stamler, Regulation by S-nitrosylation of protein post- translational modi ﬁcation, Journal of Biological Chemistry 287 (2012) 4411 –4418, http://dx.doi.org/10.1016/j.redox.2014.06.001 22147701 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Stamler, Identi ﬁcation of S-nitrosylated targets of thioredoxin using a quantitative proteomic approach, Biochemistry 49 (2010) 6963 –6969, http://dx.doi.org/10.1016/j.redox.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[36] A. Martínez-Ruiz, S. Lamas, Detection and proteomic identi ﬁcation of S-nitrosylated proteins in endothelial cells, Archives of Biochemistry and Biophysics 423 (2004) 192 –199, http://dx.doi.org/10.1016/j.redox.2014.06.001 14871481 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Arnér, M. Benhar, Multi- level regulation of 2-Cys peroxiredoxin reaction cycle by S-nitrosylation,Journal of Biological Chemistry 288 (2013) 11312 –11324, http://dx.doi.org/ 10.1016/j.redox.2014.06.001 23479738 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[38] H. Wang, M. Xian, Chemical methods to detect S-nitrosation, Current Opinion in Chemical Biology 15 (2011) 32 –37,http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Payne, Identi ﬁcation of S-nitrosylated proteins after chronic exposure of colon epithelial cells to deoxycholate, Proteomics 6 (2006) 1654 –1662, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Ho, Comprehensive identi ﬁcation and modi ﬁed-site mapping of S-nitrosylated targets in prostate epithelial cells, PloS One 5 (2010) e9075, http://dx.doi.org/10.1016/j.redox.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"De La Mata, J. Muntané, A. Rodríguez-Ariza, Alteration of S-nitrosothiol homeostasis and targets for protein S-nitrosation in human hepatocytes, Proteomics 8 (2008) 4709 –4720, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Wink, Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide, Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 8894 –8899, http://dx.doi.org/10.1016/j.redox.2014.06.001 15178764 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Thomas, Nitric oxide and cancer therapy: the emperor has NO clothes, Current Pharmaceutical Design 16 (2010) 381 –391, http://dx.doi.org/ 10.1016/j.redox.2014.06.001 20236067 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Handy, Homocysteine and glutathione peroxidase-1, Antioxidants and Redox Signaling 9 (2007) 1923 –1940, http://dx.doi.org/ 10.1016/j.redox.2014.06.001 17822368 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Ketterer, D.W. Jacobsen, Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine, Journal of Biological Chemistry 276 (2001) 30111 –30117, http://dx.doi.org/10.1016/j.redox.2014.06.001 11371573 .S.",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"E .R a b b a n i ,M .M u l l i n s ,D .S i n g e l ,J .L o s c a l z o , Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen, Journal of Clinical Investigation 91 (1993) 308 –318, http://dx.doi.org/10.1016/j.redox.2014.06.001 8380812 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Tew, A novel role for human sul ﬁredoxin in the reversal of glutathionylation, Cancer Research 66 (2006) 6800 –6806, http://dx.doi.org/10.1016/j.redox.2014.06.001 16818657 .",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"[51] M. Sikora, ŁMarczak, J. Kubalska, A. Graban, H. Jakubowski, Identi ﬁcation of N- homocysteinylation sites in plasma proteins, Amino Acids 46 (2014) 235 –244, http://dx.doi.org/10.1016/j.redox.2014.06.001 24292153 .",OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
"Glushchenko, D.W. Jacobsen, Molecular targeting of proteins by L-homocys- teine: mechanistic implications for vascular disease, Antioxidants & Redox Signal-ing 9 (2007) 1883 –1898, http://dx.doi.org/10.1016/j.redox.2014.06.001 17760510 .S.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/main.PMC4085344.pdf
http://dx.doi.org/10.1016/j.redox.2014.04.009,OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1021/tx025671k  ,  12641432  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/   S0022- 510X(98)00042-  2 , 9588853  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1089/ars.2009.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1146/annurev.bi.52.070183.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1006/cimm.1995.1144  ,  7543373  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1046/j.1471-4159.1999.0720751.x  , 9930749  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1039/   P19910001907  .,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/0891-5849(91)   90192-6  , 1937131  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/j.freeradbiomed.2004.06.009  , 15288117  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1007/BF02536025  .,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1161/   hq0701.092135  , 11451748  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1161/01.RES.0000119171.44657.45  ,  14752028  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1146/annurev.ph.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1042/   BJ20031049  , 14616092  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/S0008-  6363(03)00425-  5 , 12909314  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/   S0098- 2997(03)00015-  3 , 12892998  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/S0098-  2997(03)00018-  9 , 12893001  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.1007/BF02545311  .,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1021/   ja100399m  , 20408520  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/   10.1002/mnfr.200800131  , 19006094  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.2174/157017806776611818  .,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/   S0163- 7827(03)00014-  6 , 12689622  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1161/ATVBAHA.107.153742  ,  17872449  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/   10.1172/JCI115499  , 1752940  .",Non-OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2010.05.011  , 20685357  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
"http://dx.doi.org/10.1016/j.taap.2014.01.001  , 24423726  .",OADS,/arxiv_data1/oa_pdf/8e/13/main.PMC4085345.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
CellsContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.06.005 2213-2317/ &2014 Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Michaelis, N. Weissmann, S. Dimmeler, A.M. Shah, R. P. Brandes, Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase, Circulation Research 110 (2012) 1217 –1225, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Zweier, S-glutathionylation uncouples eNOS andregulates its cellular and vascular function, Nature 468 (2010) 1115 –1118, http://dx.doi.org/10.1016/j.redox.2014.06.005 21179168 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Channon, Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease, Nitric Oxide: Biology andChemistry/Of ﬁcial Journal of the Nitric Oxide Society 25 (2011) 81 –88, http://dx.doi.org/10.1016/j.redox.2014.06.005 21550412 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Hawkins, Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypo-chlorous and hypothiocyanous acids, Free Radical Research 46 (2012) 975 –- 995, http://dx.doi.org/10.1016/j.redox.2014.06.005 22348603 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Sollott, Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanyinginduction of the mitochondrial permeability transition in cardiac myocytes,Journal of Experimental Medicine 192 (2000) 1001 –1014, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 11015441 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Bateman, L. Trimble, J. Sanghara, R. Pollex, C. Ramachandran, M.J. Gresser, Z. Huang, Catalytic inactivation of protein tyrosine phosphatase CD45 and protein tyrosine phosphatase 1B by polyaromatic quinones, Biochemistry 43 (2004) 4294 –- 4303, http://dx.doi.org/10.1016/j.redox.2014.06.005 15065873 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Winterbourn, Reconciling the chemistry and biology of reactive oxygen species, Nature Chemical Biology 4 (2008) 278 –286, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 18421291 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Immunoblot detection with antibodies speci ﬁc for the hyperoxidized cysteine-containing sequence, Journal of Biological Chemistry 278 (2003) 47361 –47364, http://dx.doi.org/10.1016/j.redox.2014.06.005 14559909 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[16] P. Eaton, Protein thiol oxidation in health and disease: techniques for measuring disul ﬁdes and related modi ﬁcations in complex protein mixtures, Free Radical Biology & Medicine 40 (2006) 1889 –1899, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 16716890 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[17] J.R. Winther, C. Thorpe, Quanti ﬁcation of thiols and disul ﬁdes, Biochimica et Biophysica Acta 1840 (2014) 838 –846, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Newton, R. Dorian, E.M. Kosower, Analysis of biological thiols: Derivatization with monobromotrimethylammoniobimane and characteriza-tion by electrophoresis and chromatography, Analytical Biochemistry 107(1980) 1 –10,http://dx.doi.org/10.1016/j.redox.2014.06.005 6449160 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Fahey, Analysis of biological thiols: derivatization with monobromobimane and separation by reverse-phase high-perfor-mance liquid chromatography, Analytical Biochemistry 114 (1981) 383 –387, http://dx.doi.org/10.1016/j.redox.2014.06.005 7304929 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Lucy, HPLC simultaneous analysis of thiols and disul ﬁdes: on-line reduction and indirect ﬂuorescence detection without derivatization, Analyst 129 (2004) 710 –713, http://dx.doi.org/10.1016/j.redox.2014.06.005 15284913 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Stamler, Detection of protein S- nitrosylation with the biotin-switch technique, Free Radical Biology &Medicine 46 (2009) 119 –126, http://dx.doi.org/10.1016/j.redox.2014.06.005 18977293 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Van Eyk, Cysteine oxidative posttranslational modi ﬁcations: emerging regulation in the cardi- ovascular system, Circulation Research 112 (2013) 382 –392, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[24] M. Sakoh-Nakatogawa, S. Nishikawa, T. Endo, Roles of protein-disul ﬁde isomerase-mediated disul ﬁde bond formation of yeast Mnl1p in endoplasmic reticulum-associated degradation, Journal of Biological Chemistry 284 (2009)11815 –11825, http://dx.doi.org/10.1016/j.redox.2014.06.005 19279007 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"cysteine residues, Methods in Molecular Biology (Clifton, NJ) 966 (2013) 325 –336, http://dx.doi.org/10.1016/j.redox.2014.06.005 23299744 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[26] J.R. Burgoyne, P. Eaton, Contemporary techniques for detecting and identify- ing proteins susceptible to reversible thiol oxidation, Biochemical SocietyTransactions 39 (2011) 1260 –1267, http://dx.doi.org/10.1016/j.redox.2014.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Kim, R.T. Raines, Dibromobimane as a ﬂuorescent crosslinking reagent, Analytical Biochemistry 225 (1995) 174 –176, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[28] J.R. Burgoyne, P. Eaton, Detecting disul ﬁde-bound complexes and the oxidative regulation of cyclic nucleotide-dependent protein kinases by H 2O2, Methods in Enzymology 528 (2013) 111 –128, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 23849862 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[30] J.P. Brennan, R. Wait, S. Begum, J.R. Bell, M.J. Dunn, P. Eaton, Detection and mapping of widespread intermolecular protein disul ﬁde formation during cardiac oxidative stress using proteomics with diagonal electrophoresis,Journal of Biological Chemistry 279 (2004) 41352 –41360, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 15292244 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[31] J.P. Brennan, S.C. Bardswell, J.R. Burgoyne, W. Fuller, E. Schröder, R. Wait, S. Begum, J.C. Kentish, P. Eaton, Oxidant-induced activation of type I proteinkinase A is mediated by RI subunit interprotein disul ﬁde bond formation, Journal of Biological Chemistry 281 (2006) 21827 –21836, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 16754666 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[33] O. Prysyazhna, O. Rudyk, P. Eaton, Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension, Nature Medicine18 (2012) 286 –290, http://dx.doi.org/10.1016/j.redox.2014.06.005 22245782 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Botnar, P. Eaton, Protein kinase G oxidation is a major cause of injury during sepsis,Proceedings of the National Academy of Sciences 110 (24) (2013) 9909 –9913, http://dx.doi.org/10.1016/j.redox.2014.06.005 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[35] O. Rudyk, O. Prysyazhna, J.R. Burgoyne, P. Eaton, Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1alpha knockin mouse, Circula- tion 126 (2012) 287 –295, http://dx.doi.org/10.1016/j.redox.2014.06.005 22685118 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Stamler, A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans, Nature 410 (2001) 490 –494, http://dx.doi.org/10.1016/j.redox.2014.06.005 11260719 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Stamler, Regulated protein deni- trosylation by cytosolic and mitochondrial thioredoxins, Science (New York,NY) 320 (2008) 1050 –1054, http://dx.doi.org/10.1016/j.redox.2014.06.005 18497292 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Stamler, Thioredoxin-interacting protein(Txnip) is a feedback regulator of S-nitrosylation, Journal of BiologicalChemistry 284 (2009) 36160 –36166, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Shokat, Human carbonyl reductase 1 is an S-nitrosoglutathione reductase, Journal of BiologicalChemistry 283 (2008) 35756 –35762, http://dx.doi.org/10.1016/j.redox.2014.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Freeman, R. Radi, Xanthine oxidase- mediated decomposition of S-nitrosothiols, Journal of Biological Chemistry 273(1998) 7828 –7834, http://dx.doi.org/10.1016/j.redox.2014.06.005 9525875 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Molecular Cell Biology 6 (2005) 150 –166, http://dx.doi.org/10.1016/j.redox.2014.06.005 15688001 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Stamler, S-nitrosylation in cardiovas- cular signaling, Circulation Research 106 (2010) 633 –646, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 20203313 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Chen, Methods for detection and characterization of protein S-nitrosylation, Methods (San Diego, Calif.) 62(2013) 138 –150, http://dx.doi.org/10.1016/j.redox.2014.06.005 23628946 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Dennehy, D.C. Liebler, H. Ischiropoulos, Identi ﬁcation of S-nitrosylation motifs by site-speci ﬁc mapping of the S-nitrosocysteine proteome in human vascular smoothmuscle cells, Proceedings of the National Academy of Sciences of the UnitedStates of America 103 (2006) 7420 –7425, http://dx.doi.org/10.1016/j.redox.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Durán, A. Beuve, Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylylcyclase contribute to nitrate tolerance, Circulation Research 103 (2008) 606 –614, http://dx.doi.org/10.1016/j.redox.2014.06.005 18669924 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Snyder, Protein S-nitrosylation: a physiological signal for neuronal nitric oxide, Nature CellBiology 3 (2001) 193 –197, http://dx.doi.org/10.1016/j.redox.2014.06.005 11175752 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Gladwin, Copper depen- dence of the biotin switch assay: modi ﬁed assay for measuring cellular and blood nitrosated proteins, Free Radical Biology & Medicine 44 (2008)1362 –1372, http://dx.doi.org/10.1016/j.redox.2014.06.005 18211831 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Stamler, A protein microarray-based analysis of S-nitrosylation, Proceedings of the National Academy of Sciences of theUnited States of America 106 (2009) 18948 –18953, http://dx.doi.org/10.1016/ j.redox.2014.06.005 19864628 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Casey, Site-speci ﬁc analysis of protein S-acylation by resin- assisted capture, Journal of Lipid Research 52 (2011) 393 –398, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[52] R. Marouga, S. David, E. Hawkins, The development of the DIGE system: 2D ﬂuorescence difference gel analysis technology, Analytical and Bioanalytical Chemistry 382 (2005) 669 –678, http://dx.doi.org/10.1016/j.redox.2014.06.005 15900442 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Carroll, The redox biochemistry of protein sulfenylation and sul ﬁnylation, Journal of Biological Chemistry 288 (2013) 26480 –26488, http://dx.doi.org/10.1016/j.redox.2014.06.005 23861405 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Carroll, Sulfenic acid chemistry, detection and cellular lifetime, Biochimica et Biophysica Acta 1840 (2014) 847 –875, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 23748139 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[57] A.T. Saurin, H. Neubert, J.P. Brennan, P. Eaton, Widespread sulfenic acid formation in tissues in response to hydrogen peroxide, Proceedings of theNational Academy of Sciences of the United States of America 101 (2004)17982 –17987, http://dx.doi.org/10.1016/j.redox.2014.06.005 15604151 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Freeman, B. Alvarez, Sulfenic acid formation in human serum albumin by hydrogen peroxide andperoxynitrite, Biochemistry 42 (2003) 9906 –9914, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 12924939 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[61] C. Maller, E. Schröder, P. Eaton, Glyceraldehyde 3-phosphate dehydrogenase is unlikely to mediate hydrogen peroxide signaling: studies with a novelanti-dimedone sulfenic acid antibody, Antioxidants & Redox Signaling 14(2011) 49 –60,http://dx.doi.org/10.1016/j.redox.2014.06.005 20518697 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Dick, Polysul ﬁdes link H2S to protein thiol oxidation, Antioxidants & Redox Signaling 19 (2013) 1749 –1765, http://dx.doi.org/10.1016/j.redox.2014.06.005 23646934 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Molecular Cell Biology 13 (2012) 499 –507, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 22781905 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Mustafa, T. Sen, R. Xu, S. Kim, S. H. Snyder, Hydrogen sul ﬁde-linked sulfhydration of NF- κB mediates its antiapoptotic actions, Molecular Cell 45 (2012) 13 –24,http://dx.doi.org/ 10.1016/j.redox.2014.06.005 22244329 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Janssen-Heininger, in situ analysis of protein S-glutathionylation in lung tissue using glutaredoxin-1-catalyzed cysteine derivatization, American Journalof Pathology 175 (2009) 36 –45,http://dx.doi.org/10.1016/j.redox.2014.06.005 19556513 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Cotgreave, Identi ﬁcation of S-glutathionylated cellular proteins during oxidative stress and constitutive metabolism by af ﬁnity puriﬁcation and proteomic analysis, Archives of Biochemistry and Biophysics 406 (2002) 229 –240, http://dx.doi.org/10.1016/j.redox.2014.06.005 12361711 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Kiley, G. Storz, Exploiting thiol modi ﬁcations, PLoS Biology 2 (2004) e400, http://dx.doi.org/10.1016/j.redox.2014.06.005 15547642 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Souza, R. Radi, Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite, Archives of Biochemistry and Biophysics 360 (1998) 187 –- 194, http://dx.doi.org/10.1016/j.redox.2014.06.005 9851830 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Kang, K. Kim, S.G. Rhee, Reversing the inactivation of peroxiredoxins caused by cysteine sul ﬁnic acid formation, Science (New York, N.Y.) 300 (2003) 653 –656, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 12714748 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Iguchi-Ariga, H. Ariga, Establishment of speci ﬁc antibodies that recognize C106-oxidized DJ-1, Neuroscience Letters 404 (2006) 166 –169, http://dx.doi.org/10.1016/j.redox.2014.06.005 16781058 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Signi ﬁcant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients, Neuroscience Letters 465 (2009) 1–5,http://dx.doi.org/10.1016/j.redox.2014.06.005 19733211 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Freeman, Formation and signaling actions of electrophilic lipids, Chemical Reviews 111 (2011) 5997 –6021, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Darley-Usmar, Methods for imaging and detecting modi ﬁcation of proteins by reactive lipid species, Free Radical Biology & Medicine 47 (2009) 201 –212, http://dx.doi.org/10.1016/j.redox.2014.06.005 19446632 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Oh, N. Giles, A. Landar, V. Darley-Usmar, Accumulation of 15-deoxy-delta (12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects onpotency for intracellular antioxidant defence induction, Biochemical Journal 411 (2008) 297 –306, http://dx.doi.org/10.1016/j.redox.2014.06.005 18237271 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Darley-Usmar, Cellular mechanisms of redox cell signalling: role of cysteine modi ﬁcation in controlling antioxidant defences in response to electrophilic lipid oxidation products, Biochemical Journal 378 (2004) 373 –382, http://dx.doi.org/10.1016/j.redox.2014.06.005 14616092 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Cole, Electro-philic tuning of the chemoprotective natural product sulforaphane, Proceed- ings of the National Academy of Sciences of the United States of America 107 (2010) 9590 –9595, http://dx.doi.org/10.1016/j.redox.2014.06.005 20439747 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Freeman, Detection and quanti ﬁcation of protein adduction by electrophilic fatty acids: mito- chondrial generation of fatty acid nitroalkene derivatives, Free RadicalBiology & Medicine 46 (2009) 1250 –1259, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Molecular Cell Biology 8 (2007) 74 –84,http://dx.doi.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Bernard, M.J. Shattock, W. Fuller, The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation, Journal of Biological Chemistry 286 (2011) 36020 –36031, http://dx.doi.org/10.1016/j.redox.2014.06.005 21868384 .",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Burcham, Modi ﬁed protein carbonyl assay detects oxidised membrane proteins: a new tool for assessing drug- and chemically-induced oxidative cell injury, Journal of Pharmacological and Toxicological Methods 56 (2007) 18–22,http://dx.doi.org/10.1016/j.redox.2014.06.005 17395496 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Levine, Quanti ﬁcation of protein carbonylation, Methods in Molecular Biology (Clifton, N.J.) 965 (2013) 265 –281, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 23296665 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Butter ﬁeld, N. Gagliano, Oxidative damage in human gingival ﬁbroblasts exposed to cigarette smoke, Free Radical Biology & Medicine 52 (2012) 1584 –1596, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[94] M. Fedorova, N. Kuleva, R. Hoffmann, Identi ﬁcation, quanti ﬁcation, and functional aspects of skeletal muscle protein-carbonylation in vivo during acute oxidative stress, Journal of Proteome Research 9 (2010) 2516 –2526, http://dx.doi.org/10.1016/j.redox.2014.06.005 20377239 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[95] Y. Yang, J. Loscalzo, S-nitrosoprotein formation and localization in endothe- lial cells, Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 117 –122, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Murphy, Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing, Mechanisms of Ageing and Development 126 (2005) 982 –986, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Murphy, Speci ﬁc modi ﬁcation of mitochondrial protein thiols in response to oxidative stress: a proteomics approach, Journal of Biological Chemistry 277 (2002) 17048 –17056, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Murphy, Using exomarkers to assess mitochondrial reactive species in vivo, Biochimica et Biophysica Acta (BBA) –General Subjects 1840 (2014) 923 –930, http://dx.doi.org/10.1016/j.redox.2014.06.005 23726990 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Belousov, Genetically encoded ﬂuorescent redox sensors, Biochimica et Biophysica Acta 1840 (2014) 745 –756, http://dx.doi.org/ 10.1016/j.redox.2014.06.005 23726987 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Dick, Fluorescent protein-based redox probes, Antioxidants & Redox Signaling 13 (2010) 621 –650, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Belousov, HyPer-3: a genetically encoded H(2)O(2) probe with improved performance for ratiometric andﬂuorescence lifetime imaging, ACS Chemical Biology 8 (2013) 535 –542, http://dx.doi.org/10.1016/j.redox.2014.06.005 23256573 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Dick, Real-time imaging of the intracellular glutathione redox potential, Nature Methods 5 (2008) 553 –559, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Belousov, Genetically encoded ﬂuorescent indicator for imaging NAD (þ)/NADH ratio changes in different cellular compartments, Biochimica et Biophysica Acta 1840 (2014) 951 –957, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"[106] P. Niethammer, C. Grabher, A.T. Look, T.J. Mitchison, A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebra ﬁsh, Nature 459 (2009) 996 –999, http://dx.doi.org/10.1016/j.redox.2014.06.005 19494811 .",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
"Misgeld, Multiparametric optical analysis of mitochondrial redox signals during neuronal physiology and pathology in vivo, Nature Medicine 20 (2014) 555 –560, http://dx.doi.org/10.1016/j.redox.2014.06.005 24747747 .O.",OADS,/arxiv_data1/oa_pdf/92/ed/main.PMC4085346.pdf
http://dx.doi.org/10.1016/j.redox.2014.02.008,OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1159/000328798  , 21860212  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/j.biocel.2006.07.001  , 16978905  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/   S0047- 6374(97)00076-  6 , 9379714  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1089/ars.2005.7.385  , 15706085  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1101/gad.13.1.76  , 9887101  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1006/bbrc.1997.6943  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1093/toxsci/kfn267  ,  19129213  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"Pickett, The rat quinone reductase  antioxidant  response   element-identiﬁcation  of nucleotide  sequence  required  for basal and in-  ducible activity and detection  of ARE binding proteins in hepatoma  and non-  hepatoma  cell lines, Journal of Biological  Chemistry  270(41) (1995) 24468– 24474. http://dx.doi.org/10.1074/jbc.270.41.24468  , 7592662  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1093/   nar/gkq212  , 20460467  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1074/jbc.M300931200  , 12682069  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1128/MCB.24.16.7130-7139.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1038/sj.onc.1205905  ,  12360409  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/   10.1038/sj.onc.1204506  , 11439354  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"844 Anuranjani,  M. Bala / Redox Biology 2 (2014) 832–846   of cysteine to serine in the DNA binding region of Nrf2 decrease  its ca-  pacity to upregulate  ARE mediated  expression  and antioxidant  induction  of  NAD(P)H:Quinone  oxidoreductase  1 gene, Oncogene  21(14) (2002) 2191– 2200. http://dx.doi.org/10.1038/sj.onc.1205288  , 11948402  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1128/MCB.26.8.2887-2900.2006  , 16581765  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1046/j.1365-2443.2001.00469.x  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1128/MCB.25.24.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/   10.1073/pnas.0914036107  , 20133743  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1128/MCB.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1128/MCB.23.22.8137-8151.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1128/MCB.25.3.1089-1099.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/   10.1128/MCB.25.11.4501-4513.2005  , 15899855  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/   10.1073/pnas.0308347100  , 14764898  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1083/jcb.200909017  , 20065088  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"Park, S.G. Kim, Phosphatidylinositol  3-kinase  regulates   nuclear translocation  of NF-E2 related factor 2 through actin rearrangement   in response  to oxidative  stress, Molecular  Pharmacology  62(5) (2002) 1001– 1010. http://dx.doi.org/10.1124/mol.62.5.1001  , 12391262  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1074/jbc.M307633200  , 12947090  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/   jbc.M206911200  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1074/jbc.M206530200  , 12145307  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1080/   03602530600971974  , 17145701  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1096/fj.10-171553  ,  21097520  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"Koistinaho,T.Malm,  Review“targeting  glycogensyn-   thase kinase-3  βfor therapeutic  beneﬁt against oxidative  stress in Alzheimer  ’ s  disease: involvement  of the Nrf2-ARE  pathway”,  International  Journal of  Alzheimer  ’ s Disease 2011(985085)  (2011) 9. http://dx.doi.org/10.4061/2011/   985085 .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.M110.121863  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1074/jbc.M111.312694  , 22275372  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1093/   carcin/bgn095  , 18413364  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1074/jbc.M111.274902  , 21990354  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1124/mol.111.073262  , 21873460  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1002/hep.21831  , 17668877  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/   0092- 8674(90)90524-  I , 2185891  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"[83] J. Zhu, S. Petersen,  L. Tessarollo,  A. Nussenzweig,  Targeted  disruption  of NBS1  leads to early embryonic  lethality in mice, Current Biology 11(2) (2001) 105– 109. http://dx.doi.org/10.1016/S0960-  9822(01)00019-  7 , 11231126  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1093/nar/25.15.2985  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/   jbc.273.10.5858  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1667/   0033-7587(2002)158[0486:QDOIID]2.0.CO;2  , 12236816  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"Kastan, DNA damage activates  ATM through intermolecular   autophosphorylation  and dimer dissociation,  Nature 421(6922)  (2003) 499– 506. http://dx.doi.org/10.1038/nature01368  , 12556884  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"ATM and ATR substrate  analysis reveals extensive  protein networks   responsible  to DNA damage, Science (New York, N.Y.) 316(5828)  (2007) 1160– 1166. http://dx.doi.org/10.1126/science.1140321  , 17525332  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.2307/3578920  , 7597148  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1158/1078-  0432.CCR-  10- 1215 , 21088254  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1101/gad.10.19.2401  , 8843193  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1073/   pnas.152053599  , 12097646  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1006/bbrc.1998.0139  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/S0039-  6060(99)70182-  0 , 10455911  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1126/science.285.5425.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1084/jem.192.4.565  ,  10952726  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1002/art.21398  ,  16255056  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1002/art.10859  , 12687539  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.M110.128348P  .,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1089/ars.2010.3356  , 20969478  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1074/jbc.M113.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1083/jcb.200304135  , 14744997  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1093/cvr/cvq373  , 21113057  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1074/jbc.M111.299685  , 21990362  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1182/   blood- 2002- 05- 1300 , 12456506  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1038/337471a0  , 2464767  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1006/cbir.1995.1087  ,  7543787  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1074/jbc.274.13.8455  ,  10085077  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/S0006-  291X(02)02670-  0 ,  12445828  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1038/sj.cdd.4401107  , 12478469  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1084/   jem.192.9.1373  , 11067885  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/j.cell.2005.09.022  , 16325585  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1038/nrd2488  , 18404150  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/   S1074- 7613(01)00232-  1 , 11728344  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1093/nar/   gks612 , 22735704  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.4161/cc.8.20.9565  ,  19806015  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"DNA damage acti-  vates a complex  transcriptional  response  in murine lymphocytes  that includes  both physiological  and cancer predisposition  program,  BMC Genomics  14(1)  (2013) 163. http://dx.doi.org/10.1186/1471-  2164- 14- 163 .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/   10.1073/pnas.1207718109  , 23045680  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1016/j.freeradbiomed.2012.04.019  , 22609006  .",OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"[155] H. Pan, H. Wang, X. Wang, L. Zhu, L. Mao, The absence of Nrf2 enhances  NF-  kB dependent  inﬂammation  following  scratch injury in mouse primary cul-  tured astrocytes,  Mediators  of Inﬂammation  2012 (2012) 9. http://dx.doi.org/   10.1155/2012/217580  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
"http://dx.doi.org/10.1002/ptr.3613  , 21971692  .",Non-OADS,/arxiv_data1/oa_pdf/73/f4/main.PMC4085347.pdf
http://dx.doi.org/10.1016/j.redox.2014.05.002,OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1056/   NEJMra067279  , 17989387  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1111/1440-1681.12068  , 23414429  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1542/peds.112.5.e359  , 14595077  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1056/   NEJM196702162760701  , 5334613  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1016/S0006-  2952(00)00440-  8 , 11008123  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
http://dx.doi.org/10.1097/MPG.,Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1016/j.jpeds.2007.04.029  , 17643781  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
http://dx.doi.org/10.1124/jpet.,Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"[17] J.C. Lavoie, P. Chessex,  T. Rouleau,  D. Migneault,  B. Comte, Light-induced  byprod-  ucts of vitamin C in multivitamin  solutions,  Clinical Chemistry  50 (2004) 135– 140. http://dx.doi.org/10.1373/clinchem.2003.025338  , 14709641  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1016/S0891-5849(01)   00480-4  , 11368918  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1016/j.freeradbiomed.2012.10.541  ,  23085223  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1124/jpet.110.166223  ,  20375199  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/   10.1007/s12038-  010- 0026- 2 , 20689178  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1007/   s00894- 008- 0395- 8 , 19593404  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1016/0076-  6879(82)86218-  6 , 6290844  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1016/j.mam.2008.05.005  , 18601945  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.2302/kjm.54.184  , 16452828  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1038/74994  , 10802706  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.3181/0811-  MR- 318 , 19176873  .",Non-OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
"http://dx.doi.org/10.1016/   S0014- 5793(01)02593-  5 , 11445067  .",OADS,/arxiv_data1/oa_pdf/d2/26/main.PMC4085348.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Con ﬂicting data in rodents and the lack of a bene ﬁcial effect of CO inhalation in human volunteers on systemic in ﬂammation [8,9] also questions whether inhalation is the most effective route for CO delivery.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.06.002 2213-2317/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: CO, carbon monoxide; ET-CORM, enzyme-triggered carbon monoxide-releasing molecule; HUVEC, human umbilical vein endothelial cells;VCAM-1, vascular cell adhesion molecule 1; NF κΒ, nuclear factor kappa-light- chain enhancer of activated B-cells; HO-1, haem oxygenase 1; Nrf2, nuclear factor(erythroid-derived); TNF- α, tumour necrosis factor alpha nCorrespondence to: Vth Medical Clinic, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, Mannheim D-68167, Germany.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"References [1] T. Sjostrand, Endogenous formation of carbon monoxide: the CO concentration in the inspired and expired air of hospital patients, Acta Physiologica Scandinavica 22 (1951) 137 –141, http://dx.doi.org/10.1016/j.redox.2014.06.002 14933136 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"[2] T. Sjostrand, The in vitro formation of carbon monoxide in blood, Acta Physiologica Scandinavica 24 (1952) 314 –332, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Forster, Endogenous carbon monoxide production in man, Journal of Clinical Investigation 42 (1963) 1172 –1178, http://dx.doi.org/10.1016/j.redox.2014.06.002 14021853 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"[4] T. Sjostrand, The formation of carbon monoxide by in vitro decomposition of haemoglobin in bile pigments, Acta Physiologica Scandinavica 26 (1952) 328 –333, http://dx.doi.org/10.1016/j.redox.2014.06.002 13007488 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Otterbein, The therapeutic potential of carbon monoxide, Nature Reviews Drug Discovery 9 (2010) 728 –743, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Mayr, A. Spiel, J. Leitner, C. Marsik, P. Germann, R. Ullrich, O. Wagner, B. Jilma, Effects of carbon monoxide inhalation during experimental endotox- emia in humans, American Journal of Respiratory and Critical Care Medicine 171 (2005) 354 –360, http://dx.doi.org/10.1016/j.redox.2014.06.002 15557136 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"[9] M. Stupfel, G. Bouley, Physiological and biochemical effects on rats and mice exposed to small concentrations of carbon monoxide for long periods, Annals of the New York Academy of Sciences 174 (1970) 342 –368, http://dx.doi.org/ 10.1016/j.redox.2014.06.002 5289610 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Mann, R. Foresti, Therapeutic applications of carbon monoxide-releasing molecules, Expert Opinion on Investigational Drugs 14 (2005) 1305 –1318, http://dx.doi.org/10.1016/j.redox.2014.06.002 16255672 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Bernardes, Developing drug mole- cules for therapy with carbon monoxide, Chemical Society Reviews 41 (2012) 3571 –3583, http://dx.doi.org/10.1016/j.redox.2014.06.002 22349541 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"[12] F. Zobi, CO and co-releasing molecules in medicinal chemistry, Future Medicinal Chemistry 5 (2013) 175 –188, http://dx.doi.org/10.1016/j.redox.2014.",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Ford, A photochemical precursor for carbon monoxide release in aerated aqueous media, Inorganic Chemistry 49 (2010)1180 –1185, http://dx.doi.org/10.1016/j.redox.2014.06.002 20039612 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"[17] U. Schatzschneider, Photoactivated biological activity of transition-metal complexes, European Journal of Inorganic Chemistry 2010 (2010) 1451 –1467, http://dx.doi.org/10.1016/j.redox.2014.06.002 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Schmalz, Acyloxybutadiene tricar- bonyl iron complexes as enzyme-triggered co-releasing molecules (ET- CORMs): a structure-activity relationship study, Dalton Transactions 41 (2012) 13862 –13875, http://dx.doi.org/10.1016/j.redox.2014.06.002 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Edition in English) 50 (2011) 2392 –2396, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Yard, Enzyme-triggered co-releasing mole- cules (ET-CORMs): evaluation of biological activity in relation to their structure, Free Radical Biology & Medicine 65 (2013) 78 –88,http://dx.doi.",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Chang, A reaction-based ﬂuorescent probe for selective imaging of carbon monoxide in living cells using a palladium- mediated carbonylation, Journal of the American Chemical Society 134 (2012) 15668 –15671, http://dx.doi.org/10.1016/j.redox.2014.06.002 22970765 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Billiar, L. E. Otterbein, Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species, FASEB Journal: Ofﬁcial Publication of the Federation of American Societies for Experimental Biology 21 (2007) 1099 –1106, http://dx.doi.org/10.1016/j.redox.2014.06.002 17264172 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Fan, Carbon monoxide inhalation rescues mice from fulminant hepatitis through improv- ing hepatic energy metabolism, Shock 27 (2007) 165 –171, http://dx.doi.org/ 10.1016/j.redox.2014.06.002 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Fan, Heme oxygenase-1-derived carbon monoxide stimulates adenosine triphosphate generation in human hepato- cyte, Biochemical and Biophysical Research Communications 336 (2005) 898 –902, http://dx.doi.org/10.1016/j.redox.2014.06.002 16154535 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Vieira, Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astro-cytes: Role of Bcl-2, Journal of Biological Chemistry 287 (2012) 10761 –10770, http://dx.doi.org/10.1016/j.redox.2014.06.002 22334654 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"[28] L. Lo Iacono, J. Boczkowski, R. Zini, I. Salouage, A. Berdeaux, R. Motterlini, D. Morin, A carbon monoxide-releasing molecule (CORM-3) uncouples mito- chondrial respiration and modulates the production of reactive oxygenspecies, Free Radical Biology & Medicine 50 (2011) 1556 –1564, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Sun, Effect of carbon monoxide-releasing molecules II-liberated CO on suppressing in ﬂammatory response in sepsis by interfering with nuclear factor kappa B activation, PloS One 8 (2013) e75840, http://dx.doi.org/10.1016/j.redox.2014.06.002 24116078 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Luke, Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney trans- plantation, Kidney International 79 (2011) 1080 –1089, http://dx.doi.org/ 10.1016/j.redox.2014.06.002 21270767 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Fraser, R. F. Potter, G. Cepinskas, Carbon monoxide liberated from co-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced in ﬂammation in the small intestine, In ﬂammation 33 (2010) 92 –100, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Chung, Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells, Biochemical and Biophysical Research Communications 343 (2006) 965 –972, http://dx.doi.org/10.1016/j.redox.2014.06.002 16574070 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
": 1950) 179 (2007) 7840 –7851, http://dx.doi.org/10.1016/j.redox.2014.06.002 18025230 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Hillebrands, I. Mandel, R. Loesel, G. Beck, L. Schilling, P. Schnuelle, B. Yard, CORMs protect endothelial cells during cold preservation,resulting in inhibition of intimal hyperplasia after aorta transplantation in rats, Transplant International: Of ﬁcial Journal of the European Society for Organ Transplantation 23 (2010) 1144 –1153, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Yard, N. Rafat, Inhibition of VCAM-1 expression in endothelialcells by CORM-3: The role of the ubiquitin-proteasome system, p38, and mitochondrial respiration, Free Radical Biology & Medicine 52 (2012) 794 –- 802, http://dx.doi.org/10.1016/j.redox.2014.06.002 22210380 .",OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Green, R. Foresti, R. Motterlini, CORM-3, a carbon monoxide-releasing molecule, alters the inﬂammatory response and reduces brain damage in a rat model of hemor- rhagic stroke, Critical Care Medicine 40 (2012) 544 –552, http://dx.doi.org/ 10.1016/j.redox.2014.06.002 21926571 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Potter, D. D. Fraser, G. Cepinskas, Carbon monoxide-releasing molecule CORM-3 sup- presses vascular endothelial cell SOD-1/SOD-2 activity while up-regulating the cell surface levels of SOD-3 in a heparin-dependent manner, Free Radical Biology & Medicine 49 (2010) 1534 –1541, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"[40] C. Cicala, A. Ianaro, S. Fiorucci, A. Calignano, M. Bucci, R. Gerli, L. Santucci, J. L. Wallace, G. Cirino, NO-naproxen modulates in ﬂammation, nociception and downregulates T cell response in rat Freund ’s adjuvant arthritis, British Journal of Pharmacology 130 (2000) 1399 –1405, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Wallace, G. Caliendo, V. Santagada, G. Cirino, Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346), British Journal of Pharmacology 159 (2010) 1236 –1246, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Wallace, S. Cuzzocrea, A hydrogen sul ﬁde-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury, FASEB Journal: Of ﬁcial Pub- lication of the Federation of American Societies for Experimental Biology 27 (2013) 4489 –4499, http://dx.doi.org/10.1016/j.redox.2014.06.002 23901068 .",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
"Wallace, G. Caliendo, V. Santagada, G. Cirino, S. Fiorucci, Gastrointestinal safety and anti-in ﬂammatory effects of a hydrogen sul ﬁde-releasing diclofe- nac derivative in the rat, Gastroenterology 132 (2007) 261 –271, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8d/f3/main.PMC4085349.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
751Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.06.004 2213-2317/ &2014 The Author.,OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ΔΨ, membrane potential; Drp1, dynamin-related protein-1; GFP, green ﬂuorescent protein; LC3, microtubule-associated protein-1 light chain-3; LTR, LysoTracker Red; 3 MA, 3-methyladenine; MDV, mitochondria-derived vesicle; MFFR, MitoFluor Far Red; mtDNA, mitochondrial DNA; MV633, MitoView 63 3; PAS, preautophagic structure; PI3K, phosphatidylinositol 3-kinase; TMRM, tetramethyrhodamine methyester; TOM20, transporter of the outer membrane -20 ☆This work was supported, in part, by Grants 2 R01 DK37034, 1 R01 DK073336, P30 CA138313, P20 GM103542 and C06 RR015455 from the National Institutes of He alth and Grant 14.Z50.31.0028 from the Russian Federation.",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[3] I. Kim, J.J. Lemasters, Mitochondrial degradation by autophagy (mitophagy) in GFP-LC3 transgenic hepatocytes during nutrient deprivation, American Jour- nal of Physiology: Cell Physiology 300 (2011) C308 –C317, http://dx.doi.org/ 10.1016/j.redox.2014.06.004 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[4] J.J. Lemasters, Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging, Reju-venation Research 8 (2005) 3 –5,http://dx.doi.org/10.1016/j.redox.2014.06.004 15798367 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[5] I. Kim, S. Rodriguez-Enriquez, J.J. Lemasters, Selective degradation of mito- chondria by mitophagy, Archives of Biochemistry and Biophysics 462 (2007) 245–253, http://dx.doi.org/10.1016/j.redox.2014.06.004 17475204 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"A morphometric approach to the kinetics of intracellular degradation by autophagy, Journal of Cell Biology 78 (1978) 152 –167, http://dx.doi.org/ 10.1016/j.redox.2014.06.004 670291 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Klionsky, Autophagy ﬁghts disease through cellular self-digestion, Nature 451 (2008) 1069 –1075, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"47 (2008) 1773 –1785, http://dx.doi.org/10.1016/j.redox.2014.06.004 18393362 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Molecular Cell Biology 12 (2011) 9 –14, http://dx.doi.org/10.1016/j.redox.2014.06.004 21179058 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[11] S. Rodriguez-Enriquez, Y. Kai, E. Maldonado, R.T. Currin, J.J. Lemasters, Roles of mitophagy and the mitochondrial permeability transition in remodeling ofcultured rat hepatocytes, Autophagy 5 (2009) 1099 –1106, http://dx.doi.org/ 10.1016/j.redox.2014.06.004 19783904 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"States of America 107 (2010) 11835 –11840, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Klionsky, Development by self-digestion: molecular mechan- isms and biological functions of autophagy, Developmental Cell 6 (2004) 463–477, http://dx.doi.org/10.1016/j.redox.2014.06.004 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[15] I. Tanida, T. Ueno, E. Kominami, LC3 and autophagy, Methods in Mole- cular Biology (Clifton, N.J.) 445 (2008) 77 –88, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[18] I. Tanida, Autophagosome formation and molecular mechanism of autophagy, Antioxidants & Redox Signaling 14 (2011) 2201 –2214, http://dx.doi.org/ 10.1016/j.redox.2014.06.004 20712405 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Suen, R.J. Youle, Parkin is recruited selectively to impaired mitochondria and promotes their autophagy, Journal of Cell Biology 183 (2008) 795 –803, http://dx.doi.org/10.1016/j.redox.2014.06.004 19029340 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Aggarwal, A.T. Quintanilha, R. Cammack, L. Packer, Damage to mitochondrial electron transport and energy coupling by visible light, Biochimica et Biophysica Acta 502 (1978) 367 –382, http://dx.doi.org/10.1016/j.redox.2014.06.004 656406 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[24] E. Alexandratou, D. Yova, P. Handris, D. Kletsas, S. Loukas, Human ﬁbroblast alterations induced by low power laser irradiation at the single cell level using confocal microscopy, Photochemical & Photobiological Sciences: Of ﬁcial Journal of the European Photochemistry Association and the European Society for Photobiology 1 (2002) 547 –552, http://dx.doi.org/10.1016/j.redox.2014.06.004 12659495 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[25] I. Kim, J.J. Lemasters, Mitophagy selectively degrades individual damaged mitochondria after photoirradiation, Antioxidants & Redox Signaling 14 (2011) 1919 –1928, http://dx.doi.org/10.1016/j.redox.2014.06.004 21126216 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Chu, Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl- 4-phenylpyridinium-induced cell death, American Journal of Pathology 170 (2007) 75 –86,http://dx.doi.org/10.1016/j.redox.2014.06.004 17200184 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Fon, et al., A vesicular transport pathway shuttles cargo from mitochondria tolysosomes, Current Biology 22 (2012) 135 –141, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Shoubridge, H.M. McBride, Reconstitution of mitochondria derived vesicle formation demonstrates selec- tive enrichment of oxidized cargo, PloS One 7 (2012) e52830, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Shutt, H.M. McBride, Staying cool in dif ﬁcult times: mitochondrial dynamics, quality control and the stress response, Biochimica et Biophysica Acta 1833 (2013) 417 –424, http://dx.doi.org/10.1016/j.redox.2014.06.004 .",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[32] W.W. Li, J. Li, J.K. Bao, Microautophagy: lesser-known self-eating, Cellular and Molecular Life Sciences 69 (2012) 1125 –1136, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Macleod, BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy, Molecularand Cellular Biology 27 (2007) 6229 –6242, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Ney, Role of BNIP3 and NIX in cell death, autophagy, and mitophagy, Cell Death and Differentiation 16 (2009) 939 –946, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[38] S. Matsuda, Y. Kitagishi, M. Kobayashi, Function and characteristics of PINK1 in mitochondria, Oxidative Medicine and Cellular Longevity 2013 (2013) 601587, http://dx.doi.org/10.1016/j.redox.2014.06.004 23533695 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Kim, et al., Mitochondria supply membranes for autophagosome biogenesis during starvation, Cell 141 (2010) 656 –667, http://dx.doi.org/10.1016/j.redox.2014.06.004 20478256 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[40] M. Hamasaki, N. Furuta, A. Matsuda, A. Nezu, A. Yamamoto, N. Fujita, et al., Autophagosomes form at ER-mitochondria contact sites, Nature 495 (2013) 389–393, http://dx.doi.org/10.1016/j.redox.2014.06.004 23455425 .",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"[42] T. Cui, C. Fan, L. Gu, H. Gao, Q. Liu, T. Zhang, et al., Silencing of PINK1 induces mitophagy via mitochondrial permeability transition in dopaminergic MN9D cells, Brain Research 1394 (2011) 1 –13,http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
"Gustafsson, R.A. Gottlieb, Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells, Autophagy 6 (2010) 462 –472, http://dx.doi.org/10.1016/j.redox.2014.06.004 20364102 .J.J.",OADS,/arxiv_data1/oa_pdf/15/53/main.PMC4085350.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"They include inhaled corticoster-oids, which may be supplemented with long-acting β2-agonists when necessary, leukotriene antagonists, which are less effectivethan corticosteroids but have no side effects, and monoclonalantibodies such as mepolizumab and omalizumab.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.06.009 2213-2317/ &2014 The authors.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Nijkamp, Reactive oxygen species as mediators in asthma, Pulmonary Pharmacology & Therapeutics 14 (2001) 409 –420, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"induced colitis, Alimentary Pharmacology & Therapeutics 15 (2001) 1989 –- 1999, http://dx.doi.org/10.1016/j.redox.2014.06.009 11736731 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Theil, Ferritin as an iron concentrator and chelator target, Annals of the New York Academy of Sciences 1054 (2005) 136 –140, http://dx.doi.org/ 10.1016/j.redox.2014.06.009 16339659 .",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Richards, et al., Oxidant generation promotes iron sequestration in BEAS-2B cells exposed to asbestos, American Journal of Respiratory Cell and Molecular Biology 34 (2006) 286 –- 292, http://dx.doi.org/10.1016/j.redox.2014.06.009 16272461 .",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[7] J.R. Moloney, R.T. Oliver, HLA antigens, nasal polyps and asthma, Clinical Otolaryngology and Allied Sciences 5 (1980) 183 –189, http://dx.doi.org/ 10.1016/j.redox.2014.06.009 7408219 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[10] S. Schaal, I. Beiran, H. Rozner, I. Rubinstein, M. Chevion, et al., Desferrioxamine and zinc-desferrioxamine reduce lens oxidative damage, Experimental Eye Research 84 (2007) 561 –568, http://dx.doi.org/10.1016/j.redox.2014.06.009 17239855 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[11] D. Vlahakos, N. Arkadopoulos, G. Kostopanagiotou, S. Siasiakou, L. Kaklamanis, et al., Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 pro- duction, ameliorates sepsis in ﬂammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs, Arti ﬁcial Organs 36 (2012) 400 –408, http://dx.doi.org/10.1016/j.redox.2014.06.009 22187937 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[12] S. Bao, M.J. Liu, B. Lee, B. Besecker, J.P. Lai, et al., Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB, American Journal of Physiology: Lung Cellular and MolecularPhysiology 298 (2010) L744 –L754, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Chitambar, Medical applications and toxicities of gallium compounds, International Journal of Environmental Research and Public Health 7 (2010) 2337 –2361, http://dx.doi.org/10.1016/j.redox.2014.06.009 20623028 .",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Oliveira, Desferrioxamine modulates chemically induced T helper 2-mediated autoimmunity in the rat, Clinical and Experi- mental Immunology 135 (2004) 194 –199, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[17] M. Chevion, A site-speci ﬁc mechanism for free radical induced biological damage: the essential role of redox-active transition metals, Free Radical Biology & Medicine 5 (1988) 27 –37,http://dx.doi.org/10.1016/j.redox.2014.06.009 3075945 .",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[18] E. Banin, Y. Morad, E. Berenshtein, A. Obolensky, C. Yahalom, et al., Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard, Investiga tive Ophthalmology & Visual Science 44 (2003) 2966 –2972, http://dx.doi.org/10.1016/j.redox.2014.06.009 12824239 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[19] M. Chevion, L. Chuang, J. Golenser, Effects of zinc-desferrioxamine on Plasmodium falciparum in culture, Antimicrobial Agents and Chemotherapy 39 (1995) 1902 –1905, http://dx.doi.org/10.1016/j.redox.2014.06.009 7486946 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[20] M. Karck, S. Tanaka, E. Berenshtein, C. Sturm, A. Haverich, et al., The push-and- pull mechanism to scavenge redox-active transition metals: a novel concept inmyocardial protection, Journal of Thoracic and Cardiovascular Surgery 121 (2001) 1169 –1178, http://dx.doi.org/10.1016/j.redox.2014.06.009 11385385 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[21] Y. Morad, E. Banin, E. Averbukh, E. Berenshtein, A. Obolensky, et al., Treatment of ocular tissues exposed to nitrogen mustard: bene ﬁcial effect of zinc desferrioxamine combined with steroids, Investigative Ophthalmology & Visual Science 46 (2005) 1640 –1646, http://dx.doi.org/10.1016/j.redox.2014.06.009 15851563 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Lacoste, G. Barnéon, N. Ghavanian, et al., Eosino- philic in ﬂammation in asthma, New England Journal of Medicine 323 (1990) 1033 –1039, http://dx.doi.org/10.1016/j.redox.2014.06.009 2215562 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Twentyman, et al., Mucosal in ﬂammation in asthma, American Review of Respiratory Disease 142 (1990) 434 –457, http://dx.doi.org/10.1016/j.redox.2014.06.009 2200318 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[25] K. Shinagawa, M. Kojima, Mouse model of airway remodeling: strain differ- ences, American Journal of Respiratory and Critical Care Medicine 168 (2003) 959 – 967, http://dx.doi.org/10.1016/j.redox.2014.06.009 12857720 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Gelfand, Insights into the pathogenesis of asthma utilizing murine models, International Archives of Allergy and Immunology 135 (2004) 173 –186, http://dx.doi.org/10.1016/j.redox.2014.06.009 15375327 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Nilsson, M. Bassen, K. Sävman, I. Kjellmer, A simple and rapid method for the determination of “free ”iron in biological ﬂuids, Free Radical Research 36 (2002) 677 –684, http://dx.doi.org/10.1016/j.redox.2014.06.009 12180193 .",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Pérez-Arellano, Iron metabolism in the lower respiratory tract, Thorax 53 (1998) 594 –600, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Torti, Serum ferritin: past, present and future, Biochimica et Biophysica Acta 1800 (2010) 760 –769, http://dx.doi.org/10.1016/j.redox.2014.06.009 20304033 .",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[36] R.K. Watt, The many faces of the octahedral ferritin protein, Biometals: An International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine 24 (2011) 489 –500, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Torti, Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha, Journal of Biological Chemistry 270 (1995) 15285 –15293, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Yang, et al., Alleviation of OVA-induced airway in ﬂammation by ﬂowers of Inula japonica in a murine model of asthma, Bioscience, Biotechnology, and Biochemistry 75 (2011) 871 –876, http://dx.doi.org/10.1016/j.redox.2014.06.009 21597181 .",OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Kruzel, A. Bacsi, B. Choudhury, S. Sur, I. Boldogh, Lactoferrin decreases pollen antigen-induced allergic airway in ﬂammation in a murine model of asthma, Immunology 119 (2006) 159 –166, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[41] I. Rahman, W. MacNee, Oxidative stress and regulation of glutathione in lung inﬂammation, European Respiratory Journal 16 (2000) 534 –554, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Vega, et al., 2-Methoxyestradiol (2-ME) reduces the airway in ﬂammation and remodeling in an experimental mouse model, Clinical Immunology (Orlando, FL) 129 (2008) 313 –324, http://dx.doi.org/10.1016/j.redox.2014.06.009 18793875 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"Foster, A.M. Koskinen, P. Coyle, et al., Altered zinc homeostasis and caspase-3 activity in murine allergic airway in ﬂamma- tion, American Journal of Respiratory Cell and Molecular Biology 27 (2002) 286 –296, http://dx.doi.org/10.1016/j.redox.2014.06.009 12204890 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[45] S. Schaal, I. Beiran, E. Bormusov, M. Chevion, A. Dovrat, Zinc-desferrioxamine reduces damage to lenses exposed to hyperbaric oxygen and has an ameli-orative effect on catalase and Na, K-ATPase activities, Experimental Eye Research 84 (2007) 455 –463, http://dx.doi.org/10.1016/j.redox.2014.06.009 17174302 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
"[46] A. Obolensky, E. Berenshtein, M. Lederman, B. Bulvik, R. Alper-Pinus, et al., Zinc-desferrioxamine attenuates retinal degeneration in the rd10 mousemodel of retinitis pigmentosa, Free Radical Biology & Medicine 51 (2011) 1482 –1491, http://dx.doi.org/10.1016/j.redox.2014.06.009 21824515 .",Non-OADS,/arxiv_data1/oa_pdf/6b/ce/main.PMC4085351.pdf
http://dx.doi.org/10.1016/j.redox.2014.02.007,OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1161/01.CIR.99.10.1355  ,  10077521  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1016/S0300-483X(00)   00209-2  , 10962137  .",OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1016/   S0891- 5849(97)00136-  6 , 9433896  .",OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
http://dx.doi.org/10.1016/j.atherosclerosis.,OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
http://dx.doi.org/10.1016/j.cmet.,OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"Kerppola,  Close encounters  of many kinds: Fos–Jun interactions   that mediate transcription  regulatory  speciﬁcity,  Oncogene  20 (2001) 2438– 2452. http://dx.doi.org/10.1038/sj.onc.1204385  , 11402339  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1016/j.mam.2009.04.001  ,  19371762  .",OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/   10.1046/j.1365-2044.2001.02083.x  , 11493234  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1161/01.CIR.99.23.3063  , 10368126  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1155/S0962935193000031  , 18475499  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1016/S0163-  7827(00)00006-  0 ,  10799717  .",OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1161/01.CIR.102.1.82  ,  10880419  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1016/S0891-5849(99)   00144-6  , 10569640  .",OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"[28] N. Aytan, T. Jung, F. Tamturk,  T. Grune, N Kartal-Ozer,  Oxidative  stress related  changes in the brain of hypercholesterolemic  rabbits, Biofactors  33 (2008) 225– 236. http://dx.doi.org/10.1002/biof.5520330308  , 19478426  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1146/annurev.biochem.67.1.425  ,  9759494  .",OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1002/(SICI)1097-4644(20000315)76:   4 < 596::AID-  JCB8 > 3.3.CO;2-  E , 10653979  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.07.028  , 16973441  .",OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1172/JCI118442  , 8567974  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"Touyz, G. Yao, E. Viel, F. Amiri, E.L. Schiffrin,  Angiotensin  II and endothelin-1   regulate MAP kinases through different  redox-dependent  mechanisms  in hu-  man vascular smooth muscle cells, Journal of Hypertension  22 (2004) 1141– 1149. http://dx.doi.org/10.1097/00004872-  200406000-  00015 , 15167449  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
"http://dx.doi.org/10.1126/   science.1101909  , 15567863  .",Non-OADS,/arxiv_data1/oa_pdf/41/b1/main.PMC4085352.pdf
